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Outline of the thesis 
 
 
In this thesis we report novel studies on the molecular regulation of the transcriptional 
repressor Tel (Translocation Ets Leukemia). Tel is highly evolutionarily conserved, is 
indispensable for development and is of major importance in leukemogenesis. However, its 
mechanism of action remains poorly understood. The aim of this thesis was to gain more 
insight in the mechanisms that underlie the regulation of cell fate by Tel. 
 
The work in this thesis is presented as follows:  
Chapter 1 is an introduction which summarizes the literature about Tel and its Drosophila 
orthologue Yan as it was known prior to the work presented here.  
Chapter 2 shows that Tel is modified by SUMO (Small Ubiquitin-like Modifier) on the 
highly conserved lysine 11 (K11), which serves to inhibit DNA binding of Tel.  
Chapter 3 describes the regulation of Tel and Yan by the F-box protein Fbl6, which 
mediates ubiquitination and subsequent degradation of Tel/Yan. 
Chapter 4 reports that Tel regulates angiogenesis through recruitment of the generic 
corepressor C-terminal Binding Protein (CtBP). This complex integrates intracellular 
Vascular Endothelial Growth Factor (VEGF) signaling and intercellular Delta-like 4 
(Dll4)/Notch signaling. The impact of these findings is discussed in the general discussion 
in Chapter 5. Taken together the work in this thesis provides significant advances in the 
molecular details of Tel regulation. Furthermore, the work in chapter 4 should be of 







































Chapter 1  
General Introduction 
 
Tel is a member of the Ets family of transcription factors 
Genetic control of cell fate is mediated by transcription factors, which maintain or adapt 
gene expression programs in response to the integration of a vast amount of inter- and 
intracellular signals. The family of Ets (E26 translocation specific) transcription factors is 
one of the largest families of transcription factors and they are crucial mediators of 
development, affecting processes as diverse as neuronal development, angiogenesis, 
hematopoiesis, immune response. Importantly, they have been demonstrated to play 
decisive roles in the evolution of disease such as cancer. The defining feature of this family 
is the presence of a highly conserved Ets DNA binding domain (1,2). Currently almost 30 
members have been identified in mammals which have been classified into 9 subfamilies of 
related genes, based upon homology in their Ets domain (Figure 1) (2-4). One subset 
contains a second conserved domain, the SAM (Sterile Alpha Motif) domain, which is 
often involved in protein-protein interactions (1,2,5).  
The Ets family is highly evolutionarily conserved and has been found in all metozoans. 
This reflects their central position as master regulators of processes in development and cell 
signaling (3,4). Besides their role in physiological processes Ets family members have been 
intensively studied in the context of cancer development. The first Ets genes were 
characterized as oncogenes by retrovirally induced cancers in avian and mouse systems. 
Deregulation of Ets factors, by altered expression or by chromosomal translocations, has 
subsequently often been linked causally to human cancer (6). These important roles in 
development and cancer progression have emphasized the need to understand the molecular 
mechanisms that govern the functions of Ets transcription factors.  Their activity is 
controlled by intricate activating and inhibiting protein networks and many Ets factors have 
been identified as nuclear targets of signaling pathways. Therefore, they are well placed to 
study how signaling networks communicate to define cellular processes.  
12 
 
Ets transcription factors – phylogram     
               Subfamily 
 
Figure 1. Phylogram of Ets transcription factors in humans. Phylogram is a branching diagram                 
(tree) assumed to be an estimate of a phylogeny; branch lengths are proportional to the amount of                      
inferred evolutionary change. The Ets family of transcription factors can be subdivided in 9                         
subfamilies; Tel and Tel-2 are the only members of the Tel-subfamily.  
In this thesis these questions are explored using the Ets transcription factor Tel 
(Translocation Ets Leukemia)/ETV6 as a window into these processes. Whereas most Ets 
family members have been identified as transcriptional activators, Tel takes a unique place 
as a dedicated repressor of gene expression. The tel gene was originally identified at the 
breakpoint of a fusion with the platelet derived growth factor receptor β (PDGFRβ) 
resulting from a chromosomal translocation t(5;12) in a patient with chronic 
myelomonocytic leukemia (7).  Subsequently Tel was found to be involved in many other 
leukemogenic translocations (8). Moreover genetic inactivation of tel in mice leads to 
embryonic lethality because of a yolk sac angiogenesis defect (9).  Consistent with its 
essential role in embryogenesis, Tel is highly conserved in all vertebrates. Tel is only 
distantly related to the majority of Ets family members, exhibiting significant homology to 














Intestinalis) express a Tel orthologue. In Drosophila this orthologue is named Yan and the 
fact that Tel is conserved in Drosophila melanogaster confers significant advantages in 
studying its function: fundamental characteristics in their regulation are likely to be 
conserved and therefore by comparing molecular regulation of Yan and Tel crucial insights 
into their most important functions may be gained.  The fruitfly also provides a very 
powerful in vivo system because it is tractable genetically and biochemically. The ensuing 
introduction will summarize current knowledge of the function of these transcription 
factors.   
Tel and Yan are transcriptional repressors with a conserved Ets DNA binding- and 
SAM domain  
The tel gene is located on chromosome 12p, spanning over 240 kilobases, and containing 8 
exons (13). Tel is highly conserved in metazoan evolution, where the vertebrate gene is 
referred to as tel and the invertebrate gene is called yan (14,15). The genes encode a 
proteins of approximately 60 kDa (Tel) and 80 kDa (Yan), which are both predominantly 
localized in the nucleus (16, 17, 18) . Tel and Yan possess two conserved domains: the Ets 
domain which characterizes all Ets factors, and the SAM domain which is a feature of a 
sub-set of the Ets family of proteins.  A variety of different Ets responsive reporter systems 
have been used to establish that Tel and Yan act as transcriptional repressors and that the 
conserved domains are indispensable for their repressive capability (19,20).   
The Ets domain is approximately 85 amino acids long, consisting of three alpha helices and 
four beta sheets that adopt a so called winged-helix-turn-helix structure (1).  As is 
established for all family members the Ets domain of Tel mediates DNA binding to specific 
GGA sequences, often referred to as Ets binding sites (or EBS). In electrophoretic mobility 
assays (EMSA) this interaction was sensitive to mutations in the GGA core, showing that 
Tel is a sequence specific transcription factor (18).  Reporters that express Luciferase under 
control of EBS have been employed to demonstrate that Tel and Yan repress genes via 
binding to EBS. Interestingly replacing the Ets domain of Tel with the corresponding 
domain of the activator Ets1 did not change the Tel-mutant into an activator, but the 
chimeric protein still acted as a repressor (20). The Ets-domain therefore does not seem to 
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confer any properties required for repression of target genes, besides the requirement to 
bind DNA.  
The determination of amino acids within the Ets domain of Tel that contact the DNA has 
been inferred from crystal structure studies of other Ets family members like Fli1, PU.1, 
GABP ,  SAP-1
 
and Elk-1 (21-25). These studies have demonstrated that 2 highly 
conserved arginines in helix 3 of the Ets domain directly form hydrogen bonds with the 
bases of the GGA sequence.  Accordingly, mutation of these residues in Tel inhibits DNA 
binding and leads to mislocalization of the protein to the cytoplasm, indicating that DNA 
binding is a prerequisite for correct nuclear localization (this thesis Chapter 3).   
 
 
Figure 2. Schematic representation of Tel and Yan protein structures. Tel and Yan are characterized 
by two highly conserved domains, the SAM domain (which mediates protein-protein interactions) and 
the Ets DNA binding domain. 
 
The fact that all Ets transcription factors bind to the same consensus sequence, GGA, which 
consists of only three nucleotides, could imply that all Ets factors can bind (simultaneously) 
to a large part of the genome and poses the fundamental question as to how specificity of 
binding is achieved.  It has been suggested that bases surrounding the GGA core confer 
specificity to binding sites, either by directly mediating interaction with the protein or 
indirectly by creating a structure that facilitates access of the protein to make direct contacts 
with the GGA core.  In an attempt to further characterize flanking bases important for 






TG(/T)A(/C)GGAAGT, which was different from the optimal sequence for binding of Fli-
1, SAP1 or Pu-1(26). This may indeed contribute to achieving Tel specific binding, but this 
requires validation through use of endogenous targets in a cell-based assay or in vivo 
situation. In addition specificity may be mediated by cofactors that direct differential 
binding to specific promoters, but for Tel (and Yan) this has remained underexplored.    
The other conserved domain, the SAM domain consists of approximately 70 amino acids, 
which are structurally ordered into 5 helices (5). SAM domains are generally involved in 
protein-protein interactions and in the case of Tel and Yan it also mediates homotypic 
oligomerization (27-30). Structural studies have revealed that the Tel and Yan SAM 
domains adopt an identical three dimensional structure. Isolated SAM domains form a 
helical oligomer in vitro, which is mediated by hydrophobic interactions between two 
regions of the SAM domain referred to as the mid-loop (ML) surface and the end helix 
(EH) surface. Each ML surface associates with residues in the EH surface of another 
monomer thus Tel/Yan can, in principal, form an open-ended oligomer. Based upon this 
structural model key residues in the ML surface and in the EH surface were mutated. 
Confirming the structural analysis, these mutations yielded monomeric mutants of Tel/Yan 
that were unable to oligomerize. These mutants were defective in repressing transcription 
demonstrating that oligomerization is essential to repressive function (27-29).  It is 
noteworthy that replacing the SAM domain with an unrelated oligomerization domain of 
the Epstein-Barr virus encoded EB1/Zebra resulted in a Tel-mutant that was still able of to 
repress efficiently, suggesting that oligomerization is the main propensity of the SAM 
domain that is required for efficient repression (20). Via oligomerization, Tel is thought to 
repress gene expression by ‘spreading’ over large segments of DNA, thus forming a large 























Figure 3. Repression by Tel and Yan is mediated by oligomeric complexes. Tel and Yan bind to the 
DNA via the Ets domain. The SAM domain mediates selfassociation; the resulting oligomers are 
thought to block access of transcriptional activators to the DNA.  
 
Posttranscriptional regulation  
A variety of different Tel isoforms exist, which result from various posttranscriptional and 
posttranslational regulations.  There are two major isoforms of Tel protein: the full length 
protein and a version herein known as TelM43, which arises from initiation of translation 
from an internal start codon (at position 43) (This thesis Chapter 2; 20).  
Moreover, by alternative splicing at least 5 other isoforms of Tel can be generated.  
Interestingly, some of these transcripts yield isoforms that lack either the SAM- or the Ets 
domain and exhibit dominant-negative effects over full length Tel. A Tel-∆Ets isoform was 
isolated and ectopically expressed. This isoform interacts with full length Tel and can effect 
mislocalization of full length Tel into the cytoplasm (31). Considering the relatively low 
expression of these transcripts, its biological role is not clear, but perhaps these splice 
variants aid the fine tuning Tel function.  
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On the other hand Yan is posttranscriptionally regulated by targeting by a micro-RNA, 
miR7. miR7 binds to binding sites in the 3’UTR of Yan and inhibits protein synthesis of 
Yan. Overexpression of miR7 in the Drosophila eye led to a pronounced decrease of Yan 
protein in progenitor cells.  Conversely in loss of miR7 flies Yan protein levels were 
increased. The control of Yan by miR7 is subject to a reciprocal feedback loop as Yan also 
represses miR7 expression. This regulation correlates with the finding that expression of 
miR7 and Yan is mutually exclusive in the Drosophila eye (32). To date, a similar 
mechanism for regulating Tel has not been reported, however, it is interesting to speculate 




In Drosophila, a combination of genetic, biochemical and molecular biological studies on 
phosphorylation of Yan have provided a firm foundation for the importance of 
posttranslational modifications in modulating the activity of these transcription factors. In 
multiple developmental contexts in Drosophila Receptor Tyrosine Kinase (RTK) signaling 
relays extracellular signals to nuclear effectors, thus guiding cellular proliferation and 
differentiation. Upon activation of the receptor at the cell surface, an intracellular cascade is 
initiated which via the GTPase RAS, eventually results in the phosphorylation of Mitogen 
Activated Protein Kinase (MAPK). In the nucleus, MAPK phosphorylates target proteins, 
and alters the activity of nuclear transcription factors (33). Yan is a direct target of the 
MAPK enzyme and is a central negative regulator of this pathway, inhibiting differentiation 
of progenitor cells by repressing target genes of MAPK signaling (16,17, 19,34,35). Yan 
competes with another Ets transcription factor, the activator Pointed P2, for common 
binding sites in regulatory regions of target genes (36-38). In absence of MAPK signaling 
Yan outcompetes Pointed P2 and represses target genes thus forming a barrier for 
differentiation. To overcome this barrier, MAPK phosphorylates Yan, leading to its nuclear 
export and downregulation. A concomitant phosphorylation of Pointed P2 turns the 
dormant transcription factor into a potent activator, allowing Pointed P2 to activate genes 
that were previously repressed by Yan. This phosphorylation induced ‘switch’ of Ets 
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responsive target genes leads to a transcriptional program required for differentiation 
(16,17,19,34,35).   
Yan contains 9 MAPK consensus sites, of which serine 127 is the crucial, regulatory  
MAPK-phosphorylation site; in Drosophila tissue culture S2-cells, coexpression of Ras 
induces nuclear export of Yan, which is dependent upon phosphorylation by MAPK, as a 
mutant in which all MAPK consensus sites are mutated remains nuclear upon Ras 
stimulation. However mutation of S127 is sufficient to retain nuclear localization. Even so, 
mutation of other sites does affect efficiency of induction of nuclear export. It appears that 
S127 is the major site of phosphorylation but other sites do contribute to modulating the 
activity of Yan (17).  
A crucial mediator of phosphorylation of Yan is Mae (Modulator of the Activity of Ets), 
which was identified as a SAM domain containing protein which serves to facilitate 
phosphorylation of Yan by MAPK (39). A structure based approach has provided crucial 
insight in to the underlying mechanism. The Mae SAM domain interacts with the Yan 
SAM in a similar fashion as Yan SAM self-associates. The ML surface of Mae SAM 
interacts with the EH surface of Yan. However Mae SAM does not contain an additional 
functional EH surface to interact with an additional Yan (or Mae) subunit and will therefore 
prevent any further oligomerization. Crucially, the affinity of the YanSAM for MaeSAM 
was ~1000 fold higher than for itself. Therefore if Mae is present in stoichiometric excess 
over Yan it can depolymerize the Yan oligomer and thereby abolish repression of gene 
expression by Yan (27). 
Depolymerization of Yan by Mae is required for nuclear export since monomeric forms of 
Yan are constitutively exported from the nucleus even in the absence of Ras/MAPK 
signaling. This can be inhibited by abrogating expression of the nuclear exportin Crm1 by 
RNAi.  Consistently, loss of mae in tissue culture cells and in vivo leads to a failure of Ras-
mediated nuclear export of Yan (40). However, in mediating nuclear export Mae plays a 
dual role; on the one hand it induces depolymerization of Yan, which is required before 
nuclear export can occur. On the other hand it was found to compete for binding of Yan 
with Crm1 in co-precipitation experiments. By doing so Mae controls the equilibrium of 
oligomeric and monomeric forms of Yan by limiting extent of the oligomers, but also by 
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preventing excessive nuclear export of monomers (41). Importantly, phosphorylation by 
MAPK shifts the balance towards binding of Yan to Crm1 over an interaction with Mae, 
thus leading to nuclear export of Yan. Two positive feedback mechanisms now increase the 
availability of Mae to depolymerize Yan. First the pool of Mae proteins that were 
previously bound to the Yan monomers is now free to depolymerize the remaining 
oligomers. Second, Mae itself is a transcriptional target of Yan. An initial inactivation of 
Yan derepresses mae expression, which can subsequently act to enforce further Yan 
depolymerization and subsequent nuclear export (41,42).   
 Although not as intensively studied as phosphorylation of Yan, it appears that Tel activity 
is also under control of phosphorylation events. Even though none of the consensus 
MAPK-sites of Yan appear to be obviously conserved in Tel, it has been shown that Tel 
does respond to MAPK signaling by Extracellular signal regulated kinase (ERK), which 
was shown to induce phosphorylation of Tel in cooperation with Epidermal Growth Factor 
(EGF). Tel does contain several putative MAPK-phosphorylation sites and mutational 
analysis delineated the main ERK responsive sites as serine 213 and 257. As Yan is 
sensitized for downregulation, phosphorylation by ERK also appears to serve to 
downregulate Tel function in mammals. In reporter assays addition of ERK and EGF 
inhibited repression of Tel and this correlated with a decrease in DNA binding in vitro. 
Also, a phosphomimicking mutant exhibited a phenotype similar to ERK stimulated Tel 
and was shown to act as a dominant negative over wild type Tel, indicating that 
phosphorylated Tel may also influence unphosphorylated Tel (43).  
Another member of the MAPK superfamily, P38 (a stress induced kinase) was also shown 
to phosphorylate Tel preferentially at S257. Similar to the effect of ERK, P38 
phosphorylation also attenuated trans-repressive activity of Tel. The influence of P38 on 
Tel regulation also indicates that Tel function is sensitive to cellular stress; in agreement 
with this notion various conditions that induce cellular stress and hence P38 activation, like 
serum starvation or addition of hypertonic saline, asinomycin and sodium arsenite, inhibited 
Tel repressive function (44). It is likely that Tel is phosphorylated by a number of different 
kinases, perhaps dependent upon the cellular context.  By example in both of these studies 
another site, serine 22, was shown to have profound effects on the phosphorylation status of 
Tel, as a single alanine mutation of S22 abolished phosphorylation of Tel in the absence of 
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ectopically induced kinase activity (43-44). Therefore, it is conceivable that a large fraction 
of Tel is constitutively phosphorylated on S22 by an as of yet unidentified kinase.    
SUMOylation 
Besides being regulated by phosphorylation, Tel is also posttranslationally modified by 
conjugation with SUMO (Small Ubiquitin-like Modifier). Sumoylation has emerged as a 
major strategy of modifying the activity of a large variety of proteins, many of which are 
transcription factors. A first link between Tel and Sumoylation was established when UBC9 
(Ubiquitin Conjugating enzyme 9) was identified as a protein that interacts with Tel in a 
yeast-2-hybrid screen. Like ubiquitin, SUMO is also conjugated to target proteins by a 
cascade of E1 (activating),E2 (conjugating) and E3 (ligating) enzymes and UBC9 is the 
sole SUMO E2-conjugating enzyme in mammals. The interaction of Ubc9 involves binding 
to the SAM domain and relieves repression by Tel (45).  Indeed, later work demonstrated 
that Tel is modified by SUMO-1, which requires the presence of the SAM domain. 
Coexpression of SUMO-1 induced a change in subcellular localization of Tel, albeit in a 
small percentage of the cells. Whereas in the majority of cells Tel is found diffusely in the 
nucleus in these cells Tel colocalizes with SUMO-1 in nuclear bodies. It was proposed that 
lysine 99 (K99) was the substrate for modification by Tel, as mutation of this residue led to 
a decrease in sumoylation (46).   
Sumoylation was also suggested to be involved in nuclear export of Tel. In mouse 
embryonic fibroblast cells (NIH-3T3 cells) a substantial amount of Tel was found in the 
cytoplasmic fraction of cell lysates. The cytoplasmic fraction strongly decreased after 
Leptinomycin B-treatment, which inhibits the active export of proteins from the nucleus, 
indicating a conserved role for Crm1 in nuclear export of Tel and Yan.  The TelK99R 
mutant exhibited a more nuclear distribution than the wildtype Tel, which correlated with 
an increased ability to trans-repress a luciferase reporter (47). It remains to be investigated 
how generalized these findings are since in the majority of reports Tel was found almost 
exclusively in the nucleus, which may imply that NIH-3T3 cells do not provide an accurate 
model for studying effects on Tel localization. It has been postulated that the SUMO-1 
induced Tel bodies serve as docking stations that prepare Tel for nuclear export but the 
evidence for this remains sparse. In this respect it may be of interest that the tyrosine kinase 
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v-Src was implicated in regulating Tel localization. Ectopic expression of v-Src led to a 
relocalization of Tel to the cytoplasm and led to a relief of repression by Tel. The 
downstream effectors were not identified leaving the possibility open that v-Src regulates 
Tel localization in a SUMO-dependent fashion. Interestingly Tel M43 was not affected in 
its localization by v-Src implying that an important feature of the first 42 aminoacids 
determines v-Src responsiveness and thereby impinges on differential Tel regulation (48).  
 
Tel recruits various corepressors to mediate repression of target genes 
There are a number of ways by which Tel might execute repression of gene expression. As 
described above, Tel can inhibit gene expression by the formation of homotypic oligomers 
which bind DNA and thus block access for transcriptional activators. However, its 
repressive action is not explained solely by a physical barrier to activation: the precise 
mechanism of how Tel mediates repression seems to be a far more complex process as Tel 
has been shown to recruit a number of different co-repressors which are involved in altering 
chromatin structure.   
Co-immunoprecipitations and gene reporter studies have highlighted that Tel recruits the 
related co-repressors NCOR (Nuclear Corepressor), SMRT (silencing mediator of retinoid 
and thyroid hormone receptors) and mSin3A  (49-54). The interactions with these co-
repressors can confer repressive function to isolated domains of Tel in reporter assays; 
mSin3A binds to Tel via the SAM domain (50), whereas Smrt (49,53) and NCOR(52,54) 
bind via regions in the central part of the protein. NCOR and SMRT were originally 
identified as repressors of unliganded Nuclear Receptors, but associate with a wide number 
of transcription factors, thus impinging upon many aspects of development and 
homeostasis. They also interact with each other, with mSin3A and many chromatin 
remodeling enzymes, such as histone deacetylases (HDACs). A body of evidence indicates 
that all components can enhance repression by Tel, which was largely shown by reporter 
assays (49-54). In one study it was also shown that mSin3A and NCOR can synergistically 
cooperate to augment repression (54). 
The hierarchy of these corepressors is not well characterized; for example it is unclear 
whether NCOR, SMRT or both are generally recruited by Tel. One study has reported that 
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NCOR readily interacts with Tel, but SMRT does not in vitro (54). Recently, this was 
disputed by a report describing repression of inflammatory genes in macrophages, where 
Tel specifically recruits SMRT to Ets binding sites in regulatory regions of target genes.  In 
contrast NCOR was not found to be associated with promoter regions containing Ets 
binding sites, but apparently has a preference for AP1 binding sites. Subsequently, Tel was 
shown to have a much higher affinity for SMRT than for NCOR.  Upon activation of 
macrophages by lipopolysaccharide (LPS), a component of the outer membrane of bacteria) 
the association with DNA of the Tel/SMRT complex was strongly reduced, allowing pro-
inflammatory genes to be derepressed (53).  It will be interesting to decipher other signaling 
cues that mediate derepression of the Tel complex. 
 
In light of the fact that these corepressors are associated with HDACs, a role for HDACs in 
Tel regulation was investigated.  Here, Tel was also found to associate with HDAC3, but 
not with other HDACs.  The dependence on HDAC activity is emphasized by the fact that 
the histone deacetylase inhibitor trichostatin A (TSA) has been shown to inhibit Tel 
mediated repression of the mouse mmp3 gene, stromelysin-1. The repression of mmp3 by 
ectopic expression of Tel coincided with a decrease in acetylated Histone H3 association 
with the stromelysin-1promoter. Furthermore, in a functional assay, Tel mediates 
aggregation of NIH-3T3 cells, which was also inhibited by TSA. Collectively, these data  
indicate that Tel repression is mediated by histone deacetylation (52).  
 
In contrast, another reported corepressor for Tel is Tip60 (60 kDa trans-acting regulatory 
protein of HIV type 1 (Tat)-interacting protein), which is a Histone Acetyl Transferase 
(HAT) and was identified in a yeast-2-hybrid assay using Tel as bait. This interaction seems 
to require the ETS DNA binding domain of Tel and the C-terminus of Tip60, and 
overexpression of Tip60 enhances repression. The involvement of Tip60 did not mediate 
direct acetylation of Tel itself, but may acetylate associated histones (55,56).  The 
repressive complex recruited by Tel thus seems to contain histone deacetylases and histone 





Besides the HDAC dependent cofactors, the  Polycomb protein L3MBT (lethal(3)malignant 
brain tumor), which reportedly inhibits gene expression independent from histone 
deacetylation, is also linked to Tel. L3MBT contains a SAM domain which binds to the Tel 
SAM domain. L3MBT was further shown to augment repression by Tel (57). L3MBT is a 
part of a subfamily of polycomb proteins containing a SAM domain. Interestingly, one 
family member called Polyhomeotic forms helical oligomers which structurally strongly 
resemble the Tel oligomers (58). Since Polycomb proteins are found in large multiprotein 
repressive complexes it would be tempting to speculate that Tel is part of this family of 
repressors which are classified by their function, but not by any specifically shared 
properties in sequence or structure. However, Tel does not seem to localize to specific loci 
in the nucleus, nor does it associate with Rae28, the mouse Polyhomeotic (20). 
 
 
Binding partners of Tel 
Gene expression results from a balancing of the actions of activating and repressive 
transcription factors either by competitive occupancy of common promoter elements or 
through direct protein:protein interactions. This has been shown to be an important mode of 
regulation of the activity of the Ets family (59). In this context, the relationship between Tel 
and Fli-1, a context-dependent Ets transcriptional activator, may prove to be very 
significant as Fli-1 has been implicated in processes that require Tel function as well, i.e. 
hematopoiesis and angiogenesis. There is evidence that Tel represses expression of fli1 
(20), but it may also interact with the Fli1 protein (60,61). This interaction seems to inhibit 
Fli-1 mediated transactivation of megakaryocytic specific promoters. Further experiments 
demonstrated that Fli-1 overexpression induced the K562 erythroleukemia cell line to 
differentiate along the megakaryocytic lineage, but expressing the combination of Fli-1 and 
Tel reversed this phenotype (60). Both Tel and Fli-1 are required for the survival of the 
megakaryocytic lineage in vivo (9,62) but in cell culture systems Tel inhibits whereas Fli-1 
stimulates megakaryocytic differentiation (60,63).  Tel may associate with Fli-1 to provide 
regulated expression of common target genes during megakaryocyte differentiation. This 
combinatorial regulation may not be restricted to megakaryocyte regulation as both Tel and 
Fli-1 are expressed in vascular endothelial cells (This thesis Chapter 4; 64).   
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 Another Ets factor that forms a complex with Tel is the recently identified Tel-2. Tel-2 is 
the closest human relative to Tel, exhibiting an overall 50% homology in primary amino 
acid sequence. The conserved SAM domain and Ets domain are regions of highest 
homology (resp 63% and 88% identical residues) (11).  As may be expected from the 
sequence analysis Tel2 binds to core Ets binding sites and can act as a repressor. 
Interestingly, Tel2 can selfassociate and was also able to associate with Tel via the SAM 
domains (10,12). Since both related proteins act as repressors it would not be inconceivable 
that Tel and Tel2 act together in a repressive complex. The only data available on Tel/Tel2 
regulation actually suggests the opposite since Tel2 was shown to relieve inhibition of Ras-
induced cellular transformation by Tel (65). Whereas Tel is ubiquitously expressed, the 
expression of Tel2 is more restricted to a small set of tissues including hematopoietic cells 
(10-12). Therefore Tel2 will not be required in each cell type to regulate function of Tel, 
but may function in a tissue-specific fashion.  
 
Biological role of Yan and Tel in development and disease  
Tel is widely, perhaps ubiquitously, expressed during development and in adult tissues (9), 
and has also been detected in a variety of human cancer cell lines (18). In contrast, Yan 
expression seems to be associated with undifferentiated cells in Drosophila 
(16,17,35,66,67). The biological roles of Yan and Tel have largely been inferred from loss 
and gain of function studies in Drosophila and mice. Loss of these factors leads to 
embryonic lethality suggesting that Tel and Yan are essential for normal development (9, 
68). Specific roles will be described below. In the first section I shall highlight some of the 
roles of Yan during Drosophila development. In the next section I shall do likewise for the 
role of Tel in mouse development. Finally, I shall suggest ways in which these roles are 
conserved with important implications for the role of Tel in human disease.  
Regulation of differentiation in Drosophila 
The best characterized system requiring Yan function in vivo is photoreceptor development 
of the Drosophila eye. The adult eye consists of ~800 repeating units called ommatidia. 
Each ommatidium contains 20 cells, which consist of eight photoreceptor cells, four 
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nonneural cone cells, and eight other accessory cells. At the larval stage, development of 
ommatidia occurs in a well-defined sequence of differentiation steps, whereby a monolayer 
of epithelium called the eye imaginal disc gives rise to all specialized cells. A wave of 
differentiation progresses from posterior to anterior across the eye imaginal disc led by an 
indentation called the morphogenetic furrow. This process is governed by intricate 
intercellular signals, as each differentiating cell induces its neighbor to adopt a certain cell 
fate. Receptor Tyrosine Kinase signaling via at least 2 pathways, namely the Epidermal 
Growth Factor Receptor (EGFR) and the sevenless (sev) pathway, is instrumental in 
establishing the various ommatidial cell fates. The differentiated cells generally express 
RTK ligands that activate RTK signaling in the neighboring cells, who respond through 
activating the phosphorylation cascade that activates ERK/MAPK (32,69) .  As previously 
described, a key event in response to MAPK-signaling is a rapid downregulation of Yan 
resulting in a transition from repression to activation of differentiation genes, which is also 
mediated by the activation of Pointed P2 (70,71).  
 
During larval stage, yan expression is strong in uncommitted cells of the eye imaginal disc 
but declines as soon as they start differentiating into the specialized cells of the 
ommatidium (16).  
Moreover, loss of Yan induces aberrant differentiation of photoreceptors, most of which 
exhibit R7 specific markers and this leads to a rough eye structure (16,68). This phenotype 
was suppressed in pointed defective mutants and enhanced by mutating Ras indicating that 
Yan opposes Ras/MAPK activation (16,19,3,17). The link between Ras/MAPK signaling 
and Yan was further substantiated by expressing Yan
ACT
, which is deficient in MAPK 
phosphorylation sites, in an eye-specific context. Yan
ACT
  is highly stable, and flies 
expressing Yan
ACT 
exhibit severe eye defects, namely a strongly reduced eye size and a 
total lack of normal ommatidial structures. Also Yan
ACT 
protein is still detected in cells 
posterior to the morphogenetic furrow, where normally endogenous Yan is downregulated. 
These cells are devoid of the neuronal marker Elav indicating that ectopic expression of 
Yan
ACT  
induces a block in photoreceptor differentiation (17).  Combined with the tissue 
culture data, which demonstrated that Yan was phosphorylated and exported upon 
Ras/MAPK signaling, these studies have established that Yan must be downregulated by 




At the transcriptional level, Yan activity in the Drosophila eye is at the intersection of the 
Notch and RTK signaling pathways. Notch signaling is a highly conserved pathway, 
consisting of a transmembrane receptor, which is signaled to via a variety of intercellular 
ligands. Notch signaling restricts cellular differentiation during Drosophila eye 
development (69). The major downstream effector of Notch signaling, the transcription 
factor Suppressor of Hairless (Su(H)) was shown to be required for Yan expression in the 
developing eye and reduction of Su(H) enhanced the eye phenotypes of mutant yan alleles. 
Analysis of the yan promoter identified a 122 bp eye-specific enhancer region containing 3 
consensus binding sites that were bound by Su(H). Within one of these sites an Ets binding 
site was found, which was bound by Pointed in EMSA. Moreover Pointed was able to 
compete with Su(H) for binding to the enhancer region.  A reporter which placed lac Z 
expression under the control of the yan enhancer region faithfully recaptures yan expression 
in the eye disc. This yan enhancer exhibited reduced activity in response to ectopic 
expression of Pointed, while loss of Pointed induced the opposite effect. This work 
suggests that activation of RTK signaling downregulates Yan via 2 complementary 
mechanisms:  
a posttranslational mechanism that mediates rapid downregulation of the pre-existing pool 
of Yan proteins and a posttranscriptional mechanism that presumably enables long term 
attenuation of yan transcription (72). On the other hand Notch signaling may regulate yan 
expression via multiple levels, which may work in concert with various negative feedback 
loops; while Su(H) is required for Yan expression other downstream effectors of Notch 
were able to repress the yan enhancer (72). This negative regulation of Yan by Notch 
signaling has also been demonstrated by genetic interactions as extra copies of Notch were 
able to enhance a loss of Yan phenotype (67). 
 
The requirement for Yan is not restricted to a role in the developing eye; Yan also acts as 
an inhibitor of differentiation in various mesodermal and ectodermal cell types. Expression 
of Yan is high in embryonic ectoderm and mesoderm, but is undetectable in tissues derived 
from these germlayers such as the central nervous system (ectoderm), or muscles and guts 
(mesoderm). In addition, ectopic expression of Yan
ACT  
inhibited mesodermal and neuronal 




Embryonic lethality in Yan null alleles results from massive head defects, as apparent by a 
large hole in the dorsoanterior region. This phenotype is associated with a loss of 
differentiation of dorsal head ectoderm, a region that normally gives rise to the visual 
system, the medial parts of the brain and the epidermis of the head (67). Furthermore Yan is 
associated with patterning of cell fate along the dorso-ventral axis. During Drosophila 
embryonic development cells respond to gradients of morphogens by alterations in genetic 
profile. This allows the establishment of multiple cell types, which can subsequently give 
rise to different tissues or structures in the adult animal. The EGFR pathway is involved in 
a variety of these decisions. In the ventral ectoderm it specifies the cell fate along a 
dorsoventral axis, and can be summarized as leading to ventral or lateral cell fate induction.  
In this context Yan suppresses ventral fate by repressing ventral markers orthodenticle 
(otd), argos (aos) and tartan (trn). EGF signaling operates in a dorsoventral gradient; 
therefore the ventral most cells receive high EGF signaling which derepresses Yan 
presumably by a similar mechanism as in the developing eye. This allows activation of the 
ventral genes by Pointed.  Loss of Yan broadens the zone of cells that maintain a 
‘lateral’gene expression profile, whereas Yan
ACT
 was able to restrict the number of cells 
that acquire a ventral phenotype. Thus Yan ensures a graded response to EGF signaling 
(35).  
 
Finally, Yan acts downstream of Drosophila Jun N-terminal Kinase (D-JNK), another 
member of the family of MAPKs. JNK is an essential mediator of dorsal closure. After 
germband  retraction a hole is left in the dorsal surface of the epidermis of the embryo. 
Dorsal closure involves the migration of both sides of the epidermis until they meet in the 
middle and fuse to seal the inner embryo. JNK signaling plays a central role in dorsal 
closure and induces a variety of downstream effectors such as the TGF-beta homologue 
decapentaplegic. Mutant DJNK exhibits a strong defect in dorsal closure, but this 
phenotype is suppressed in a mutant yan background. Overexpression of Yan
ACT
  in the 
lateral epithelium led to embryonic lethality because of an inability to effect dorsal closure. 
As DJNK can phosphorylate Yan in vitro, it appears that JNK fulfills a similar role in 
downregulating Yan during dorsal closure as ERK does during photoreceptor development 
(73).  Interestingly dorsal closure has been used as a model for closure of the epidermis in 
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wound healing; this may be of particular relevance in the context of Tel, which not only has 
been shown to regulate epithelial invasive processes but may also be involved in all other 
key processes of wound healing, such as aggregation of platelets (since Tel is required for 
survival of the megakaryocytic lineage), inflammation (where dynamic regulation of Tel is 
required for macrophage activation) and angiogenesis (which is defective in Tel knockout 
mice) (9,53,74). Thus, Tel could be of crucial importance during the whole process of 
wound healing.  
 
Role of Tel during mouse embryo development 
Hematopoiesis 
In the original Tel knockout mice study, the specific role of Tel in developmental processes 
could not be satisfactorily studied because loss of tel leads to embryonic lethality. However, 
it was established that Tel was indispensible  for early embryonic hematopoiesis; progenitor 
cells derived from yolk sacs of Tel knockout mice were tested for their ability to form 
erythroid or myeloid colonies and exhibited no difference from cells from wild type mice 
(9). In a follow-up study the problem of embryonic lethality was circumvented by 
deploying chimeric mice which were generated by injecting Tel ablated embryonic stem 
(ES) cells in blastocysts of wild type mice. By isolating hematopoietic cells at different 
stages, the contribution of the Tel knockout ES cells would serve to ascertain at which stage 
Tel is required during hematopoiesis. Tel knockout ES cells did not contribute to 
development of any of the hematopoietic lineages or organs (bonemarrow, thymus and 
spleen) in adult mice. By contrast Tel knockout ES cells readily contributed to fetal liver 
hematopoiesis and non-hematopoietic organs like brain, heart, liver, kidney and muscle, 
implying a specific requirement for Tel in adult hematopoiesis (74).  
During development blood formation is initiated at the yolk sac around embryonic day (E) 
7,5. At E11,5 the fetal liver takes over and after birth hematopoiesis mainly occurs in the 
bone marrow, where the pluripotent hematopoietic stem cells reside, which sustain the pool 
of all hematopoietic lineages. Since fetal liver hematopoiesis was unaffected it seemed that 
Tel was required for either migration of hematopoietic stem cells (HSCs) to the bone 
marrow or survival of the HSCs in the bone marrow. Direct insight into this role was 
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provided by an inducible Tel knockout mouse, in which excision of the Tel allele was only 
driven in the adult. Hematopoietic stem cells were strongly reduced over a course of 2 
weeks after loss of Tel was induced.  Indeed bone marrow from the induced Tel knockout 
mice could not rescue lethally irradiated wild type mice by bone marrow transplantation, 
indicating that the pool of HSCs was non-functional. Tel was the first transcription factor, 
which was shown to be strictly required for survival of HSCs (75).  
Furthermore, loss of Tel was induced by lineage specific promoters in adult mice, which 
demonstrated that Tel expression is dispensable for commitment to and survival of the 
erythroid, T-cell and B-cell lineages, but is required for late differentiation of 
megakaryocytes (75). Yet, some data indicates that Tel may still act during certain later 
stages of hematopoiesis. Ectopic expression of Tel was shown to stimulate erythroid 
differentiation in a variety of cell culture systems (76-78), whereas differentiation into the 
megakaryocyte lineage was inhibited and associated with repression of megakaryocyte 
specific genes like GPIIb, GPIalhpa and PF 4(77,63).  Moreover Tel expression has been 
shown to change dynamically during various stages of differentiation (61,77,63,79), which 
collectively seem to suggest that Tel is generally down regulated a few days after 
differentiation. The exception was the megakaryocytic lineage where Tel expression was 
sustained much longer, perhaps again indicating the exclusive requirement in this lineage 
(77).  
A Conserved Role for Tel/Yan in Tubulogenesis? 
Angiogenesis 
Development of branching networks such as the tracheal system in Drosophila and the 
human vasculature may be guided by shared molecular mechanisms. A central pathway is 
reiteratively used to pattern successive branching of the structure. The response is modified 
by genetic feedback mechanisms and other signaling effects to give distinct branching 
outcomes, determining where sprouting will occur and in what direction, size and shape of 
the branch and where along the branch the next branch will sprout (79,80). 
The foundation of the paradigm for tubular morphogenesis was laid in the studies on 
Drosophila tracheal development. The tracheal tubular system is built up by a hierarchical 
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process of branching. Tracheal precursor cells that are in a planar region proliferate and 
migrate to form sacs of approximately 80 cells. From these tracheal sacs the tracheas 
develop by branching into increasingly finer tubes. From each sac 6 primary sprouts will 
develop, where one or two cells bud of and recruit a number of trailing cells to form 
multicellular branches.  Subsequently, each primary branch gives rise to 25 secondary 
branches, which result from single cells sprouting out and wrapping around themselves to 
form unicellular hollow tubes. From each secondary tube numerous terminal branches are 
generated by extending cytoplasmic filopodia that also contain lumens. Terminal branching 
is repeated several times leading to hundreds of terminal filopodia that are derived from one 
cell and eventually connect to internal tissues (81).  
The major pathway guiding these branching processes is the Drosophila Fibroblast Growth 
Factor (FGF) pathway, characterized by the branchless (bnl) ligand (orthologous to human 
FGF) and breathless (btl) receptor (orthologous to human FGF receptor).  In clusters of 
cells surrounding the tracheal sacs Branchless is secreted and is bound by the Breathless 
receptor on receiving tracheal epithelial cells. Activation of the receptor tyrosine kinase 
initiates intracellular Ras/MAPK signaling and leads to sprouting of the primary branches 
that also induces genetic programs that are required for following rounds of sprouting. 
Primary branches grow towards the source of Branchless, which thus acts as a 
chemoattractant. The exposure to Branchless is therefore not equal in all cells that make up 
the branch as the cells that are at the leading edge, the tip cells, receive the highest signal, 
whereas the following stalk cells are subject to a lower signal of Branchless (81,82). These 
graded signals also establish differences in gene expression, most notably high expression 
of breathless in tip cells. Tip cells are especially motile, exhibiting high numbers of 
filopodia, making them excellent sensors of the FGF guidance cue.  The specification of tip 
and stalk cell is essential to controlled development of branches and is further regulated by 
intercellular Notch signaling. Branchless signaling induces expression of Delta, a ligand for 
Notch signaling. Cells that are subjected to the highest concentration of Branchless will 
also express highest amounts of Delta. Delta then activates Notch signaling in neighboring 
cells which suppresses tip cell phenotype. This negative regulation by Notch thus ensures 
that only one cell will be the tip cell at a particular time and position (83).  
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These major regulators (Branchless and Notch) are involved in all phases of branching, 
whereas each phase of branching also involves stage specific mediators (80). Crucially, 
Pointed (the Drosophila orthologue of the human transactivator ETS1) and Yan (the 
Drosophila orthologue of Tel) are also involved in translating the Branchless signal into a 
genetic output, mainly at the stage of secondary and terminal branching. Pointed expression 
is induced, while Branchless also leads to MAPK dependent phosporylation and 
degradation of Yan. This downregulation of Yan is required for activation of genes that 
allow secondary and terminal branching. Yan degradation is specific to tip cells, implying 
that a threshold of Branchless signal must be overcome, which provides a mechanism that 
determines when a new branch will sprout (84).  
Although their roles have not been well-defined it is of interest to note that one of their 
downstream targets is Sprouty(84). Sprouty is an inhibitor of FGF signaling, by an 
incompletely defined mechanism which may involve binding of various signaling 
intermediates of the cascade, such as Grb2, Sos1 or Raf1(84,85). The regulation of Sprouty 
by Yan therefore provides another negative feedback loop that controls the amplitude and 

























Figure 4. Schematic representation of branching morphogenesis in Drosophila tracheal development.  
A portion of a tracheal sac is shown giving rise to increasingly finer branches following successive 
generations of branching. Branching is initiated upon a signal of FGF, which activates MAPK 
signaling in the epithelial cells. This results in activation of Pointed, and a concomitant 
downregulation of Yan, which serves to activate target genes. FGF signaling is counterposed by 
inhibitory intercellular Notch signaling, which allows controlled growth of the developing branch.   
 
If tubulogenesis is conserved then we would expect the molecular mechanisms that guide 
vascular branching of endothelial cells in humans to share a number of features of those 
that orchestrate tracheal development in Drosophila. From an initial primitive vasculature 








network is established by remodeling of this primary network by the process of 
angiogenesis, which involves a large number of subsequent branching steps. The main 
inducing pathway of branching during angiogenesis is Vascular Endothelial Growth Factor 
(VEGF) signaling (85). Just as tracheal cells respond to FGF, endothelial cells similarly 
sprout from existing vessels and migrate towards a source of VEGF. This has been well 
studied in a mouse retinal angiogenesis model where blood vessels develop from a central 
capillary ring and sprout outwardly. VEGF expression was particularly prevalent in the 
avascular periphery and declined in response to the approaching retinal plexus (85,86). 
VEGF further directs specification of tip- or stalk cell phenotype, again by activating 
downstream MAPK signaling, which induces expression of the Notch ligand, Delta- like 4 
(Dll4), which inhibits tip cell fate. In a variety of in vitro and in vivo models, loss of 
Dll4/Notch leads to excessive sprouting, underscoring that Notch signaling is normally 
required for inhibition of tip cell specification during angiogenesis (87).  Thus, the basic 
apparatus regulating the fundamental aspects of endothelial sprouting employs similar 
signaling modules that are vital to tracheal development. Importantly, this conservation 
extends to the level of downstream effectors, as Ets 1, the mammalian homologue of 
Pointed, has been shown to stimulate angiogenesis, while Sprouty 4, one of the mammalian 
homologues of Drosophila Sprouty was shown to inhibit VEGF mediated activation of 
ERK (88). A similar conserved role for Tel in angiogenesis has long been implied by the 
fact that the early lethality of Tel knockout mice results from a lack of development of 
branching vitelline vessels in the yolksac. In a small subset of yolksacs of Tel knockout 
mice an initial vasculature does develop, but eventually regresses (9). The mechanism 
underlying this deficit is not known, but Tel may act in endothelial sprouting by a similar 
mechanism to the regulation of FGF signaling by Yan during tracheal development.  
Cancer development 
 Since its original identification Tel has garnered massive attention for its role in 
leukemogenesis. Currently more than 40 translocations involving Tel have been described 
and they are generally found in a wide variety of hematological malignancies. The fusion 
partners of Tel can be broadly categorized in two classes, namely receptor tyrosine kinases 
(like for example PDGFR2, Abl and JAK) and transcription factors such as AML-1 and 
MN1 (8). Mechanistically, the presence of the SAM domain leads to oligomerization of the 
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fusion protein, which leads to the constitutive activation of the RTK (30). The unrestrained 
signaling via the receptor in turn activates many downstream pathways, which 
collaboratively induce transformation.  
On the other hand, fusion proteins involving transcription factors are presumed to generate 
an inappropriate transcriptional response of target genes of Tel and/or the fusion partner. 
The best characterized chimera is the Tel-AML-1 fusion because of its high occurrence, 
accounting for 25% of all pediatric B-cell Acute Lymphoblastic Leukemia (ALL) (89). 
AML-1 is normally a transcriptional (co-)activator, but the fusion with Tel (which includes 
the SAM and central region) converts it into a repressor. Interestingly, in the majority of 
cases of childhood ALL with the t(12;21) the rearrangement of one allele was found to be 
accompanied by a loss of Tel on the other allele, suggesting that Tel can act as a tumor 
suppressor (90). In the context of translocations where malignancy depends on the 
dimerization properties that the Tel SAM domain confers, it is likely that wild type Tel will 
inhibit homo-oligomerization of the fusion protein by competing for binding.  
There is some evidence that disruption of Tel function effects cellular transformation by 
means other than translocations. By example, there is evidence indicating that Tel may 
function as a tumour suppressor by affecting multiple core processes that are pivotal to 
cancer progression. First, Tel inhibits cell growth of various cell lines by inducing a G1 
arrest (91).  Second, Tel affects cellular adhesion as 2 independent groups have shown that 
Tel induces aggregation of Ras transformed NIH-3T3 cells (91-93). Third, by repressing 
the matrix metalloproteinase MMP3 (/stromelysin 1) Tel affects remodeling of the 
extracellular matrix (ECM) (92). Remodeling of the ECM is an important phase during 
invasion by tumors and upregulation of mmp3 has been associated with metastasis. Tel may 
further affect the status of the ECM by regulating expression of a variety of components 
that make up the ECM such as fibronectin (93).  These effects on the ECM are in line with 
the fact that Tel inhibits focal adhesion formation (94), which depends on ECM remodeling 
and is also a sign of invasiveness. Fourth, Tel can induce apoptosis in certain cell lines via 
repression of the pro-survival gene Bcl-Xl (94) or by mediating upregulation of P53 (95).  
In accordance with these data Tel inhibits tumour growth as assessed by in vitro colony 
formation and matrigel invasion assays. This was further extended in vivo as Tel retarded 
tumour formation of Ras transformed fibroblasts in nude mice. Significantly, similarly 
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sized tumours were less invasive and exhibited less metastasis in the Tel-expressing cells 
(91,92).  
In Drosophila a study of border cell movement also indicates a conserved role for the Tel 
orthologueYan, in invasive processes. Border cells are a defined group of cells that migrate 
from the anterior pole of the ovarian follicular epithelium between other cells (nurse cells) 
to the oocyte boundary during Drosophila oogenesis. Yan is dynamically expressed during 
this process; upon exit of the follicular epithelium yan expression is upregulated via Notch 
and JAK/STAT pathways, which was related to a down regulation of Drosophila E-
Cadherin (DE-Cad) to increase motility of the border cells. Like the well characterized 
human E-Cadherin  DE-Cad plays a crucial role in intercellular adhesiveness. To sustain 
invasive migration between the nurse cells, Yan is down regulated (again by Receptor 
Tyrosine Kinase signaling). The absence of Yan then allows upregulation of DE-Cad, 
which presumably provides interaction between border cells and nurse cells, which is 
required for invasion.  The fact that both loss of Yan and ectopic expression of Yan
ACT
 
result in a delay in border cell migration, implies that a regulated expression of Yan is 
critical in these migratory and invasive movements (93). From these studies, it is reasonable 
to assume that differential expression of Tel may strongly influence tumor progression:  on 
the one hand by regulating tumor invasiveness by regulating remodeling of the EMC and 





Tel and its invertebrate orthologue Yan are firmly established as essential regulators of cell 
fate that are crucial to development. Their activity is fine tuned by a variety of 
(post)transcriptional and especially posttranslational mechanisms, while various cofactors 
have been identified that modulate their activity.  
Current data suggests that the most important modes of regulation for Tel and Yan are 
posttranslational. For Yan it is now well established that signaling via the 
RTK/Ras/MAPK-axis leads to an inactivation of Yan. Downregulation of Yan, as 
exemplified by an absence of Yan in differentiated cells, results at least partially from its 
nuclear export and the mechanisms guiding this nuclear export have been well 
characterized. The consequences of nuclear export or the actual mechanism that lead to a 
loss of Yan protein have been less well-defined. It has been suggested that nuclear export 
leads to degradation of Yan which may be associated with the presence of so-called PEST-
sequences, which are found in proteins with a short half-life. This notion was strengthened 
by the fact that a mutant Yan which lost the PEST sequences exhibited greatly enhanced 
stability and was insensitive to MAPK signaling (17). It will therefore be of great interest to 
dissect the mechanisms regulating degradation of Yan.  
For Tel evidence suggest that phosphorylation and SUMOylation negatively regulate its 
activity. Where phosphorylation leads to an inhibition of DNA binding, SUMOylation 
perhaps regulates localization of Tel. The precise nature of the effect that SUMO mediates 
requires additional research and how this integrates into regulation of gene transcription 
will have to be explored in more detail.  
Tel recruits a number of different co-factors, but the composition of the Tel complex during 
developmental processes is not clear.  Although the initial studies identifying the various 
co-repressors as partners for Tel have been important, they have generally not been 
followed up by studying their role in more detail or in biological systems. The factors 
determining the composition of the complex are likely to be manifold, like cell type, 




In the past, the fruitfly has proved to be a very powerful model system to establish how 
Yan/Tel might orchestrate biological processes. Despite the fact that mouse studies have 
identified that Tel is required for important processes such as hematopoiesis and 
angiogenesis, they have not provided a framework that explains the underlying molecular 
principles. Future work should aim to fill these gaps in the knowledge of Tel and Yan. In 
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Cell proliferation and differentiation are governed by a finely controlled balance between repression and
activation of gene expression. The vertebrate Ets transcriptional repressor Tel (ETV6) and its invertebrate
orthologue Yan, play pivotal roles in cell fate determination although the precise mechanisms by which
repression of gene expression by these factors is achieved are not clearly defined. Here, we report the
identification and characterization of the primary site of sumoylation of Tel, lysine 11 (K11), which is highly
conserved in vertebrates (except Danio rerio). We demonstrate that in cells PIAS3 binds to Tel and stimulates
sumoylation of K11 in the nucleus. Both Tel monomers and oligomers are efficiently sumoylated on K11 in
vitro; but in cells only Tel oligomers are found conjugated with SUMO, whereas sumoylation of Tel monomers
is transitory and appears to sensitize them for proteasomal degradation. Mechanistically, sumoylation of K11
inhibits repression of gene expression by full-length Tel. In accordance with this observation, we found that
sumoylation impedes Tel association with DNA. By contrast, a Tel isoform lacking K11 (TelM43) is strongly
repressive. This isoform results from translation from an alternative initiation codon (M43) that is common
to all Tel proteins that also contain the K11 sumoylation consensus site. We find that PIAS3 may have a dual,
context-dependent influence on Tel; it mediates Tel sumoylation, but it also augments Tel’s repressive function
in a sumoylation-independent fashion. Our data support a model that suggests that PIAS-mediated sumoy-
lation of K11 and the emergence of TelM43 in early vertebrates are linked and that this serves to refine
spatiotemporal control of gene expression by Tel by establishing a pool of Tel molecules that are available
either to be recycled to reinforce repression of gene expression or are degraded in a regulated fashion.
Genetic analyses of Tel (11, 39, 40) and its Drosophila or-
thologue Yan (14, 19, 23, 25) have yielded compelling evidence
that these proteins are unique Ets repressors (14, 17, 19, 23)
that are crucial regulators of progenitor cell differentiation.
Moreover, perturbation of normal Tel function can lead to the
development of cancers, especially leukemias (6, 7, 8), in which
at least 22 translocations involving Tel have been reported. A
model is emerging that suggests that monomers of Tel directly
associate via their conserved SAM (sterile alpha motif) do-
mains and that the resulting DNA-bound oligomers (currently
of indeterminate length) act as a physical barrier to the tran-
scription-activating apparatus (reviewed in references 22, 34,
and 38). However, the exact nature of repression by Tel/Yan is
incompletely defined. In Drosophila, a protein named Mae
(modulator of the activity of Ets) orchestrates Yan derepres-
sion by binding to Yan, thereby disrupting Yan self-association
and binding to DNA, and sensitizing it to mitogen-activated
protein kinase-dependent down-regulation (1, 21, 31, 33).
Hitherto, a similar mechanism of regulation of Tel has not
been uncovered in vertebrates.
A number of recent reports have highlighted the importance
of sumoylation as a generic regulator of protein function (re-
viewed in reference 10), including Tel (4, 42). Currently, an
important focus is the role of PIAS (protein inhibitor of acti-
vated STAT) proteins, which have an intrinsic SUMO E3-
ligase capacity that catalyzes covalent conjugation of SUMO
(small ubiquitin-like modifier) proteins to target substrates
(29). A variety of functions have been ascribed to PIAS pro-
teins that serve to moderate transcriptional activity (30), in-
cluding that of some ETS transcription factor family members
such as Elk-1 (44, 45) and Fli-1 (36). Mammals have four
separate PIAS genes named PIAS1, PIAS2 (also referred to as
PIASx, of which there are two variants, PIASx and PIASx),
PIAS3, and PIAS4 (also referred to as PIAS or PIASy).
Loss-of-function studies in mice of either PIAS1 (16), PIAS2
(26), or PIASy (41) revealed relatively minor phenotypes, and
mice homozygous for the loss of these alleles were viable,
perhaps the result of genetic redundancy. Drosophila has a
single PIAS gene [Su(Var)2-10] that is indispensable for em-
bryo development and viability (3, 9) and that encodes poten-
tially nine different polypeptides (see the FlyBase database
[http://flybase.bio.indiana.edu]).
Deciphering the precise mechanisms of action of Yan/Tel is
important for understanding the control of progenitor cell
differentiation and tissue patterning. Here, we report the iden-
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tification and characterization of a new, conserved Tel sumoy-
lation site. We find that sumoylation of Tel is PIAS-mediated
and serves to limit Tel’s repressive function. Whereas in Dro-
sophila, derepression by Yan is orchestrated by Mae, in verte-
brates Tel function is regulated posttranslationally through
sumoylation of K11 and further modulated posttranscription-
ally, yielding a highly repressive nonsumoylated isoform of Tel.
METHODS AND MATERIALS
MS. Protein bands were excised from sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) gels, reduced, alkylated, and in-gel digested
using trypsin (modified, sequencing grade; Promega) as previously described
(32). For matrix-assisted laser desorption ionization–time of flight (MALDI-
TOF) analysis, tryptic digestions were desalted using C18 ZipTips (Millipore).
Peptides were eluted using approximately 1 l of 10 mg/ml dihydroxybenzoic
acid in 50% acetonitrile–0.1% trifluoroacetic acid directly on a stainless steel
MALDI target plate (Bruker Daltonics, Bremen, Germany). MALDI-TOF anal-
yses were performed on an Ultraflex II time-of-flight mass spectrometer (Bruker
Daltonics, Bremen, Germany) controlled by the Flexcontrol, version 2.0, soft-
ware package. For liquid chromatography-mass spectrometry (LC-MS) analysis,
samples were injected onto a capillary high-performance LC system (Ultimate;
Dionex, Amsterdam, The Netherlands) equipped with a peptide trap column
(Pepmap 100; 0.3-mm internal diameter by 1 mm; Dionex, Amsterdam, The
Netherlands) and an analytical column (Pepmap; 0.075 by 150 mm; Dionex,
Amsterdam, The Netherlands). The mobile phases consisted of 0.04% formic
acid–0.4% acetonitrile (phase A) and 0.04% formic acid–90% acetonitrile (phase
B). A 45-min linear gradient from 0 to 60% mobile phase B was used at a flow
rate of 0.2 l/min. The outlet of the high-performance LC system was coupled to
an HCT IonTrap (Bruker Daltonics, Bremen, Germany) using a nanoelectro-
spray ionization source. The spray voltage was set at 1.2 kV, and the temperature
of the heated capillary was set to 165°C. Eluting peptides were analyzed using the
data-dependent tandem MS (MS/MS) mode over an m/z range of 400 to 1,600.
The five most abundant fragments in an MS spectrum were selected for MS/MS
analysis by collision-induced dissociation using helium as the collision gas.
In vitro sumoylation assays. Glutathione S-transferase (GST)-tagged Tel mu-
tants were sumoylated in Escherichia coli BL21(DE3) by essentially following the
published procedure (35). In vitro translated proteins were sumoylated according
to methods previously described (37).
Cell-based sumoylation assays. Sumoylation assays were adapted from the
established methods (24) with the following modifications. His-Sumo pull-downs
were performed with 50 l of Ni-nitrilotriacetic acid beads (Qiagen) for 3 h at
room temperature in 6 ml of 6 M guanidinium-HCl, 0.1 M Na2HPO4 
NaH2PO4, and 0.01 M Tris-HCl (pH 8.0) plus 20 mM imidazole and 10 mM
-mercaptoethanol (buffer A). The beads were successively washed twice with
1 ml of each of the following buffers: buffer A plus 0.2% Triton X-100, 8 M
urea, 0.1 M Na2HPO4  NaH2PO4, and 0.01 M Tris-HCl (pH 8.0) plus 20 mM
imidazole, 10 mM -mercaptoethanol, and 0.2% Triton X-100 (buffer B); and
a buffer containing 8 M urea, 0.1 M Na2HPO4  NaH2PO4, and 0.01 M
Tris-HCl (pH 6.3) plus 20 mM imidazole, 10 mM -mercaptoethanol, and
0.2% Triton X-100 (buffer C). Sumoylated proteins were eluted in 60 l of
urea sample buffer: 37.5% buffer C, 39.3% Laemmli buffer (3), 20 mM
imidazol, and 3.2% -mercaptoethanol. The samples were boiled and ana-
lyzed by Western blot analysis.
In vivo 35S labeling: pulse-chase experiments. Cells were washed free of
medium and seeded into 6-cm tissue culture dishes (Gibco) for each time point,
in methionine-free Dulbecco’s modified Eagle’s medium (DMEM; Gibco). Cells
were routinely incubated for 3 h, and then the medium was supplemented with
50 Ci of 35S-labeled methionine. After 3 h of labeling, cells were washed free
of label and then incubated in DMEM containing 10% fetal calf serum for the
times indicated in Fig. 1G. Labeled hemagglutinin (HA) epitope-tagged Tel
proteins were immunoprecipitated from the cell lysates as described below.
Immunofluorescence. Cells were grown on glass coverslips and transfected
using Fugene-6 (Roche). Cells were fixed after 24 h with 4% paraformaldehyde
for 15 min at room temperature (RT) (all the following steps were done at RT)
and permeabilized in 0.2% Triton X-100–phosphate buffered saline for 5 min.
Cells were washed with phosphate buffered saline and blocked with 5% goat
serum for 1 h, incubated with primary antibodies for 1 h, washed, and incubated
with secondary antibodies for 30 min. Following extensive washing, cells were
mounted, and immunostaining was visualized with a Leica DM5500 B micro-
scope.
Luciferase reporter. Cells were seeded in 24-well plates and transfected with
0.75 g of Tel, PIAS, or SUMO plasmids along with 2 g of pGL2-TK-ETS
luciferase reporter (where TK is thymidine kinase) (1) and 0.5 g of lacZ
reporter. Cells were lysed 24 h posttransfection, and luciferase activity was
measured using a luciferase assay substrate (Promega). Luciferase activity was
normalized by measuring -galactosidase activity.
Analysis of stromelysin-1 mRNA in stable cell lines. U20S cells were seeded at
40 to 60% confluence in 10-cm tissue culture dishes and transfected with 5 g of
Tel mutant plasmid and 0.5 g of pCDNA3.1 using Fugene (Roche). After 48 h
medium was replaced by medium containing 200 g/ml G418.
After 3 weeks of selection, expression of Tel mutants was confirmed by West-
ern blotting and immunofluorescence. Total RNA from stable cell lines was
prepared using Trizol (Invitrogen) following the manufacturer’s protocol. First-
strand cDNA synthesis was derived from 1 g of total RNA using a TaqMan kit
(Roche) according to the manufacturer’s protocol. Expression levels of strome-
lysin-1 and GAPDH (the glyceraldehyde-3-phosphate dehydrogenase gene) were
determined by quantitative real-time PCR using the following primer sets: 5-C
AAAACATATTTCTTTGTAGAGGACAA and 3-TTCAGCTATTTGCTTG
GGAAA for Stromelysin-1 and 5-TGCCATGTAGACCCCTTGAAG and 3-
ATGGTACATGACAAGGTGCGG for GAPDH. Real-Time PCRs were
performed in 10-l reaction volumes using a 7900 HT Fast Real-Time PCR
System detection apparatus (Applied Biosystems) and Sybr Green PCR Master-
mix (Applied Biosystems) according to the manufacturer’s protocol.
Protein-DNA interaction assays. A total of 50 pmol of biotinylated double-
stranded oligonucleotides harboring three consecutive Ets DNA-binding sites
(Invitrogen) was coupled to My One Streptavidin C1 beads (Invitrogen) accord-
ing to the manufacturer (Invitrogen). Interaction with Tel proteins was assessed
in binding buffer: 20 mM HEPES, 30 mM KCl, 0.1 mH EDTA (pH 8.0), 4 mM
MgCl, 0.8 mM Na2HPO4, 20% glycerol, protease inhibitors, 1 g of dI-dC
competitor, and 4 mM spermidine. Either 100 ng of GST fusion proteins or 10%
of an in vitro translated protein was used. Reactions were performed for 30 min
at RT. The beads were successively washed four times with binding buffer using
a magnetic holder. Associated proteins were eluted in 3 Laemmli buffer and
analyzed by Western blotting following SDS-PAGE.
Cell culture, biochemistry, and molecular biology. Cell lines were cultured in
DMEM supplemented with 10% fetal bovine serum and antibiotics. Cells were
transfected with Fugene-6 (Roche) according to the manufacturer’s protocol. In
general, 1 g of each construct was transfected into cells seeded at 40 to 60%
confluence in a 6-cm dish, and cells were lysed at 24 to 48 h posttransfection.
Tel-HA and Tel-Flag constructs were fused in frame with either an HA or Flag
epitope tag and cloned into the pCS2 expression vector. GST Tel was cloned in
frame with GST in pGEX-2TK vector. Mutants were generated by PCR. For
immunoprecipitations cells were lysed in 1 ml of either ice-cold radioimmuno-
precipitation assay buffer-SDS (1 mM EDTA, 50 mM Tris, pH 8.0, 150 mM
NaCl, 10% glycerol, 1% Triton X-100) or ice-cold protein lysis buffer (50 mM
Tris, pH 7.5, 1% NP-40, 0.1% SDS, 0.5% Na-deoxycholate, 150 mM NaCl) with
protease inhibitors (phenylmethylsulfonyl fluoride, trypsin, pepstatin A, leucine,
and aprotinin) and NaF. Cell lysates were needle treated and centrifuged. Im-
munoprecipitations were carried out with 0.75 l of anti-HA (rabbit polyclonal
antibody to HA tag from Abcam) or anti-Flag (mouse M2 from Sigma Aldrich)
antibody. Generally, lysates were preincubated with the antibody for 1 h, follow-
ing which suitable beads (protein G-Sepharose 4 fast flow [Amersham Pharmacia
Biotech] for mouse Flag immunoprecipitations and protein A-Sepharose [Sigma-
Aldrich] for rabbit HA immunoprecipitations) were added for a further 2-h
incubation. Associated proteins were analyzed by Western blotting. For pull-
down assays, Tel proteins were labeled with [35S]methionine using a TNT-
coupled reticulocyte in vitro translation system (Promega) and incubated with
GST Tel fusions that were immobilized on glutathione-Sepharose beads as
previously described (1).
Antibodies and drugs. The following antibodies were used: anti-Flag mouse
M2 monoclonal (Sigma-Aldrich), anti-HA.11 mouse monoclonal (Covance),
anti-GST rabbit (My Probe), anti-HA rabbit polyclonal (Abcam), anti-Tel rabbit
polyclonal (kindly provided by Ruud Delwel and Olivier Bernard), anti-His
(His1; Sigma), anti-SUMO1 (21C7; Zymed), anti-SUMO-2/3 (AV-SM23-0100;
Eurogentec) (37), and anti-PIAS3 (sc-14017; Santa Cruz) antibodies. For
MG132 experiments cells were incubated with 3 M MG132 (Calbiochem) for
6 h prior to lysis.
RESULTS
Tel is sumoylated on K11. To study how the transcriptional
repressor Tel is regulated, we monitored its posttranslational
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modifications. Figure 1A shows that in cells, a fraction of
endogenous Tel is covalently conjugated with SUMO proteins.
Tel-specific antibodies detect a species of endogenous Tel
whose gel migration is indistinguishable from sumoylated (ec-
topically expressed) Tel. To confirm that this protein was in-
deed sumoylated Tel, we established cell lines that stably ex-
press relatively low levels of His epitope-tagged SUMO-1 or
SUMO-2. This enabled the purification of cellular proteins
that are covalently conjugated with SUMO following denatur-
ing lysis with guanidinium solution. By this means we found
that endogenous Tel was covalently conjugated with both
SUMO-1 and SUMO-2 (Fig. 1A). These findings are consis-
tent with previous analyses that identified Tel as a substrate for
sumoylation (4, 42). To unambiguously identify the site(s) of
sumoylation, we exploited the fact that both SUMO-1 and
SUMO-2 are efficiently, covalently conjugated to Tel in vitro
(Fig. 1B) and performed an MS analysis of the sumoylated and
nonsumoylated fractions of Tel. While K99 of the Tel SAM
domain was previously implicated as a site of sumoylation (4,
42), we found Tel to be predominantly sumoylated on the
N-terminal lysine 11 (K11) (Fig. 1C) (this was also determined
for SUMO-2 [P. J. Hensbergen and D. A. Baker, unpublished
data]) but not on K99. Importantly K11 forms part of a “clas-
sic” sumoylation motif, KXE (where X is any residue and  is
a large hydrophobic amino acid) (24), specifically IKQE, that is
highly conserved in all sequenced vertebrates with the notable
FIG. 1. The highly conserved lysine residue (K11) is the primary
substrate for SUMO conjugation to Tel. (A) Endogenous Tel is
sumoylated. The left panel shows a Western blot of different amounts
of a cell lysate that were prepared from U2OS cells. Tel proteins were
detected with a Tel antibody directed against the C terminus of Tel
(highlighted with arrows) (20). Endogenous Tel proteins were com-
pared with ectopically expressed Tel sumoylated with SUMO-2 as a
control. We established U2OS cell lines stably expressing His epitope-
tagged SUMO-1 or SUMO-2. Sumoylated endogenous Tel was recov-
ered from cells lysed in guanidinium, by nickel bead purification (right
panel) (sumoylation assay). (B) In vitro sumoylation assay. Both
SUMO-1 and SUMO-2 are efficiently, covalently conjugated to Tel
almost exclusively on K11 by one of two methods. Fusions between
GST and either full-length wild-type Tel or full-length Tel in which
lysine at position 11 was mutated to an arginine residue (TelK11-R)
were coexpressed in E. coli along with a SUMO E1-ligase (Aos1 or
Uba2) and a SUMO E2-ligase (Ubc9) either for SUMO-1 or for
SUMO-2 conjugation; proteins were then purified onto glutathione-
Sepharose beads. A Coomassie blue-stained gel shows sumoylated Tel,
which is absent from TelK11-R preparations (highlighted with aster-
isks); the results were confirmed by Western blotting (data not shown).
A complementary study shows in vitro [35S]methionine-translated Tel
proteins that were sumoylated in vitro (37) and then incubated with or
without the active site of a SUMO-protease (Lifesensors). (C) MS
reveals Tel to be sumoylated on K11. In vitro sumoylated and non-
sumoylated Tel were separated by SDS-PAGE and subjected to in-gel
digestion with trypsin. MALDI-TOF MS demonstrated an m/z value of
3,800.9 [MH] within the tryptic digest of Tel-SUMO-1 which was
absent in unsumoylated Tel. This peptide corresponds to the tryptic
peptide of SUMO-1 (trypSUMO-1, ELGMEEEDVIEVYQEQTGG)
conjugated to K11 within the N-terminal tryptic peptide of Tel. As a
control a nonsumoylated tryptic peptide (T128–160; m/z 3,940.0
[MH]) of Tel is shown. The SUMO-1-conjugated peptide was also
identified by LC-iontrap MS (m/z 955.0 [M  4H]4), and its sequence
was subsequently confirmed by MS/MS. (D) K11 forms part of a classic
sumoylation consensus site (KXE; specifically IKQE, underlined)
that is highly conserved in all sequenced vertebrates with the exception
of D. rerio. An alternative initiation codon (M43; underlined) is
present in all Tel proteins also harboring a K11 sumoylation site (and
is absent in D. rerio). Western blotting of cell lysates revealed an
additional Tel protein (indicated with an arrow), approximately 11
kDa larger than unmodified Tel that is lost following mutation of the
sumoylation consensus site, TelK11-R or TelE13-A. Likewise, muta-
tion of K11 abolishes in vitro sumoylation of Tel. (E to G) In cells, K11
is necessary and sufficient for full (detectable) sumoylation of Tel. HA
epitope-tagged versions of wild-type Tel or Tel expressing mutations
that disrupt the sumoylation consensus site, TelK11-R or TelE13-A,
were cotransfected into 293T cells along with His epitope-tagged
SUMO-1 or SUMO-2 (E). Also assayed are two other Tel mutants:
TelK99-R, in which the lysine residue at position 99 has been replaced
with an arginine residue, and TelD101-A, in which the aspartic acid
residue at position 101 has been changed to an alanine residue. A
schematic representation of the mutants tested is included. Sumoy-
lated Tel was recovered from cells lysed in guanidinium by nickel bead
purification. Conditions for immunoprecipitating sumoylated Tel from
cells were optimized (F) to allow in vivo labeling of Tel with [35S]me-
thionine in order to monitor the stability of the pool of sumoylated Tel
(G). IP, immunoprecipitation.
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exception of Danio rerio (Fig. 1D). Significantly, a putative
alternative initiation codon (M43) (20) is present in all known
vertebrate Tel proteins also harboring a K11 sumoylation site
(and is absent in D. rerio). We confirmed that K11 forms part
of a bona fide sumoylation site and is a target for sumoylation
both in vitro and in tissue culture cells. Figure 1B to E show
that whereas wild-type Tel was efficiently sumoylated, Tel mu-
tants that either lack K11 (TelK11-R) or carry a point mutation
in the sumoylation consensus motif (TelE13-R) were almost
completely resistant to SUMO conjugation both in vitro and in
cells. Similar results were obtained using HeLa, U20S, MCF7,
and U937 cells. Consistent with these findings, pulse-chase
experiments in cells revealed a pool of Tel that is sumoylated
on K11 that appears to be at least as stable as nonsumoylated
Tel (Fig. 1F and G). In contrast to previous reports (4, 42), we
found that mutation of K99 of the SAM domain to arginine or
alanine did not abrogate Tel sumoylation (either monomeric
or oligomeric Tel) either in cells (Fig. 1E) or in vitro (M. G.
Roukens, M. Alloul-Ramdhani, D. A. Baker, and P. J. Hens-
bergen, unpublished data). Likewise, disruption of the putative
consensus sumoylation site surrounding K99 as a result of
replacing aspartic acid 101 with alanine (also arginine) (data
not shown) had no significant effect on SUMO-1 and SUMO-2
conjugation (Fig. 1E). Collectively, these data argue that Tel is
efficiently sumoylated and that the primary target of sumoyla-
tion is the highly conserved K11 residue.
K11 of Tel oligomers, but not Tel monomers, is found con-
jugated with SUMO in cells. There is strong molecular evi-
dence that monomers of Tel form homotypic oligomers via the
SAM domain (13). A current model suggests that once bound
to DNA, these oligomers repress gene expression (13, 21, 31,
33). We initiated our analyses of the molecular mechanisms of
Tel sumoylation by first determining whether sumoylation is
common to both Tel monomers and oligomers. To this end we
generated Tel mutants that are unable to self-associate. Figure
2A shows that whereas wild-type Tel efficiently self-associates,
Tel proteins harboring mutations that inhibit SAM domain
oligomerization (13, 21, 31) fail to associate with one another
in cells (Fig. 2A) and in vitro (data not shown). Figure 2B and
C show that in cells, monomeric Tel proteins (containing mu-
tations of helices 2, 3, 4, and 5 but not helix 1 of the SAM
domain) (Fig. 2A) (M. G. Roukens and D. A. Baker unpub-
lished data) are only very weakly sumoylated (42). Rather than
reflecting inefficient sumoylation, the more likely explanation
is that sumoylation of monomers in cells is transient. Strong
evidence for this comes from the fact that monomers are effi-
ciently sumoylated on K11 in vitro (Fig. 2D). Moreover, a pool
of Tel monomers that are efficiently sumoylated on K11 were
readily detected in cells following treatment with proteosome
inhibitors, suggesting that the sumoylating machinery does rec-
ognize Tel monomers (Fig. 2E). These results suggest that in
common with Tel oligomers, monomers of Tel can be effi-
ciently sumoylated but that in cells monomer sumoylation is
transitory and appears to sensitize Tel for proteasomal degra-
dation.
PIAS3 interacts with Tel and promotes sumoylation of K11.
Next, we investigated the mechanisms mediating Tel sumoyla-
tion. PIAS proteins function as E3 ligases, which catalyze the
covalent attachment of SUMO to numerous transcription fac-
tors, thereby modulating their activity (30). Therefore, we as-
sessed the role of PIAS proteins in Tel sumoylation. Several
lines of evidence indicate that PIAS3 acts as a SUMO E3 ligase
for Tel. First, in cells coexpression of PIAS3 strongly stimu-
lates Tel sumoylation (Fig. 3A) (similar results were obtained
with SUMO-1) (data not shown). Coexpression of other PIAS
family members had either only very modest effects on Tel
sumoylation levels or no detectable impact (Fig. 3A). We fur-
ther demonstrated that PIAS3 specifically stimulates SUMO
conjugation on lysine K11 since mutation of this residue abol-
ishes PIAS3-enhanced Tel sumoylation. Second, small inter-
fering RNA (siRNA)-mediated knockdown of endogenous
PIAS3 significantly reduced the levels of sumoylation of both
ectopically expressed Tel (Fig. 3B) and most significantly also
endogenous Tel (Fig. 3C), strongly implying that sumoylation
of endogenous Tel is dependent on PIAS3. Third, immunohis-
tochemistry (Fig. 3D) and live-cell imaging of cyan fluorescent
protein-Tel and yellow fluorescent protein-PIAS3 fusion pro-
teins (data not shown) showed that these proteins colocalize in
cells (Fig. 3D). Finally, Tel efficiently coimmunoprecipitates
both endogenous (data not shown) and exogenous PIAS3 from
cellular extracts, indicating that the two proteins physically
interact (Fig. 3E). Tel also interacted with PIAS4; however,
Fig. 3A shows that PIAS4 had relatively little influence on Tel
sumoylation even when expressed at very high levels. To map
the region of Tel that is required for PIAS3 binding, we gen-
erated a number of Tel deletion mutants. While wild-type Tel
readily bound to PIAS3, Tel	EDBD, which lacks the Ets
DNA-binding domain (EDBD), failed to associate with PIAS3
FIG. 2. K11 of Tel polymers, but not Tel monomers, is found conjugated with SUMO in cells. (A) Disruption of the SAM domain prevents
Tel self-association. HA epitope-tagged and Flag epitope-tagged fusions of wild-type Tel or Tel expressing mutations that disrupt the SAM domain
(A*, which contains an arginine residue in place of an alanine residue; deletion of the SAM domain is shown as 	SAM) were expressed in 293T
cells in the indicated combinations. A schematic representation of the mutants tested is included. (B and C) Monomeric forms of Tel exhibit low
levels of sumoylation in cells. (B) HA epitope-tagged versions of wild-type Tel or Tel expressing mutations that disrupt the SAM domain (described
above) were cotransfected into 293T cells along with His epitope-tagged SUMO-1 or SUMO-2, and a sumoylation assay was performed. (C) The
experiment in panel B was performed using Tel mutants in which each of the five helices that comprise the SAM domain were individually deleted.
A schematic representation of the mutants tested is included. (D) Tel monomers are efficiently sumoylated in vitro on K11. Fusions between GST
and either full-length wild-type Tel or full-length Tel harboring mutations that disrupt the SAM domain (see above) were sumoylated in E. coli
as described in the legend of Fig. 1A. Sumoylated forms of Tel are highlighted (*) and were confirmed by Western blotting and also MS (data not
shown). Shown also is an HA Western blot to detect Tel following an in vitro sumoylation assay (37) using the indicated Tel proteins that were
made by in vitro translation in the presence of 1 mM unlabeled methionine. Sumoylated proteins that are absent from TelA* proteins containing
a mutation of K11 to an arginine (TelA*/K11-R) are highlighted with arrows. (E) Inhibiting proteasome function stabilizes the pool of Tel
monomers sumoylated on K11 in cells. Cells were cotransfected with the indicated Tel constructs along with His epitope-tagged SUMO-2.
Following incubation with or without MG132, a sumoylation assay was performed. IP, immunoprecipitation.
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(Fig. 3F). This interaction assay was performed in relatively
stringent lysis buffer that disrupts cellular membranes and
thereby allows proteins that are normally localized in the cy-
toplasm to interact with proteins that are normally localized in
the nucleus. Two of the described mutations, Tel	EDBD and
Tel	C34, which lacks the C-terminal 34 amino acids, are both
mislocalized from the nucleus to the cytoplasm (Fig. 3G). The
lack of PIAS3 binding is not due to mislocalization of
Tel	EDBD since Tel	C34, which is similarly mislocalized,
efficiently bound to PIAS3 under the same conditions (Fig.
3F). We noticed that Tel	C34 sumoylation levels are strongly
attenuated, and in contrast to wild-type Tel, ectopic expression
of PIAS3 fails to appreciably augment its sumoylation (Fig.
3H) even though Tel	C34 can efficiently associate with PIAS3
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FIG. 3. PIAS3 stimulates sumoylation of Tel on K11. (A) Ectopic expression of PIAS3 strongly stimulates sumoylation of K11 of Tel. Tel or
TelK11-R was transfected into 293T cells with or without His epitope-tagged SUMO-2, either alone or together with the indicated PIAS constructs.
Sumoylated Tel was recovered from cells by a sumoylation assay. (B) Endogenous PIAS3 is essential for normal Tel sumoylation. Cells were
transfected with the indicated constructs and a sumoylation assay was performed 2 days later. In the absence of an effective antibody specific for
human PIAS3, the efficiency of PIAS3 knockdown was assessed by targeting Flag epitope-tagged PIAS3 expressed in U2OS cells. A nonspecific
siRNA was used as a control. (C) Endogenous PIAS3 is required for sumoylation of endogenous Tel. We established U2OS cell lines stably
expressing either His epitope-tagged SUMO-1 or SUMO-2. The indicated cell lines were transfected with either a control siRNA (directed against
GFP) or siRNAs directed against PIAS3, and a sumoylation assay was performed 2 days later. The efficiency of PIAS3 knockdown was assessed
by targeting Flag epitope-tagged PIAS3 expressed in U2OS cells. A nonspecific siRNA was used as a control (right panel). (D) Colocalization of
Tel and PIAS3 in the nucleus. Cells were transfected with the indicated constructs and proteins were detected with the indicated antibodies.
Tel	EDBD is the same as wild-type Tel except it lacks the EDBD. (E) Tel interacts with PIAS3. 293T cells were transfected with the indicated
constructs. Tel complexes were immunopurified from cell lysates, made using radioimmunoprecipitation assay-SDS lysis buffer, using an antibody
directed against the HA epitope, and associated PIAS protein was detected using an antibody directed against the Flag epitope. (F) Tel binding
to PIAS3 requires its EDBD in cells. The indicated HA epitope-tagged Tel proteins were coexpressed with or without PIAS3 (not shown since the
background was clear). Tel complexes were immunopurified from cell lysates using an antibody directed against the HA epitope, and associated
PIAS3 protein was detected using an antibody directed against the Flag epitope. Tel M43 lacks the N-terminal 42 amino acids; Tel A* contains
an amino substitution (arginine residue in place of an alanine residue) at position 93; Tel	SAM lacks the SAM domain; and Tel 	C34, Tel	C27,
and Tel	C12 have deletions of the C terminus of the indicated lengths. A schematic representation of the mutants tested is included. (G) Mu-
tations that disrupt the EDBD or the C terminus of Tel lead to mislocalization of Tel to the cytoplasm. Cells were transfected with the indicated
constructs, and immunohistochemistry was performed with the antibodies shown. (H) Mislocalization strongly abrogates sumoylation. Cells
were cotransfected with the indicated constructs, and a sumoylation assay was performed. DAPI, 4,6-diamidino-2-phenylindole; IP,
immunoprecipitation.
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(Fig. 3E). Coupled to the fact that PIAS3 is predominantly a
nuclear protein (Fig. 3D), this suggests that PIAS3-mediated
sumoylation of Tel occurs in the nucleus. In sum, these results
suggest that sumoylation of K11 of Tel occurs in the nucleus
and is mediated by PIAS3 via binding to the Tel EDBD.
Posttranscriptional regulation of Tel sumoylation. Figure
1D highlighted a highly conserved methionine residue (M43)
common to all Tel proteins that also contain the K11 sumoy-
lation consensus site. In agreement with previous reports we
found that cells express different Tel isoforms (Fig. 4A), and it
has been shown that one of these isoforms, TelM43, results
from use of M43 as an alternative initiation codon (2, 20, 27,
28). Importantly, TelM43 lacks the N-terminal 42 amino acid
residues including the K11 sumoylation site. As the results
shown in Fig. 1B indicate, whereas full-length endogenous Tel
appears to be detectably sumoylated, we were unable to detect
a protein of a size that would be expected if TelM43 were
sumoylated. We explored how this mechanism regulates Tel
function. To that end we expressed a C-terminally tagged tel
construct in cells that yielded two Tel proteins: full-length Tel
and a shorter form of Tel (Fig. 4A). The shorter form of Tel
results from initiation of translation from codon M43 because
expression of a tel mutant that lacks this alternative start codon
(TelM43-I) generates only full-length Tel. Figure 4B shows
that, as expected, sumoylation of TelM43, like TelK11-R, is
strongly abrogated. We found that the full-length TelM43-I
FIG. 4. Posttranscriptional regulation of Tel sumoylation. (A and B) An alternative Tel isoform produced through use of an alternative
initiation codon (M43) escapes sumoylation. TelM43 can be translated from the full-length Tel cDNA. 293T cells were separately transfected with
three different Tel constructs (A). One expressed an HA epitope at the N terminus, another expressed the HA epitope at the C terminus enabling
visualization of both Tel and TelM43 isoforms, and a final construct contained an HA epitope at the C terminus but expressed an isoleucine residue
in place of the methionine at position 43 (TelM43-I). A separate panel highlights endogenous Tel proteins detected following Western blotting
of lysates prepared from primary human hemopoietic blast cells. Sumoylation of the TelM43 isoform is strongly abrogated (B). Cells were
cotransfected with the indicated constructs, and a sumoylation assay was performed. (C) Sumoylation of K11 is independent of the TelM43 isoform.
Cells were cotransfected with the indicated constructs, and a sumoylation assay was performed. TelM43-I is described for panel A. TelM43-I/K11-R
is identical to TelM43-I except that lysine at position 11 has been mutated into an arginine residue. A schematic representation of the mutants
tested is included. (D) Nonsumoylated Tel isoforms adopt a more speckled subcellular distribution. Cells were transfected with the indicated
constructs, and proteins were detected with the indicated antibodies.
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protein, which is manufactured in cells without translation of
the smaller TelM43 protein (Fig. 4A), is sumoylated on K11 as
efficiently as wild-type full-length Tel (Fig. 4C), suggesting that
sumoylation of full-length Tel K11 neither requires nor is in-
hibited by coexpressed TelM43. Collectively, these results
show that from a single tel transcript, two different initiation
codons can be used to generate a full-length Tel protein that is
sumoylated and a smaller Tel isoform (TelM43) that is not
sumoylated on K11 and, furthermore, does not influence
sumoylation of full-length Tel K11. In cells, TelM43 and
TelK11-R adopt a defined speckled pattern of nuclear distri-
bution in contrast to wild-type full-length Tel that has a more
uniform, less speckled nuclear distribution (Fig. 4D). This
speckled pattern likely reflects the distribution of complexes
containing Tel oligomers (Tel repressive conformation) since
TelK11-R and TelM43 proteins that are unable to oligomerize
(Fig. 3A, TelK11/A* and TelM43/A*) do not have a speckled
nuclear distribution (Fig. 4D; also data not shown).
Sumoylation of K11 inhibits Tel’s repressive function. We
next examined how sumoylation of K11 affects Tel’s ability to
repress gene expression. To determine the role of sumoylation
in Tel’s repressive function, we employed three different but
complementary measures. First, we utilized a luciferase trans
repression reporter assay in which an engineered minimal Tel
regulatable promoter controls constitutive TK-driven lucifer-
ase expression (1). Figure 5A shows that ectopic expression of
Tel represses luciferase activity. By contrast, we found that
both TelM43 and TelK11-R, which are not sumoylated, ex-
erted a significantly stronger repressive effect than wild-type
Tel (Fig. 5A). To confirm that the enhanced repressiveness of
TelK11-R and TelM43 results from the absence of sumoylation
rather than from a different posttranslational modification of
K11, we also assayed the repressive activity of TelE13-A, which
disrupts sumoylation of K11 (Fig. 1E) while leaving the K11
residue accessible to other modifications. Figure 5A shows that
comparable protein levels of TelE13-A repressed luciferase
expression to the same degree as TelK11-R, suggesting that the
enhanced repressive function of TelK11-R and TelM43 does
indeed result from their resistance to repression-inhibiting co-
valent conjugation of SUMO to K11. Next, we assessed Tel’s
repressive function by monitoring an in vivo target of Tel. A
previous report highlighted the rat stromelysin-1 (MMP3) pro-
moter as a target of repression by Tel (5). Figure 5B shows that
the stromelysin-1 promoter is highly conserved between human
and rat, and, in particular, both share nearly identical consen-
sus Tel DNA-binding sites. To determine if Tel controls ex-
pression of endogenous human stromelysin-1 and if sumoyla-
tion of Tel K11 regulates this process, we established a number
of stable cell lines expressing either wild-type full-length Tel,
TelM43, TelK11-R, or Tel	EDBD. By quantitative PCR we
found that Tel strongly inhibited expression of endogenous
stromelysin-1, which requires Tel DNA-binding, because
Tel	EDBD failed to strongly inhibit stromelysin-1 expression.
Significantly, comparable expression levels of both TelK11-R
and TelM43 impeded stromelysin-1 expression far more po-
tently than wild-type Tel. Indeed, both were at least twice as
repressive as wild-type Tel (Fig. 5B) which almost exactly mir-
rors our findings with the artificial Tel promoter presented in
Fig. 5A. In support of this, we performed chromatin immuno-
precipitation assays and found that disruption of Tel sumoyla-
tion (TelK11-R and TelM43) leads to enhanced Tel associa-
tion to endogenous stromelysin-1 (data not shown). To further
corroborate these results, we placed expression of the lucifer-
ase reporter gene under the control of the human stromelysin-1
promoter and compared repression of gene expression by full-
length wild-type Tel, which is sumoylated on K11, with
TelM43, TelK11-R, and TelE13-A, which are not sumoylated
on K11. The results using this system were in strict agreement
with the prior assays (Fig. 5B); Tel that was not conjugated
with SUMO on K11 was at least two times more repressive
than wild-type Tel, which is sumoylated on K11. Collectively,
these data suggest that sumoylation of K11 negatively regulates
Tel’s ability to suppress gene expression.
This notion was further strengthened by our studies with D.
rerio Tel. Although D. rerio Tel encodes a lysine at position 12
(K12) that is equivalent to Homo sapiens Tel K11, this lysine is
not part of a typical sumoylation consensus motif, and, more-
over, D. rerio Tel lacks an internal initiation codon M43 (Fig.
1D). However, D. rerio Tel is sumoylated in cells (Fig. 5C).
There are three obvious possibilities: K12 is in fact sumoylated,
K99 is sumoylated (the sequence surrounding D. rerio Tel K99
is identical to human Tel), or the C-terminal K441 is sumoy-
lated since this forms part of a classic sumoylation consensus
motif. Figure 5C shows that mutation of K441 to an arginine
residue completely abolished D. rerio Tel sumoylation, whereas
mutation of K12 or K99 (data not shown) had no detectable
effect on D. rerio sumoylation levels. Furthermore, mutation of
R14 to E (R14-E) created a sumoylation consensus site that
allowed sumoylation of K12 (Fig. 5C). These data show that
wild-type D. rerio Tel is not normally sumoylated on K12 but
that the mutation R14-E establishes a new sumoylation site in
a position that is equivalent to H. sapiens K11. We tested these
constructs using our luciferase trans repression reporter assay.
Figure 5D shows that wild-type D. rerio Tel efficiently re-
pressed gene expression. The ability of D. rerio Tel to repress
reporter gene expression was comparable to the levels of re-
pression by human TelM43. In contrast, the D. rerio TelR14-E
mutant, which is sumoylated on K12, displayed a significantly
reduced repressive activity compared to wild-type D. rerio Tel.
Repression by D. rerio TelR14-E was similar to repression by
wild-type full-length human Tel (Fig. 5D). Together, these
data showed that sumoylation of K11 limits the ability of Tel to
repress gene expression while TelM43 is strongly repressive by
comparison with full-length wild-type Tel because it escapes
sumoylation of K11. In the assay systems described above,
PIAS3 siRNA oligonucleotides had little effect; this result may
reflect genetic redundancy, insufficient PIAS3 knockdown, or
the fact that PIAS3 appears to exert a sumoylation-indepen-
dent, stimulatory effect on repression by Tel (Fig. 5F) such that
the effects of the PIAS3 siRNA oligonucleotides on this system
are cancelled out. Disruption of other components of the
sumoylation machinery such as the SUMO E1 ligase SAE2 or
the SUMO E2 ligase Ubc9 by using siRNAs had significant
impact in our reporter assays even in the absence of Tel
(Roukens and Baker, unpublished), presumably because they
are generic regulators of protein function. This precluded any
direct, specific quantitative analysis of their roles in repression
by Tel.
We next examined how sumoylation might inhibit repres-
sion. To that end we coupled biotinylated Ets DNA-binding
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FIG. 5. Sumoylation of K11 inhibits repression by Tel. (A) Either 293T, U2OS, or NIH 3T3 cells were cotransfected with the indicated Tel
constructs along with a luciferase reporter in which an engineered minimal Tel/Yan regulatable promoter controls TK-driven luciferase expression.
Equivalent transfection efficiencies of the indicated constructs were determined by a -galactosidase assay for expression of a cotransfected LacZ
reporter, and protein levels of ectopically expressed Tel constructs were determined by Western blotting of lysates. Shown is a representative
experiment using 293T cells. Experiments were performed in triplicate. (B) Tel repression of expression of endogenous human stromelysin-1
(MMP3) is inhibited by sumoylation of K11. The upper panel shows that the promoters of rat and human stromelysin-1 share a number of
conserved, potential Tel DNA binding sites. Highlighted in bold are previously characterized Tel binding sites (5). Additional highly conserved
putative Tel binding sites are underlined. In the lower left panel, we established stable cell lines expressing the indicated Tel constructs. We
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sites to beads and compared the efficiency of binding of sumoy-
lated and nonsumoylated Tel. Consistent with our reporter
assay results, Fig. 5E shows that nonsumoylated Tel alone
interacted efficiently with the Ets DNA-binding sites while
sumoylation of K11 served to impair Tel binding to DNA of
both sumoylated Tel and also nonsumoylated Tel in the same
mixture. Under these experimental conditions, we found that
both sumoylated and nonsumoylated Tel could efficiently as-
sociate with one another, as shown by the fact that a GST-Tel
fusion protein was able to efficiently purify both sumoylated
and nonsumoylated Tel from a mixture of the two (Fig. 5E).
These results suggest that sumoylation does not inhibit Tel
self-association but does impede Tel DNA-binding.
Interestingly, in the absence of added SUMO-1 or SUMO-2,
although PIAS3 alone had little detectable influence on lucif-
erase expression, it synergistically enhanced repression by Tel
(Fig. 5F). SUMO-1 and SUMO-2 are rate limiting for stimu-
lation of sumoylation by PIAS3, because in the absence of
added SUMO-1 or SUMO-2 ectopic expression of PIAS3 fails
to appreciably augment sumoylation (M. Alloul-Ramdhani
and D. A. Baker, unpublished data). Consistent with the idea
that the observed PIAS3 corepressor function may be indepen-
dent of sumoylation, Fig. 5G shows that a PIAS3 protein lack-
ing the RING domain synergistically enhanced Tel repression
of gene expression to approximately the same degree as wild-
type PIAS3. Furthermore, in the presence of ectopic SUMO-1
or SUMO-2, PIAS3 failed to promote repression of gene ex-
pression by Tel (Roukens and Baker, unpublished). These data
suggest that as well as strongly stimulating Tel sumoylation
that inhibits repression by Tel (Fig. 3), PIAS3 might also act as
a SUMO-independent Tel corepressor.
DISCUSSION
Our study shows that PIAS3 mediates sumoylation of full-
length Tel on K11 but not of TelM43, whose evolution appears
to be linked to that of the K11 sumoylation site. Sumoylation
of K11 inhibits the ability of Tel to repress gene expression.
This establishes a mechanism that presumably allows finer
spatiotemporal control of Tel function through the production
of a nonsumoylated, repressive version of Tel and by promot-
ing the formation of a pool of (sumoylated) Tel that can sub-
sequently be recruited for repression or be degraded in a
regulated fashion.
Tel K11 is the primary site of covalent conjugation of
SUMO. We establish here that endogenous Tel is sumoylated,
and through a combination of biochemical and molecular anal-
yses, including MS, we have determined that the N-terminal
lysine at position 11 (K11) is the primary substrate for covalent
conjugation of both SUMO-1 and SUMO-2 to Tel. K11 forms
part of a bona fide sumoylation motif that is highly conserved
in all vertebrates except D. rerio. Although this is the first
report of sumoylation of Tel K11, sumoylation of Tel K99 has
been described previously (4, 42). K99 is found in the Tel SAM
domain that characterizes a subfamily of Ets transcription fac-
tors. Although it is embedded in a sequence that is not a
perfect match to known sumoylation sites, nevertheless the
sequence does resemble a consensus sumoylation site. More-
over, this sequence is not only highly conserved in all known
vertebrate Tel proteins but also shared by invertebrate ortho-
logues of Tel such as Bombyx mori Yan and, indeed, in the
SAM domains of related Ets family members such as Tel2,
Fli-1, and Erg. However, unlike our findings for K11, we failed
to uncover K99 as a target for sumoylation in any of our
analyses, leading us to conclude that K11 is the primary, reg-
ulatory site of Tel sumoylation. Interestingly, and perhaps sig-
nificantly, the sequence immediately adjacent to K99 conforms
to a recently described SUMO interaction motif (15), raising
the possibility that this hydrophobic core (LLLL in all se-
quenced vertebrates including D. rerio) may serve as an inter-
face for noncovalent docking of SUMO to Tel and may also
modulate Tel function.
K11 of Tel oligomers and monomers can be sumoylated, but
only a pool of Tel oligomers are found conjugated with SUMO
in cells. Tel can exist in two basic forms: as a monomer or as
homotypic oligomers formed by self-association of monomers
via their SAM domains (1, 13, 21, 31, 33). Our results pre-
sented in Fig. 2 strongly suggest that both Tel monomers and
Tel polymers can be sumoylated but that in cells only a pool of
prepared cDNA from these lines and performed quantitative PCR to assess the levels of expression of endogenous stromelysin-1. Shown graphically
are the relative repression levels normalized against a control human gapdh gene. Shown in the right panel is a luciferase reporter assay. Luciferase
expression was placed under the control of the human stromelysin promoter. Equivalent transfection efficiencies of the indicated constructs were
determined by a -galactosidase assay for expression of a cotransfected LacZ reporter, and protein levels of ectopically expressed Tel constructs
were determined by Western blotting of lysates. Shown is a representative experiment using U2OS cells. Experiments were performed in triplicate.
(C) D. rerio Tel does not express an N-terminal site of sumoylation but is sumoylated at position K441. Cells were transfected with the indicated
constructs together with SUMO-2, and Tel sumoylation was assessed by Western blotting. D. rerio TelK12-R is the same as wild-type D. rerio Tel
except that the lysine residue at position 12 has been replaced with an arginine residue. D. rerio TelR14-E is identical to wild-type D. rerio Tel except
that the N-terminal sumoylation consensus site has been created by replacing the arginine residue with a glutamic acid residue at position 14. D.
rerio TelK441-R is the same as wild-type D. rerio Tel except that the lysine residue at position 441 has been replaced with an arginine residue. D.
rerio TelK441-R/R14-E is the same as D. rerio TelK441-R except that the arginine residue at position 14 has been replaced with a glutamic acid
residue. A schematic representation of the mutants tested is included. (D) Cells were transfected with the indicated constructs, and a luciferase
repression assay was performed as described in panel A. (E) Sumoylation of K11 impedes the ability of Tel to associate with DNA. Tel proteins
were efficiently sumoylated following in vitro translation in reticulocyte lysates as previously described (37). Biotinylated Ets DNA-binding sites
were coupled to streptavidin beads following the manufacturer’s advice (Invitrogen) and incubated with the indicated proteins. Associated Tel
proteins were recovered by SDS-PAGE. Tel-Tel interactions were assessed by incubating GST Tel fusion proteins or GST proteins alone, along
with sumoylated and nonsumoylated in vitro translated forms of Tel. (F and G) PIAS3 enhancement of repression by Tel is sumoylation
independent. The experiment shown in panel F is the same as that described for panel A except that cells were cotransfected with or without
PIAS3. In the experiment in panel G, cells were transfected with the indicated constructs, and a luciferase reporter assay was performed as
described for panel A. PIAS3	RING is the same as PIAS3 except that the RING domain has been deleted.
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oligomeric Tel is found covalently conjugated with SUMO,
whereas the fraction of monomeric forms of Tel that are
sumoylated is minimal by comparison. This latter observation
was reported previously (42). These differences could be due to
rapid desumoylation or inherent monomer instability. For ex-
ample, unlike Tel monomers, Tel oligomers may adopt a con-
formation or subcellular localization that renders the sumoy-
lated K11 site less accessible to desumoylating enzymes.
Certainly, desumoylation will prove to play an important role
in Tel function (M. G. Roukens, M. Alloul-Ramdhani, and
D. A. Baker, unpublished data); however, we believe that the
absence of a pool of sumoylated monomers reflects pro-
nounced monomer instability. In support of this, Fig. 2E shows
that inhibiting the proteosome leads to a dramatic stabilization
of sumoylated forms of the monomer but not of sumoylated
forms of Tel oligomers, suggesting that Tel monomers are
intrinsically more unstable than Tel oligomers and that per-
haps sumoylation sensitizes Tel monomers for proteasomal
degradation. Consistent with this, in a complementary study we
find that Tel monomers are especially sensitive to ubiquitin-
mediated degradation (Roukens, Alloul-Ramdhani, and
Baker, unpublished).
Sumoylation of Tel K11 is mediated by PIAS3. Figure 3
describes our evidence that PIAS3 mediates Tel sumoylation.
A number of reports and, in particular, loss-of-function studies
in mice (16, 26, 41) suggest that PIAS proteins can perform
overlapping roles and compensate for the lack of other PIAS
proteins as a result of genetic redundancy. Importantly, we
found that disruption of PIAS3 alone strongly inhibited Tel
sumoylation, suggesting that it plays a key role in Tel function,
although one cannot rule out the possibility that other PIAS
proteins also regulate Tel perhaps in a cell-type-specific fash-
ion. We mapped the PIAS3 binding site to the EDBD of Tel,
and this finding resembles the requirement of the Fli-1 EDBD
for interaction with PIASx (36). This raises the possibility that
the EDBD of other ETS proteins is also a site of interaction
with PIAS protein family members and thus PIAS-ETS inter-
actions are a defining feature of at least a subfamily of ETS
proteins.
Sumoylation of Tel K11 suppresses repression of gene ex-
pression by Tel. To date, many studies of transcriptional reg-
ulators have demonstrated that, by and large, sumoylation
serves to reinforce repression of gene expression (44), for
example, by facilitating the recruitment of histone deacetylases
(43). By contrast, we find that sumoylation of Tel K11 strongly
suppresses Tel’s repressive function. We used three different
but complementary means to examine repression of gene ex-
pression by Tel (Fig. 5), and the robustness of these mecha-
nistic studies is revealed by the strict agreement in results
between the various assays. Specifically, we find that forms of
Tel that are not sumoylated on K11 are at least twice as
repressive as versions of Tel that can be sumoylated on K11.
The consensus sumoylation site containing K11 is a feature of
every predicted vertebrate Tel protein with the exception of D.
rerio Tel. This offered a naturally occurring “mutant” with
which to corroborate our finding that sumoylation of Tel does
indeed limit its ability to suppress gene expression. Our results
with H. sapiens Tel predicted that wild-type D. rerio should act
as a relatively efficient repressor, comparable to the highly
repressive H. sapiens TelM43, which also lacks a K11 site (Fig.
5A and B), and that acquisition of a site equivalent to that of
H. sapiens K11, which can be sumoylated (Fig. 5C), would
result in a D. rerio Tel protein with a much reduced capacity for
repression of gene expression. This is indeed what we found
(Fig. 5D). The differences between D. rerio Tel and other
vertebrate Tel proteins provide a means to explore how sumoy-
lation of K11 has refined Tel function during the course of
evolution. Strikingly, an internal initiation codon at position 43
(M43), which leads to the production of a particularly repres-
sive version of Tel because it cannot be sumoylated at the N
terminus since it lacks K11, appears to emerge along with K11
(and is absent in D. rerio). We suggest that these dual, early
vertebrate innovations of tel and Tel have collectively refined
Tel function: the capacity to yield, posttranscriptionally a non-
sumoylated, strongly repressive version of Tel (TelM43) cou-
pled to posttranslational regulation by sumoylation of K11,
which acts to limit Tel repression. This mechanism may not be
limited to Tel. The related Ets transcription factors Fli-1 and
Erg are also sumoylated, at positions K68 and K67, respec-
tively (36; also M. G. Roukens, A. Anvarian, and D. A. Baker,
unpublished data). These proteins also express an upstream
sequence (Fli-1, MDEKN; Erg, MEEKH) that resembles the
sequence in which M43 of Tel is embedded (MEEDS). It will
be of interest to determine if Fli-1 and Erg are regulated
similarly to Tel.
We found that both TelM43 and full-length Tel lacking K11
(TelK11-R) adopted a more speckled (repressive) subnuclear
distribution by comparison with wild-type full-length Tel, sug-
gesting that sumoylation of Tel influences its cellular localiza-
tion. Also consistent with our reporter data, we found that
sumoylation of Tel impeded its binding to DNA, suggesting
that sumoylation of K11 inhibits Tel repressive function by
regulating DNA occupancy by Tel. Previously, it has been
reported that Tel sumoylation regulates its subcellular local-
ization (42). Furthermore, the oncogene v-SRC stimulated ki-
nase-dependent mislocalization from the nucleus to the cyto-
plasm of full-length Tel but not TelM43, suggesting that the
N-terminal 43 amino acids of Tel encode a “signal” required
for SRC-dependent nuclear export (18). Together, these find-
ings suggest that sumoylation of K11 generates a repository of
Tel molecules that are not tethered to DNA and either are
available to be recycled, perhaps through desumoylation, to
reinforce gene expression repression or are degraded in a
regulated, context-dependent fashion. Tel sumoylation pro-
vides a framework for deciphering the precise mechanisms that
determine the cellular status of Tel, which should prove to be
of fundamental importance to understanding differentiation of
early progenitor cells that express Tel.
A potential role for PIAS3 as a sumoylation-independent
corepressor of Tel. Interestingly, and perhaps paradoxically,
under conditions that do not favor Tel sumoylation we found
that PIAS3 synergistically enhanced Tel’s repressive function,
suggesting that PIAS3 might be a context-dependent modula-
tor of Tel function: on the one hand, it strongly promotes Tel
sumoylation, thus inhibiting Tel’s repressive function, but on
the other hand, it can act as a sumoylation-independent Tel
corepressor. It will be important to ascertain whether PIAS3
has such a corepressor function in vivo and whether PIAS has
a more ancient role as a corepressor of the invertebrate Tel
orthologue, Yan, and D. rerio Tel that is independent of its
VOL. 28, 2008 SUMOYLATION OF Tel K11 INHIBITS ITS REPRESSIVE FUNCTION 2355
sumoylating function. Drosophila Yan does not express an
equivalent K11 residue (or M43 residue) and is not detectably
sumoylated in insect Schneider cells (Roukens, Anvarian, and
Baker, unpublished). It is worth noting that lowered levels of
PIAS in Drosophila lead to a failure of normal photoreceptor
and blood cell differentiation (9), which tellingly resembles
Yan loss-of-function mutations in Drosophila (abnormal eye
development phenotype) and Tel loss-of-function mutations in
mice (abnormal blood cell differentiation phenotype).
Finally, the N terminus of Tel, which encodes K11, is indis-
pensable for activating fusion proteins that result from chro-
mosomal translocations found in various leukemias (6, 12). It
will be instructive to determine a potential role for K11 sumoy-
lation in the activity of these fusion proteins.
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The vertebrate Ets transcriptional repressor Tel (ETV6) and its invertebrate orthologue, Yan, are both
indispensable for development, and they orchestrate cell growth and differentiation by binding to DNA, thus
inhibiting gene expression. To trigger cell differentiation, these barriers to transcriptional activation must be
relieved, and it is established that posttranslational modifications, such as phosphorylation and sumoylation,
can specifically impair the repressive functions of Tel and Yan and are crucial for modulating their transcrip-
tional activity. To date, however, relatively little is known about the control of Tel and Yan protein degradation.
In recent years, there has been a concentrated effort to assign functions to the large number of F-box proteins
encoded by both vertebrate and invertebrate genomes. Here, we report the identification and characterization
of a previously unreported, evolutionarily conserved F-box protein named Fbl6. We isolated both human and
Drosophila melanogaster fbl6 cDNA and show that the encoded Fbl6 protein binds to both Tel and Yan via their
SAM domains. We demonstrate that both Tel and Yan are ubiquitinated, a process which is stimulated by Fbl6
and leads to proteasomal degradation. We recently established that the sumoylation of Tel on lysine 11
negatively regulates its repressive function and that the sumoylation of Tel monomers, but not that of Tel
oligomers, may sensitize Tel for proteasomal degradation. Here, we found that Fbl6 regulates Tel/Yan protein
stability and allows appropriate spatiotemporal control of gene expression by these repressors.
Cell fate is determined by programs of gene expression,
which are strictly regulated spatiotemporally by a complex net-
work of interacting molecular mechanisms that control the
balance between transcription, translation, and degradation.
The Drosophila melanogaster transcription factor Yan and its
vertebrate orthologue, Tel (ETV6), are well placed to interro-
gate these processes. An abundance of molecular and genetic
evidence shows that these unique Ets transcription factor re-
pressors are indispensable for normal cell differentiation (15,
19, 22, 27, 35, 36, 45, 46). Importantly, the disruption of normal
Tel function leads to neoplasia (10, 11). A finely controlled
interplay between posttranscriptional and posttranslational
modifications regulates their functions (42). In the case of Tel,
the observed heterogeneity of Tel proteins in cells (37, 29, 43)
can be accounted for by at least two posttranscriptional mech-
anisms—the use of an alternative initiation codon (37, 29) and
alternative splicing (38; M. G. Roukens and D. A. Baker,
unpublished data). Together, these processes can produce Tel
isoforms that differentially control Tel function. Yan, on the
other hand, appears to be regulated posttranscriptionally by a
microRNA, miR7, that might act in a tissue-specific fashion
and that limits Yan protein translation by binding to the 3
untranslated region of yan mRNA (21). Posttranslationally,
phosphorylation and sumoylation play pivotal roles in modu-
lating the activities of Tel and Yan, particularly by impairing
the repression of transcription by these factors. Specifically,
phosphorylation of Yan is a trigger for its downregulation (2,
33, 35, 40, 41), and sumoylation of Tel is PIAS dependent (37)
and inhibits the repression of gene expression (5, 37, 49). To
date, however, relatively little is known about the control of
Tel/Yan protein degradation.
There are vital mechanisms of protein degradation for con-
trolling the timing of the action of proteins and, ultimately, the
timing of cellular processes in general. One such crucial mech-
anism of degradation is mediated by the process of ubiqui-
tination, which impinges on virtually all known eukaryotic cel-
lular processes (13). Ubiquitin is a 76-amino-acid polypeptide
that can be covalently bonded to target proteins in a number of
ways (28). Monoubiquitination has been shown to play an
essential role in endocytosis (16) and in the subcellular target-
ing of proteins (20). Polyubiquitination, in contrast, is almost
exclusively associated with protein degradation and turnover,
either via the proteasome or through endocytosis and lysoso-
mal sorting (47). Mechanistically, ubiquitination is well defined
and involves the concerted action of at least three different
catalytic components, namely the E1 (ubiquitin-activating), E2
(ubiquitin-conjugating), and E3 (ubiquitin ligase) enzymes
(48). A crucial aspect of ubiquitination-driven degradation is
how substrate specificity is achieved. One way is through the
recruitment of F-box proteins. F-box proteins are character-
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ized by the presence of an N-terminal F-box domain that is
approximately 50 amino acids long (1), and they are broadly
classified into three families: the FBW family, which contains
WD repeats; the FBL family, which contains leucine-rich re-
peats; and the FBX family, which consists of F-box proteins
with other protein interaction domains. These domains are
usually located in the C terminus of the protein, and they
associate with substrates and link them to the ubiquitinating
machinery via the F-box domain (4, 14).
We have performed yeast two-hybrid screens to identify
proteins that associate with both Tel and Yan, and by this
means, we have uncovered an F-box protein named Fbl6. Our
biochemical and genetic analyses of human and Drosophila
tissue culture cells, as well as of Drosophila embryos, suggest
that F-box-mediated ubiquitination of Tel and Yan promotes
their downregulation.
MATERIALS AND METHODS
Cell-based ubiquitination assays. Cells were transfected with the appropriate
plasmids and then incubated for 6 h with or without the proteasome inhibitor
MG132 24 to 36 h posttransfection. His-ubiquitin pulldowns were performed
with 50 l of Ni-nitrilotriacetic acid beads (Qiagen) for 3 h at room temperature
in 6 ml of 6 M guanidinium-HCl, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 0.01 M
Tris-HCl (pH 8.0), 20 mM imidazole, and 10 mM -mercaptoethanol (buffer A).
The beads were successively washed twice with 1 ml of each of the following
buffers: (i) buffer A plus 0.2% Triton X-100; (ii) 8 M urea, 0.1 M Na2HPO4, 0.1
M NaH2PO4, 0.01 M Tris-HCl (pH 8.0), 20 mM imidazole, 10 mM -mercap-
toethanol, and 0.2% Triton X-100 (buffer B); and (iii) 8 M urea, 0.1 M Na2HPO4,
0.1 M NaH2PO4, 0.01 M Tris-HCl (pH 6.3), 20 mM imidazole, 10 mM -mer-
captoethanol, and 0.2% Triton X-100 (buffer C). Ubiquitinated proteins were
eluted in 60 l of urea sample buffer, which consisted of 37.5% buffer C, 39.3%
3 Laemmli buffer, 20 mM imidazole, and 3.2% -mercaptoethanol. The sam-
ples were boiled and analyzed by Western blotting.
Immunofluorescence. Cells were grown on glass coverslips and transfected
using Fugene 6 (Roche). Cells were fixed after 24 h with 4% paraformaldehyde
for 15 min at room temperature (all of the following steps were done at room
temperature) and permeabilized in 0.2% Triton X-100–phosphate-buffered sa-
line for 5 min. Cells were washed with phosphate-buffered saline and blocked
with 5% goat serum for 1 h, incubated with primary antibodies for 1 h, washed,
and incubated with secondary antibodies for 30 min. Following extensive wash-
ing, the cells were mounted and immunostaining was visualized with a Leica
DM5500 B microscope.
Cell culture, biochemistry, and molecular biology. A schematic representation
of all of the constructs used in this study can be found in Fig. S3 in the supple-
mental material and also in the relevant figures. Mammalian cell lines were
cultured in Dulbecco’s modified Eagle medium supplemented with 10% fetal
bovine serum and antibiotics. Drosophila Schneider cells were cultured at 25°C in
Schneider cell medium (Sigma) supplemented with 10% fetal bovine serum.
Mammalian cells were transfected with Fugene 6 (Roche) and insect cells with
Effectene reagent (Qiagen), according to the manufacturers’ protocol. In gen-
eral, 1 g of each construct was transfected into cells seeded at 40 to 60%
confluence in 6-cm tissue culture dishes, and cells were lysed 24 to 48 h post-
transfection. TelHA,TelFlag, YanHA, and YanFlag constructs were fused in
frame with either a hemagglutinin (HA) or a Flag epitope tag and cloned into
either the pCS2 expression vector for expression in mammalian cells or the pMT
vector (Invitrogen) for expression in insect cells. Glutathione S-transferase
(GST)–Tel was cloned in frame with GST in the pGEX-2TK vector. Mutants
were generated by PCR. For immunoprecipitations, cells were lysed in 1 ml of
either radioimmunoprecipitation assay-sodium dodecyl sulfate buffer (1 mM
EDTA, 50 mM Tris [pH 8.0], 150 mM NaCl, 10% glycerol, 1% Triton X-100) or
protein lysis buffer (50 mM Tris [pH 7.5], 1% NP-40, 0.1% sodium dodecyl
sulfate, 0.5% Na deoxycholate, 150 mM NaCl) with protease inhibitors (phen-
ylmethylsulfonyl fluoride, trypsin, pepstatin A, leucine, aprotinin) and NaF. Cell
lysates were syringed and centrifuged. Immunoprecipitations were carried out
with 0.75 l of either anti-HA polyclonal antibody (Abcam) or anti-V5 mono-
clonal antibody (Invitrogen). Lysates were preincubated with the antibody for
1 h, after which suitable beads, protein A-Sepharose 4 fast flow (Amersham
Pharmacia Biotech) for HA immunoprecipitations or protein G-Sepharose (Sig-
ma-Aldrich) for V5 immunoprecipitations, were added for a further 2 h of
incubation. Associated proteins were analyzed by Western blotting. For pull-
down assays, Fbl6 proteins were labeled with [35S]methionine by using the TNT
coupled reticulocyte in vitro translation system (Promega) and then incubated
with GST-Tel fusions that were immobilized on glutathione-Sepharose beads as
previously described (2).
Production and infection with shRNA-expressing lentiviruses. Short hairpin
RNA (shRNA) lentiviral constructs for the knockdown of fbl6 were cloned by
insertion of the following oligonucleotides into the BglII/HindIII sites of the
pSuper vector: fbl6i#1 (5-GATCGCAAGTTGTGGCTGACCTATTCAAGA




GCATTCTCTTGAAATGCTATTACGGTTGATGC-3). The pSuper con-
structs were subsequently digested with PstI and XhoI, and the fragment was
placed in the lentiviral PLV-cytomegalovirus-green fluorescent protein vector.
shRNA lentiviral constructs for the knockdown of S-phase kinase-associated
protein 1 (Skp1) were obtained from the Mission shRNA library (Sigma-Aldrich
clones TRCN 006 496 and TRCN 011 029).
Recombinant lentiviruses were produced by the transfection of 293T cells.
Transduction of U2OS cells was performed at a multiplicity of infection of 1, with
the addition of Polybrene in a final concentration of 8 g/ml. One day postin-
fection, the medium was replaced with fresh medium (supplemented with puro-
mycin for the skp1 lines), and cells were lysed after 48 h.
In vivo 35S labeling. Cells were washed free of medium and seeded into 6-cm
tissue culture dishes (Gibco) in methionine- and serum-free Dulbecco modified
Eagle medium (Gibco). Cells were routinely incubated for 3 h, and then the
medium was supplemented with 50 Ci 35S-labeled methionine for an additional
3 h of labeling. Labeled HA epitope-tagged Tel proteins were immunoprecipi-
tated from the cell lysates as described above.
Baculovirus production and expression in cells. Recombinant baculoviruses
for expression in SF9 cells were generated using the Bac-to-Bac baculovirus
expression system (Invitrogen) according to the manufacturer’s manual.
For the ubiquitination assay, SF9 cells were seeded in Grace’s medium (In-
vitrogen) at 40 to 60% confluence in 6-cm culture dishes and infected with
recombinant viruses.
Analysis of gene expression by quantitative PCR. All methods were performed
essentially as described previously (37). The following primer sets were deployed
for real-time PCR analysis: Telq15 (CCCTGCGCCACTACTACAA) and
Telq13 (TGATTTCATCTGGGGTTTTCA), Telq25 (CTTTCGCTATCGATC
TCCTCA) and Telq23 (AGGGTGGAAGAATGGTGAAA), hFbl615 (ATGC
CCAATCGGTTTTCA) and hFbl613 (AGGACAGCACTCACCTACCAG),
hFbl625 (GGATCTTCGTGGCTGTGC) and hFbl623 (CATACAGGCCCAG
ATGAAGC), hSKP1A15 (GGAGATTCGCAAGACCTTCA) and hSKP1A13
(CACTGGTTCTCTTTGCGTACC), and Gapdh5 (TGCCATGTAGACCCCT
TGAAG) and Gapdh3 (ATGGTACATGACAAGGTGCGG).
Drosophila genetics and embryo analysis. P{GawB}NP0326, Df(2R)stan1, and
Df(2R)Exel6060 fly stocks were obtained from the Bloomington Stock Center.
Stocks were maintained using balancers expressing the green fluorescent protein.
Reverted flies were generated by transposase-mediated precise excision of the P
element in P{GawB}NP0326 flies. Precise excision was confirmed by the se-
quencing of fly genomic DNA. Stocks were maintained under standard condi-
tions, and crosses were performed by following standard procedures. For expres-
sion analyses, embryos were carefully staged, and total RNA was prepared using
the SV total RNA isolation kit in accordance with the manufacturer’s protocol
(Promega). Following cDNA synthesis using a TaqMan kit (Roche), expression
levels of relevant transcripts were determined by PCR using the following primer
sets: the fbl6 sense primer (AGGTCCTGCGTGTGACAAACTCTC) and the
fbl6 antisense primer (GAGGCAATGAGTTGGATGTGAAC); the argos sense
primer (GGATTTTCTGTTTGATCAGTTC) and the argos antisense primer
(ATTATTGGATATTTCATTCACT); the CG18335 sense primer, (ATAACG
CCGGAACCGCACTTGGTG) and the CG18335 antisense primer (GTAAAC
GGAGTCCACCAAACCCTC); the CG13220 sense primer (ACCTGACGA
ACGTGTTCCTCATCTC) and the CG13220 antisense primer (GGTTCGA
ATACCTCAGTCCTATATC); the tubulin sense primer (CGTTCACATCC
AAGCTGGTCAG) and the tubulin antisense primer (GGGTGCGGAAGC
AGATATCG).
Yeast two-hybrid assay and cDNA cloning. Full-length yan or tel cDNA was
cloned into pAS2-1 (Clontech) in frame with the GAL4 DNA binding domain.
Independent transformants (approximately 5  105) from a GAL4 activation
domain Drosophila embryo library (for Yan) or a human bone marrow library
(for Tel) were screened in Saccharomyces cerevisiae Hf7c cells according to the
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manufacturer’s protocol (Clontech). We confirmed the specificities of interac-
tions between Yan and Drosophila Fbl6 and between Tel and human Fbl6 by
transforming yeast with the cDNA of fbl6, in either the presence or the absence
of the yan bait (for Drosophila fbl6), the tel bait (for human fbl6), or an unrelated
bait. Full-length cDNAs of the human fbl6 gene and of the Drosophila fbl6 gene
were isolated by reverse transcriptase (RT)-PCR using total RNA derived from
either insect Schneider cells (for Drosophila fbl6) or U2OS human osteosarcoma
cells (for human fbl6).
Antibodies/drugs. The following antibodies (and dilutions, if applicable) were
used: anti-V5 antibody (Invitrogen); anti-Flag mouse M2 monoclonal antibody
(Sigma-Aldrich); anti-HA.11 mouse monoclonal antibody (Covance); anti-GST
rabbit antibody (My Probe), 1:5,000; anti-HA rabbit polyclonal antibody (Ab-
cam), 1:1,000; human anti-Tel rabbit polyclonal antibody, 1:1,000; anti-Yan
monoclonal antibody, 1:500; Drosophila anti-SKPA rabbit polyclonal antibody,
1:1,000; and anti-His polyclonal antibody, 1:1,000. For MG132, experiment cells
were incubated with 3 M MG132 (Calbiochem) for 6 h prior to lysis.
RESULTS
Fbl6, a conserved F-box-containing protein, associates bio-
chemically with both human Tel and Drosophila Yan. To un-
cover evolutionarily conserved pathways that might regulate
Yan/Tel function, we performed yeast two-hybrid screens using
either Drosophila Yan or its human orthologue, Tel, as bait to
identify common interacting proteins. Proteins that were re-
covered from both of the independent screens are highlighted
in Fig. S1 in the supplemental material. Since posttranslational
modifications are essential modulators of protein function, we
centered our subsequent analyses on Fbl6, a putative mediator
of protein degradation. Figure 1A (see also Fig. S2 in the
supplemental material) schematically shows that Fbl6 harbors
an F-box domain (1) and two other conserved sequence blocks,
LRD1 and LRD2, which have been previously classified as
leucine-rich domains (LRDs) (4). Our subsequent analyses are
presented in the five figures included in this article. Figures 1
to 3 describe the regulation of human Tel by human Fbl6, and
Fig. 4 and 5 explore the role of Fbl6 in Drosophila Yan function
and together suggest an evolutionarily conserved function.
The Tel SAM domain and Fbl6 LRDs are required for their
binding. We engineered a V5 epitope-tagged version of wild-
type human Fbl6 and confirmed the biochemical interaction
between Tel and Fbl6 in tissue culture cells (Fig. 1B and C).
Furthermore, we found that this interaction requires the SAM
domain of Tel (Fig. 1B) and the putative LRDs (LRD1 and
LRD2) of Fbl6 (Fig. 1C). Interestingly, disruption of the F-box
domain of Fbl6 also impairs binding to Tel (see Fig. 1C). In
cells, both Tel and Fbl6 colocalize in the nucleoplasm, and
Fbl6 is also found in the nucleolus (Fig. 1D and see Fig. 2C).
Recent reports have highlighted differential regulation of pro-
tein function by different isoforms of the same F-box protein
that are localized in either the nucleolus or the nucleus (31). It
would be interesting as a future study to determine whether
nuclear and nucleolar Fbl6 proteins play different roles in
protein regulation.
Tel is ubiquitinated. It is firmly established that F-box-con-
taining proteins couple their substrates to the conserved ubiq-
uitinating machinery that targets the protein for proteasome-
dependent degradation (14, 18, 48). Thus, we investigated
whether Tel is ubiquitinated and whether the ubiquitination of
Tel might be regulated by Fbl6. Figure 2A shows that Tel is
ubiquitinated in tissue culture cells and that ubiquitinated Tel
is targeted for degradation by the proteasome because the
incubation of cells with inhibitors of the proteasome stabilizes
the fraction of ubiquitin-conjugated Tel. In support of these
data, Fig. 2A also shows that Tel that is covalently conjugated
by a version of ubiquitin that lacks all lysines (and therefore
fails to form chains of ubiquitin that are recognized by the
proteasome) is not stabilized following inhibition of the pro-
teasome with MG132. Figure 2B shows that both the SAM
domain and the Ets DNA binding domain (EDBD) are indis-
pensable for Tel ubiquitination. Tel with EDBD deleted
(TelEDBD) can interact with Fbl6 both in cells (Fig. 1B) and
in vitro (see Fig. 3A); however, we have shown previously (37)
(Fig. 2C) that the deletion of the EDBD leads to the mislo-
calization of Tel from the nucleus to the cytoplasm. Therefore,
to determine that the failure of TelEDBD to be ubiquitinated
in cells does not result simply from subcellular mislocalization,
we engineered a Tel mutant, TelRR-AA. TelRR-AA contains
two single point mutations of arginine residues in the EDBD
that are known to make contact with DNA (25) and are suf-
ficient to promote Tel mislocalization from the nucleus to the
cytoplasm (Fig. 2C). However, unlike TelEDBD, TelRR-AA
is efficiently ubiquitinated (Fig. 2B), suggesting that the failure
of TelEDBD to be ubiquitinated does not result simply from
its mislocalization from the nucleus. Some possibilities are that
lysine residues in the EDBD are targeted for ubiquitin conju-
gation and/or that the EDBD mediates a protein interaction
that is essential for Tel ubiquitination. Indeed, the EDBDs of
all known Ets proteins harbor four highly conserved lysine
residues (three of which make contact with DNA) (25) that
may be substrates for ubiquitin conjugation. Precise definition,
by mutagenesis, of the exact site of ubiquitination is hampered
by redundancy (M. Alloul-Ramdhani, M. Op Den Brouw, and
D. A. Baker, unpublished data); however, improved antibodies
and mass spectrometry techniques should, in time, resolve this
issue. Collectively, these results show that Tel is ubiquitinated
and that ubiquitination requires both the Tel SAM domain and
the EDBD.
Fbl6 stimulates Tel downregulation and ubiquitination. We
next explored the role of Fbl6 in Tel ubiquitination. Several
lines of evidence support a role for Fbl6 in promoting Tel
downregulation and ubiquitination. First, deletion of the SAM
domain, which is essential for Fbl6 binding to Tel (Fig. 1B),
abolished Tel ubiquitination (Fig. 2B). Second, ectopic expres-
sion of wild-type Fbl6 stimulated Tel ubiquitination, whereas
Fbl6 harboring mutations that disrupt the interaction with Tel
(Fig. 1C) failed to augment Tel ubiquitination (Fig. 2D). Fur-
thermore, in contrast to wild-type Tel, Fbl6 failed to stimulate
ubiquitination of either Tel with the SAM domain deleted
(TelSAM), which is unable to bind Fbl6, or TelEDBD.
Third, shRNA-mediated knockdown of Fbl6 both stabilized
steady-state endogenous Tel protein levels (Fig. 2E) and in-
hibited ubiquitin conjugation of Tel (Fig. 2F). If ubiquitination
of Tel is indeed F-box dependent, one should expect Tel to
associate with SKP1, which is a core component of SCF ubiq-
uitin ligases, and one should also expect SKP1 to play a role in
regulating steady-state Tel protein levels. Figure 2E shows that
endogenous Tel and endogenous SKP1 were copurified as a
complex from tissue culture cells, and it also shows that, sim-
ilarly to lowering fbl6 levels, the shRNA-mediated knockdown
of SKP1 stabilized steady-state endogenous Tel protein levels.
In cells, antibodies specific for endogenous Tel detect two
differently migrating protein species (29, 43), and the higher-
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FIG. 1. (A) Schematic representation of human and Drosophila Fbl6 proteins. Fbl6 is characterized by a conserved, N-terminal F-box domain (1) that
is 40 to 50 amino acids long. Two other blocks of conserved sequences, which have previously been defined as leucine-rich regions (LRD1 and LRD2),
are represented by black rectangles (4). The alignments of the primary amino acid sequences can be found in Fig. S1 in the supplemental material.
(B) The SAM domain of Tel is needed for association with Fbl6 in cells. HA epitope-tagged wild-type Tel, TelSAM, TelEDBD, and Tel harboring
substitutions of alanine for arginine in the Ets DNA-binding motif (KMSRALRHYYK) were each coexpressed with V5 epitope-tagged human Fbl6 in
293T cells. Fbl6 complexes were immunopurified from cell lysates using an antibody directed against the V5 epitope, and associated Tel proteins were
detected using an antibody directed against the HA epitope. (C) The LRDs of Fbl6 and an intact F-box domain are essential for interacting with Tel.
V5 epitope-tagged full-length Fbl6 or the indicated Fbl6 mutants were coexpressed with Tel in 293T cells. Tel complexes were immunopurified from cell
lysates by using an antibody directed against the HA epitope, and associated Fbl6 proteins were detected using an antibody directed against the V5
epitope. Fbl6Fbox contains a deletion of the F-box domain. Fbl6W and Fbl6LP have point mutations that have been shown to disrupt the F-box domain
(37). Fbl6LRD1 and Fbl6LRD2 harbor deletions of the LRD1 and LRD2 sequences, respectively. Fbl6(LRD1  LRD2) has a deletion of both
LRD1 and LRD2. h, human. (D) Fbl6 and Tel are colocalized in the nucleus. Cells were transfected with the indicated constructs and proteins detected
with the indicated antibodies. DAPI, 4,6-diamidino-2-phenylindole.
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FIG. 2—Continued
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molecular-weight form is likely to represent phosphorylated
Tel (29). Ectopic expression of Tel also produces two differ-
ently migrating proteins, and the higher-molecular-weight Tel
form is likely to be phosphorylated Tel because incubation with
phosphatase leads to a loss of this band and a concomitant
increase in the amount of the faster-migrating, unmodified Tel
species (Fig. 2G, upper panel). Figure 2G (lower panel) shows
that wild-type Fbl6, but not Fbl6 harboring mutations in either
the F-box domain or the leucine-rich regions, strongly pro-
motes the degradation of phosphorylated Tel. This suggests
that in cells, phosphorylation of Tel might further sensitize it to
Fbl6-mediated downregulation, perhaps by enhancing the af-
finity of Fbl6 for binding to Tel. Together, these data show that
Tel is ubiquitinated and that Fbl6 stimulates Tel downregula-
tion and ubiquitination.
Tel monomers are efficiently ubiquitinated in cells. Numer-
ous studies have established that the SAM domain is essential
for the monomers of Tel to form homotypic oligomers (17, 33,
37). Moreover, we showed earlier that the SAM domain is also
indispensable both for the binding of Fbl6 and for Tel ubiq-
uitination (Fig. 1B and 2B). In light of these findings, we
compared the ubiquitination of Tel oligomers and that of Tel
monomers. First, we established that Fbl6 can associate with
both Tel oligomers and Tel monomers. Figure 3A shows that
both wild-type Tel and a Tel mutant that is unable to self-
associate (TelA*) (37) efficiently interacted with Fbl6 in vitro,
whereas TelSAM, which is also monomeric, failed to bind
Fbl6. In contrast, in cells, wild-type Tel efficiently coimmuno-
precipitated with Fbl6, but TelA*, like TelSAM, did not (Fig.
3B). However, the interaction between TelA* and Fbl6, but
not that between TelSAM and Fbl6, was stabilized in the
presence of proteasome inhibitors (Fig. 3B), and furthermore,
TelA* was far more readily ubiquitinated than the wild-type
Tel (Fig. 3C), suggesting that Tel monomers are more labile
than Tel oligomers. We recently reported a similar phenome-
non with regard to the sumoylation of Tel (37). In cells, Tel is
efficiently sumoylated on lysine 11, whereas TelA* is detectably
sumoylated on lysine 11 in cells only in the presence of the
proteasome inhibitor MG132. Figure 3C shows that the ubiq-
uitination of TelA*, like wild-type Tel ubiquitination, was also
stimulated by Fbl6, in contrast to the ubiquitination of
TelSAM, which is unable to bind Fbl6. Collectively, these
findings revealed that Tel monomers can associate with Fbl6
and are efficiently ubiquitinated.
Fbl6 associates with Tel2 and stimulates its ubiquitination.
The SAM domain defines a subfamily of Ets transcription
factors, including Tel, Tel2, Ets1, and Ets2 from vertebrates as
well as Yan and Pointed P2 from Drosophila (23, 34). Since
Fbl6 associates with Tel via its SAM domain, we tested
whether Fbl6 also interacts with other SAM domain-contain-
ing Ets family members. Figure 3F shows that Fbl6 efficiently
associated with both Tel and Tel2 but did not copurify detect-
ably with Ets1 or Ets2, both of which express SAM domains, or
PU.1, which does not contain a SAM domain. Tel2 strongly
resembles Tel, both structurally and functionally (12, 30, 32),
and may have resulted from an earlier gene duplication of the
ancestral Tel gene. We found that, like Tel, Tel2 is ubiquiti-
nated and that Fbl6 augments Tel2 ubiquitination (Fig. 3F),
suggesting that Tel and Tel2 may share a common F-box-
dependent degradation pathway. In the future, it will be of
interest to determine whether Fbl6 plays a role in regulating
the activities of other factors in vivo.
Drosophila Fbl6 interacts with the Tel orthologue, Yan. Hav-
ing established a biochemical and functional interaction be-
tween human Tel and Fbl6, we next explored whether this
mechanism might be evolutionarily conserved. To that end, we
isolated a full-length Drosophila fbl6 (also referred to as
CG13213) cDNA from insect Schneider cells. Figure 4A and B
show that, like the binding of human Fbl6 to Tel (Fig. 1B and
C), Drosophila Fbl6 efficiently associated with Yan, and this
interaction depended on the Yan SAM domain (Fig. 4A) and
the LRD2 domain of Fbl6 (Fig. 4B). In contrast to Tel-Fbl6
binding, Yan-Fbl6 binding appeared to not require the LRD1
sequence (Fig. 4B).
FIG. 2. (A) Tel ubiquitination. The left panel shows the results of an experiment in which Flag epitope-tagged wild-type Tel was cotransfected
into U2OS cells with () or without () His epitope-tagged ubiquitin and cells were subsequently incubated in the presence () or absence ()
of MG132. Ubiquitinated Tel was recovered from cells lysed in guanidinium, by nickel bead purification (hereafter termed a ubiquitination assay).
The right panel shows a ubiquitination assay using HA epitope-tagged Tel and either a wild-type His epitope-tagged ubiquitin or a His
epitope-tagged version of ubiquitin in which all of the lysine residues have been mutated (K). (B) The SAM domain and EDBD of Tel are
required for its ubiquitination. U2OS cells were transfected with the indicated constructs (described in the legend to Fig. 1B), and a ubiquitination
assay was performed as described for panel A. (C) Mutations that disrupt the EDBD of Tel lead to the mislocalization of Tel to the cytoplasm.
Cells were transfected with the indicated constructs, and immunohistochemistry was performed with the antibodies shown. (D to G) Fbl6 promotes
the ubiquitination of Tel. (D) U2OS cells were transfected with the indicated constructs (see the legend to Fig. 1C), and a ubiquitination assay
was performed as described for panel A. (E) shRNA-mediated knockdown of fbl6 and skp1 leads to stabilization of endogenous steady-state Tel
protein levels. U2OS cells were infected with lentiviruses delivering the indicated shRNAs, and following 2 days of puromycin selection, stably
infected cells were lysed and proteins levels monitored with the indicated antibodies. Tubulin was used as a loading control for proteins.
Quantitative PCR was used to demonstrate effective knockdown of fbl6 and skp1 transcripts. In both cases, quantitative PCR was also used to show
that tel transcript levels were unaffected by any of the shRNA treatments (data not shown). The rightmost panel shows that endogenous Tel and
endogenous SKP1 form a complex in tissue culture cells. U2OS cells were lysed in protein lysis buffer (see Materials and Methods), and SKP1 was
purified from the lysate with a SKP1-specific antibody. Associated endogenous Tel was detected with a Tel-specific antibody. (F) Short-hairpin
RNA (shRNA)-mediated knockdown of Fbl6 inhibits Tel ubiquitination. Cells were transiently transfected with the indicated constructs, and a
ubiquitination assay was performed 2 days later. In the absence of an effective antibody specific for human Fbl6, the efficiency of Fbl6 knockdown
was assessed separately by targeting V5 epitope-tagged Fbl6 expressed in U2OS cells. A nonspecific small interfering RNA was used as a control
(see lower panel). (G) Fbl6 strongly promotes the degradation of phosphorylated Tel. The upper panel shows [35S]methionine-labeled Tel that was
immunopurified from U2OS cells, following 3 h of labeling, and then treated with 10 U of calf intestinal phosphatase or left untreated for 30 min
at 37°C. In the lower panel, cells were transfected with the indicated constructs, incubated in the presence () or absence () of MG132, and then
lysed in Laemmli sample buffer. Proteins were detected with the indicated antibodies. Western, Western blotting; IP, immunoprecipitation; h,
human.
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Fbl6 promotes Yan downregulation and ubiquitination.
Next, we determined whether Fbl6 influences Yan protein
stability. To that end, we established a number of stable
Schneider S2 cell lines and monitored their endogenous Yan
protein levels. We and others have established that in Drosoph-
ila, a protein named Mae (modulator of the activity of Ets)
orchestrates Yan derepression by binding to Yan, thereby dis-
rupting Yan self-association and binding to DNA and sensitiz-
FIG. 3. (A) Fbl6 binds efficiently with Tel monomers in vitro. Fusions were made between GST and either full-length wild-type Tel, full-length
Tel harboring mutations that disrupt the SAM domain (TelSAM and TelA*), or TelEDBD (see text for details). 35S-labeled Fbl6 was produced
by in vitro translation in reticulocyte lysates and assessed for binding to GST-Tel. (B) Inhibition of proteasome function stabilizes the interaction
between Tel monomers and Fbl6 in cells. Cells were cotransfected with the indicated Tel constructs along with V5 epitope-tagged Fbl6. Following
incubation with () or without () MG132, Fbl6 complexes were immunopurified from cell lysates by using an antibody directed against the V5
epitope, and the associated Tel protein was detected using an antibody directed against the HA epitope. (C) Tel monomers can bind with Fbl6
and are efficiently ubiquitinated; their ubiquitination is augmented by Fbl6. U2OS cells were cotransfected with the indicated constructs together
with His epitope-tagged ubiquitin, and a ubiquitination assay was performed. (D) Fbl6 interacts with Tel2 and stimulates its ubiquitination. HA
epitope-tagged versions of the indicated Ets transcription factors were coexpressed with or without Fbl6. Fbl6 complexes were immunopurified
from cell lysates using an antibody directed against the V5 epitope, and associated Ets proteins were detected using an antibody directed against
the HA epitope. For the ubiquitination assay, cells were transfected with the indicated constructs and processed as described in the legend to Fig.
2A. Western, Western blotting; IP, immunoprecipitation; h, human.
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FIG. 4. (A) The SAM domain of Yan is needed for Yan’s association with Fbl6 in cells. HA epitope-tagged wild-type Yan, Yan expressing a
deletion of the SAM domain (YanSAM), and Yan harboring a substitution of alanine at position 86 for arginine (YanA*) were each coexpressed
with V5 epitope-tagged Drosophila Fbl6 in 293T cells. Fbl6 complexes were immunopurified from cell lysates by using an antibody directed against
the V5 epitope, and associated Yan proteins were detected using an anti-Yan monoclonal antibody. (B) The LRD2 of Drosophila Fbl6 is essential
for interacting with Yan. V5 epitope-tagged full-length Fbl6 or the indicated Fbl6 mutants were coexpressed with Yan in Drosophila S2 cells. Fbl6
complexes were immunopurified from cell lysates by using an antibody directed against the V5 epitope, and associated Yan proteins were detected
using an anti-Yan monoclonal antibody. Fbl6F-box contains a deletion of the F-box domain. Fbl6LRD1 and Fbl6LRD2 harbor deletions of
the LRD1 and LRD2 sequences, respectively. Fbl6(LRD1  LRD2) has a deletion of both the LRD1 and LRD2 sequences. (C) Fbl6 regulates
Yan downregulation in Drosophila Schneider (S2) cells. Stable S2 cell lines in which expression of the indicated constructs was placed under the
control of the metallothionine promoter were established. Cells were transfected with or without the indicated double-stranded RNA (termed fbl6
RNAi [fbl6i] and skpA RNAi [skpAi]), and 2 days later, expression of the indicated constructs was induced with a 600 M copper sulfate solution.
Following a further 24 h of incubation, Western blot analysis was performed with cell lysates by using the indicated antibodies. In the absence of
an antibody specific for Drosophila Fbl6, the efficiency of Fbl6 knockdown was assessed by separately targeting V5 epitope-tagged Fbl6 proteins
expressed in S2 cells. A nonspecific double-stranded RNA was used as a control (see lower panel). (D) Yan is ubiquitinated, a process which is
augmented by Fbl6. The indicated constructs were expressed in insect Sf9 cells using baculoviruses, and a ubiquitination assay was performed (see
the legend to Fig. 2). d, Drosophila.
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ing it to downregulation that is dependent on mitogen-acti-
vated protein kinase (2, 33, 40, 41). Figure 4C shows that
ectopic expression of a constitutively active form of Ras alone
in Drosophila S2 cells had little detectable effect on steady-
state endogenous Yan protein levels. In contrast, ectopic Mae
expression alone strongly promoted endogenous Yan down-
regulation, and this effect was enhanced by activated Ras.
Under these conditions, incubation of the cells with MG132
failed to fully rescue Yan protein levels (Roukens and Baker,
unpublished), suggesting that Ras/Mae might destabilize Yan
by proteasome-independent and proteasome-dependent path-
ways. However, we found that double-stranded-RNA-medi-
ated knockdown of Fbl6 and SKPA (suppressor of kinetochore
protein A), which is a core component of the ubiquitinating
machinery (1, 26, 39, 47, 48), inhibited Mae/Ras-dependent
Yan downregulation (Fig. 4C). These results suggest that in
cells, SKP and Fbl6 play a role in facilitating Yan degradation.
To ascertain whether Yan can be ubiquitinated and whether
Fbl6 augments Yan ubiquitination, we employed the baculo-
virus system for Yan expression in insect Sf9 cells (6). Figure
4D shows that ubiquitin was efficiently and covalently conju-
gated to Yan and that the coexpression of Fbl6 strongly stim-
ulated this ubiquitination. Together, these data suggest that
Fbl6 promotes Yan downregulation and stimulates Yan ubiq-
uitination.
Fbl6 regulates Yan protein levels in vivo. In order to inves-
tigate the in vivo role of Fbl6, we monitored Yan protein levels
in Drosophila embryos that are lacking expression of fbl6. To
that end, we analyzed the enhancer trap line, P{GawB}NP0326,
which is viable as a homozygote. Figure 5A schematically shows
that P{GawB}NP0326 contains a P element that is inserted
into the 5 untranslated region of fbl6, 60 base pairs upstream
of the initiation codon. By precise, transposase-mediated exci-
sion of the P element, we recovered several reverted lines that
were confirmed by the sequencing of their genomic DNA.
Figure 5A shows that while the revertant lines have wild-type
levels of the fbl6 transcript, fbl6 expression is strongly reduced
in P{GawB}NP0326 embryos. Moreover, P{GawB}NP0326
embryos that were hemizygous for two different chromosomal
deletions covering this region also lacked fbl6 expression (Fig.
5B). Band 47F1 on chromosome 2R is a relatively gene-rich
region, and we noted two other genes (CG13220 and
CG18335) in close proximity to the P-element insertion site in
P{GawB}NP0326. Figure 5B shows that whereas expression of
fbl6 is disrupted in P{GawB}NP0326 embryos, expression of
both CG13220 and CG18335 appears to be unaffected. To-
gether, these analyses suggest that the P element specifically
disrupts fbl6. Next, we assessed endogenous Yan protein levels
in embryos carefully staged to stage 12. Figure 5C shows that
the reverted lines express wild-type Yan protein levels,
whereas P{GawB}NP0326 embryos have enhanced Yan pro-
tein levels. Coupled to our prior biochemical analysis, this
suggests that in vivo, Fbl6 contributes to Yan downregulation.
To further validate these findings, we analyzed the expression
of argos, an epidermal growth factor receptor signaling antag-
onist, whose expression is regulated by Yan (7, 8, 9). Consis-
tent with our finding of elevated Yan protein levels in fbl6-
deficient embryos, Fig. 5D shows a wave of argos expression
during embryo development that is significantly inhibited in
P{GawB}NP0326 embryos. Collectively, our analyses suggest
that in vivo, Fbl6 participates in the process of Yan downregu-
lation.
Overall, our work suggests that an evolutionarily conserved
F-box-protein-dependent degradation pathway participates in
the regulation of the activity of both vertebrate Tel and its
invertebrate orthologue, Yan. Presumably, this serves to fur-
ther refine spatiotemporal control of gene expression by these
transcriptional repressors.
DISCUSSION
The ancestral Ets repressor Yan and its vertebrate ortho-
logue, Tel (ETV6), play pivotal roles in the control of cell
differentiation (15, 19, 22, 27, 35, 36, 45, 46). Because these
factors directly and negatively regulate gene expression (19, 22,
27, 35), deciphering the mechanisms that regulate their activity
is crucial for understanding the spatiotemporal control of cell
differentiation. We recently found that sumoylation of an N-
terminal lysine residue encoded by Tel (TelK11) serves to
inhibit repression of gene expression by Tel (37). We have
further explored Tel/Yan posttranslational regulation, and
here we report that both Tel and Yan protein downregulation
is promoted by an evolutionarily conserved F-box-protein-de-
pendent mechanism. Specifically, we found that both Tel and
Yan can be ubiquitinated and that ubiquitination is facilitated
by Fbl6, which sensitizes these proteins for degradation. It is,
of course, possible that other F-box proteins may also play a
role in regulating Tel/Yan activity, perhaps in a tissue-specific
fashion, and future studies should clarify this.
The Tel/Yan SAM domain is required for association with
the F-box protein Fbl6. We found that the SAM domain of
both Tel (Fig. 1B) and Yan (Fig. 4A) is required for the
binding of Fbl6. The SAM domain defines a subfamily of Ets
transcription factors, including Tel, Tel2, Ets1, and Ets2 from
vertebrates as well as Yan and Pointed P2 from Drosophila (23,
33), raising the possibility that at least some of these factors are
also targeted by Fbl6 or a related F-box protein. Indeed, we
found that human Fbl6 also associates with the Tel-related
Tel2 protein and promotes its ubiquitination (Fig. 3F). Fur-
thermore, we found biochemical interactions between Dro-
sophila Fbl6 and the SAM domain-containing proteins Pointed
P2 (3, 27) (but not P1, which lacks the SAM domain) and Mae
(2, 33, 41) in tissue culture cells (Roukens and Baker, unpub-
lished). However, we were unable to detect associations be-
tween Fbl6 and either Ets1 or Ets2, each of which harbors a
SAM domain, suggesting that there is specificity, perhaps
structural, that determines these interactions. Many other fam-
ilies of proteins express SAM domains, such as the polycomb
group proteins and components of the mitogen-activated pro-
tein kinase cascade (34). It should be interesting to investigate
whether Fbl6 (or related F-box proteins) plays a role in regu-
lating their activity.
Tel monomers are especially labile and prone to ubiquiti-
nation. Our data support the idea that Tel/Yan monomers are
more susceptible to ubiquitination and degradation than the
oligomeric forms of these proteins are. Apparently, and para-
doxically, the biochemical interactions between Tel/Yan
monomers and Fbl6 were found to be far weaker than the
interactions between Tel/Yan oligomers and Fbl6 (Fig. 3B and
4A). However, these interactions were strongly stabilized in
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the presence of proteasome inhibitors (Fig. 3B), suggesting
that the failure to find strong associations between these pro-
teins resulted from the instability of the Tel/Yan monomer and
of the Fbl6 complex. Consistent with this, we found that Tel
monomers were more readily ubiquitinated than wild-type Tel
(Fig. 3C). It is worth noting that, in general, wild-type Tel is
detected in cells as a phosphorylated or nonphosphorylated
protein species and that the phosphorylation of Tel appears to
further sensitize it to Fbl6-mediated degradation (Fig. 2G). In
contrast, phosphorylated forms of monomeric Tel are evi-
dently especially unstable and are detected only in the pres-
ence of proteasome inhibitors (M. G. Roukens, M. Alloul-
Ramdhani, and D. A. Baker, unpublished data). It has
previously been described that Tel is negatively regulated by
extracellular signal-regulated kinase-induced phosphorylation
of serine residues 213 and 257 (24). Phosphorylation of these
sites could be a trigger for promoting Tel ubiquitination, al-
though in our ubiquitination assays, we were unable to detect
an obvious effect of mutating these residues or an additional
putative mitogen-activated protein kinase target, serine resi-
due 22 in the N terminus of Tel (M. Alloul-Ramdhani and
D. A. Baker, data not shown). Our previous work also supports
FIG. 5. Fbl6 regulates Yan downregulation in vivo. (A) P{GawB}NP0326 flies have strongly diminished levels of fbl6 expression. RT-PCR was
performed on cDNA prepared from stage-15 embryos derived from the indicated fly lines. Levels of tubulin transcript were determined as a control
for the procedure. (B) The P element of P{GawB}NP0326 flies specifically disrupts fbl6 and not adjacent transcripts. RT-PCR was performed as
described for panel A. (C) Yan protein levels are elevated in P{GawB}NP0326 embryos. Embryos were carefully staged to stage 12 and lysed in
Laemmli sample buffer. Yan protein levels were determined by Western blotting with a Yan monoclonal antibody, and tubulin protein levels were
determined as a loading control. (D) Expression of argos is attenuated in P{GawB}NP0326 embryos. cDNA was prepared from total RNA isolated
from differently staged embryos. Levels of argos expression and control tubulin expression were determined by RT-PCR.
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the contention that Tel/Yan monomers are relatively labile
(37). Monomeric Tel was detectably and very efficiently sumoyl-
ated in cells only in the presence of proteasome inhibitors,
suggesting that this species of Tel is normally very unstable.
The current model of Tel function holds that Tel monomers
directly associate via their conserved SAM domains and that
the resulting DNA-bound oligomers oppose the transcription-
activating apparatus (reviewed in references 34, 42, and 44).
Since Fbl6 also interacts with the Tel SAM domain (Fig. 1 and
4), perhaps self-associated Tel oligomers are relatively more
resistant to F-box-mediated degradation than are Tel mono-
mers because of reduced accessibility to exposed SAM do-
mains. In the future, it should be of considerable interest to
elucidate how Tel sumoylation and ubiquitination are precisely
integrated to regulate Tel activity.
Fbl6 regulates Yan protein stability. Our work suggests that
Fbl6 regulates Yan protein levels in vivo. Drosophila embryos
that lack fbl6 expression contain significantly elevated levels of
Yan protein. Consistent with this, the levels of expression of a
downstream target of Yan named argos was sharply reduced.
Surprisingly, we were unable to find obvious morphological
phenotypes, including during photoreceptor development
(such as clear alterations in normal ommatidium development)
or wing development, either in embryos, in larvae, or in adult
flies that lack fbl6 expression (Alloul-Ramdhani and Baker,
unpublished). Moreover, we could not observe any detectable
phenotypic consequences for embryos that were deficient in
fbl6 expression and also in expressing loss-of-function muta-
tions of mae or the recently identified miR7 microRNA, both
of which are also negative regulators of Yan activity in vivo (2,
21, 41, 44; Alloul-Ramdhani and Baker, unpublished). This
may reflect genetic redundancy with other F-box-containing
proteins or perhaps a broader role for Fbl6 as a regulator of
other proteins that might counteract the function of Yan and
therefore prevent any obvious mutant phenotypes resulting
from elevated Yan protein levels. Indeed, in tissue culture
cells, we found biochemical interactions between Fbl6 and
known antagonists of Yan function, including the SAM do-
main-containing proteins Pointed P2 (3, 27) (but not P1, which
lacks the SAM domain) and Mae (2, 33, 41) (Roukens and
Baker, unpublished). Also, the nature of Tel/Yan degradation
may be tissue specific and mediated by distinct or overlapping
protein-degrading processes. For example, it has been sug-
gested previously that the PEST sequences of Yan may be
determinants of Yan stability (35), which may attract, or act
independently of, the F-box-dependent ubiquitination system.
In addition, altering the concentration of ubiquitination effec-
tors can have a substantial impact on the function of the tar-
geted proteins, which may influence whether or not a morpho-
logical phenotype is discernible. For example, different levels
of Mdm2 have profoundly different impacts on p53 function;
low levels promote p53 monoubiquitination and subsequent
nuclear export, whereas high Mdm2 levels lead to polyubiq-
uitination and proteasomal degradation (20).
Normal cell development and differentiation rely upon an
orchestrated program of actions that must be controlled pre-
cisely, both spatially and temporally. We describe here an
evolutionarily conserved pathway of Tel/Yan downregulation.
This complements our recent work on Tel sumoylation and
previous studies that delineated the function of these unique
repressors (2, 15, 19, 22, 27, 35, 36, 45, 46). Our future work
aims to uncover further regulatory features of these crucial
cellular mechanisms and to provide a unified framework for
how these different processes impinge on Tel/Yan and collabo-
ratively elicit an appropriate cellular response.
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Supplemental TABLE 1. Proteins that interact with both Drosophila Yan and human 
Tel.  
 
Independent yeast-2-hybrid screens were performed using either Yan or Tel as a bait. Yan 
was used to screen an 18 hr Drosophila embryo library (Clontech) and Tel was used to 
screen a human bone marrow library (Clontech).  
 
1) Sir2/ CG5216 
2) INT6/ CG9677 
3) Regulator of chromosome condensation 1 (RCC1)/  CG10480 
4) Pin1 (peptidyl prolyl isomerase)/ CG17051 
5) (CBP/p300)/ CG15319 
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Branching from conduits is a defining feature of the gas-delivery systems of 
invertebrates (tracheae built from epithelial cells) and vertebrates (vasculature lined 
by endothelial cells). In this paper, we show that the vertebrate transcriptional 
repressor Tel plays an evolutionarily conserved role in angiogenesis: it is 
indispensable for sprouting of primary human endothelial cells and for the normal 
development of the Danio rerio embryo blood circulatory system. Tel controls 
endothelial sprouting through binding to the generic co-repressor C-terminal binding 
protein (CtBP). In endothelial cells, the Tel:CtBP complex temporally restricts a 
VEGF-mediated pulse of dll4 expression and consequently integrates VEGFR 
intracellular signalling and intercellular Notch-Dll4 signalling. It further refines 
branching by regulating expression of other factors that constrain angiogenesis such 
as sprouty family members and ve-cadherin. Thus, the Tel:CtBP complex moderates 
the balance between stimulatory and antagonistic sprouting cues and thereby 
conditions endothelial cells for angiogenesis. Since the activity of CtBP is attuned to 
intracellular NADH levels, our results raise the possibility that Tel-mediated 
sprouting could be sensitized to the metabolic status of the tissue. Tel control of 
branching appears to be a refinement of the ancient mechanism of branching 
morphogenesis of the invertebrate tracheae that requires Yan, the invertebrate 
orthologue of Tel. Collectively, our work suggests that Tel is a central regulator of 
angiogenesis and highlights Tel and its associated networks as potential targets for the 
development of therapeutic strategies to inhibit pathological angiogenesis.   
 
The endothelium is a one cell thick, tubular network lining the luminal surface of the blood 
and lymphatic vasculature of vertebrates. Its development is highly dynamic and exhibits a 
tremendous capacity for remodeling. To allow post-parturition tissue growth and also 
wound healing, the vasculature remains quiescent rather than irreversibly fixed and has 
retained its embryonic propensity for ramifying by the process of angiogenesis yielding, in 
the case of the adult human, a system approximately 100 000 kilometers in length. Broadly 
speaking angiogenesis consists of a number of sequential steps: detachment of smooth 
muscle cells (pericytes); extracellular matrix (ECM) remodeling by proteases; movement, 
proliferation and tube formation of endothelial cells; vascular stabilization through 
association of pericytes, and the initiation of blood flow. Under normal physiological 
conditions it is meticulously controlled spatio-temporally and is essential for 
embryogenesis, tissue growth and wound healing
1,2,3,4,5
. By contrast, pathological 
angiogenesis is relatively anarchic, epitomized by the angiogenic switch whereby tumours 
excite the re-routing of the local vasculature that enables sustained tumour growth. 
Although many of the mechanisms that govern physiological and tumour angiogenesis are 
shared, the vessels that innervate tumors are architecturally flawed and appear to be placed 
in a haphazard fashion
6,7,8,9
.    
 
Current knowledge has highlighted two principal, and opposing, signal transduction 
pathways underlying angiogenesis: intracellular vascular endothelial growth factor (VEGF) 







 coupled to molecular and 
biochemical studies in primary endothelial cells
27,28,29,30,31
, have yielded an emerging 
picture in which VEGFR activation stimulates angiogenesis, whereas Delta-Notch signaling 
broadly inhibits the process. The vertebrate VEGF system, comprising five ligands and 
three receptors, is a highly conserved, tyrosine kinase signaling pathway that is integral to 
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the formation and homeostasis of the related endothelial and haematopoietic tissues in 
vertebrates
32
. There is ample evidence that this pathway is the primary impetus to 
angiogenesis by stimulating endothelial cell proliferation and differentiation as well as 
regulating endothelial cell migration by modulating their adhesiveness. By example, 
corruption of the best characterized endothelial cell mitogenic signal, VEGFA activation of 
VEGFR2, leads to a failure of embryogenesis associated with a near-absence of 




To fashion a new vessel, the angiogenesis-inducing VEGF signal must be counterposed by 
other signal(s) to ensure VEGFR activation of an appropriate amplitude and duration.  The 
Notch signaling pathway that is controlled by four distinct receptors and five ligands, plays 
an important role in this process
2,11,33
. One such ligand, Delta-like 4 (Dll4) has emerged as 
the prime mover in angiogenesis
17
 emphatically illustrated in mice, where Dll4 
heterozygous embryos, in common with VEGFA heterozygous mouse embryos, exhibit 
embryonic lethal haploinsufficiency due to vascular defects
34,35
. In addition, genetic 
evidence from studies in zebrafish
22,25
 and strong evidence from the targeting of primary 
endothelial cells with neutralizing Dll4 antibodies
30
 and pharmacological inhibitors of 
Notch receptor signaling
20
, collectively revealed Dll4 as an angiogenesis antagonist.  
 
Previous work suggested that the stimulatory VEGFR and inhibitory Dll4-Notch networks 
are directly linked and form a negative feedback loop that controls sprouting
13,36
. By 
analogy with branching of epithelial cells during development of the invertebrate 
tracheae
37,38
, in endothelial cells VEGFR activation induces Dll4 expression
20,29,39,40
 that in 
turn stimulates Notch signaling in adjacent cells leading to attenuation of VEGFR 
signaling. This signaling network leads to the functional differentiation of endothelial 
cells
16,17
. Cells with elevated Dll4 levels competitively adopt a migratory tip cell fate atop 
proliferating stalk cells
17
. Evidence suggests that the reciprocal regulation of VEGFR 
signaling output by Dll4-Notch, can be achieved by at least two means. First, Notch 
signaling can repress expression of VEGFR2
41
. Second, Notch concomitantly induces 
expression of the decoy receptor VEGFR1, further compromising VEGFR2 signaling
27
. 
While much is known about the regulatory interplay between VEGFR and Notch, the 
identity of a basic transcriptional unit responsible for directly integrating the two signaling 
pathways has remained elusive.  
 
Although most invertebrates lack an endothelium, the development of the Drosophila 
tracheae and vertebrate endothelium, seem to be controlled by similar genetic programs. In 
Drosophila, the Ets transcriptional activator Pointed (Pnt), the orthologue of vertebrate 
Ets1, plays a key role in tubulogenesis
1,37
. Pnt is induced in primary tip cells and 
orchestrates secondary branching, in part at least, through driving expression of the tyrosine 
kinase receptor antagonist Sprouty
42
 that regulates the duration of receptor activation. 
Further, correct tubulogenesis is ensured by FGFR-mediated induction of the Notch ligand 
Delta. Elevated Delta expression in tip cells then triggers Delta-Notch-mediated lateral 
inhibition, which prevents the trailing cells from adopting the same developmental 
characteristics of the tip cells
1,37,38,43
. In many well-defined developmental contexts in 
Drosophila, promotion of gene expression by Pointed is counteracted by the highly related 
Ets transcription repressor, Yan
44,45
. The activity of each is differently sensitized to the 
MAPK signal transduction pathway which stimulates Pointed whilst inhibiting Yan
46
. Thus, 
during tracheal branching, it appears that FGF-dependent increases in the levels of Pointed 
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Since Yan is important for tracheal branching in Drosophila, it is possible that its vertebrate 
orthologue Tel (Translocation ets leukemia gene) or ETV6 (ets variant gene 6) (hereafter 
referred to as Tel) may play similar roles in tubulogenesis. Consistently, mice lacking Tel 
fail to develop and exhibit defects in angiogenesis of the yolk sac
47
. The majority of Ets 
transcription factors are expressed in endothelial cells, and a substantial number of 
endothelial-specific genes seem to harbour DNA-binding motifs for Ets proteins
48,49,50
. 
Moreover, studies in mice and zebrafish suggest that Ets family members appear to play a 




Tel is unique in the Ets family in being a dedicated transcription repressor
56,57,58
. It is highly 




have revealed it to be 
essential for development and viability. Although some elements of its modus operandi 
have been delineated, a direct role in angiogenesis and how this role may be executed has 
not been described. Here we show that Tel is essential for endothelial sprouting and 
uncover a new link between Tel and the co-repressor C-terminal binding protein (CtBP)
62,63
 
that is required for this function. We find the Tel:CtBP complex modulates sprouting by 
regulating the abundance of those factors such as Dll4, SPRY and VE-Cadherin that 
normally serve to constrain the process. The Tel:CtBP complex is highly attuned to 
VEGFR signaling and in this way acts as a hub that enables a controlled balance between 
VEGFR intracellular signaling and intercellular Notch-Dll4 signaling. It is established that 
CtBPs bind to NAD(H) that promote their dimerization
64,65
. CtBP, therefore, may function 
as a redox sensor that links the cellular metabolic status to transcriptional regulation
66,67 
. 
Thus, our coupling of Tel and CtBP raises the possibility that Tel activity is sensitized to 
the redox status of the cell and has unveiled a means by which the tumor microenvironment 




Tel is essential for endothelial cell sprouting 
To study the role of the evolutionarily conserved Ets repressor Tel in endothelial sprouting 
(angiogenesis), we investigated Tel function directly in primary human endothelial cells. To 
this end we adapted a recently described 3-D primary cell culture assay
68
 that faithfully 
captures many characteristics of in vivo angiogenesis: proliferation, migration, sprouting, 
tubulogenesis, anastomosis, and yields multicellular, branching vessels with defined lumens 
(see Fig 1a). This system has a number of experimental advantages since it is tractable 
genetically, biochemically and molecularly and permits an unequivocal analysis of Tel 
function specifically in endothelial cells, less hindered by potentially disparate effects on 
endothelial sprouting of Tel expressed in other cell types. For all of our analyses we relied 
on two cell types that yielded almost identical results in all studies: freshly harvested 
human umbilical vein endothelial cells (HUVECs)
69
, and an immortalized version of these 
cells termed ECRF cells
70
. These cells differ in the kinetics of branching and their 
requirement for supporting primary fibroblasts. Whilst HUVECs strictly require fibroblasts 
and execute vessel formation in 7-9 days, ECRF cells sprout more rapidly (starting after 
one day), do not absolutely require fibroblasts and generate vessels of smaller caliber 








Figure 1. Tel is essential for endothelial sprouting. a. Establishment of an assay of endothelial 
sprouting in 3-D fibrin matrices. Primary endothelial cells were attached as a monolayer to collagen-coated beads 
of approximately 100uM diameter (400 cells/bead). Beads were embedded in a fibrin matrix and overlayed with 
primary human fibroblasts that provide essential nutrient and growth factors, thus mimicking the stromal cell-
endothelial cell interaction. Formed vessels following 7-10 days of culture vessels are shown. Vessels were stained 
with DAPI to demonstrate the multicellular nature of the sprouts, F-actin and the endothelium-specific marker 
PECAM-1. The lower panels highlight the tubular nature of the vessels: DAPI staining on the left and a CD31 
stained transverse section taken from a paraffin-embedded vessel that was cultured as above. b. Tel is required for 
endothelial sprouting. Stable endothelial cell lines were derived from primary HUVECs in which the levels of 
endogenous Tel were abrogated by one of 4 different Tel-specific shRNA-expressing lentiviruses (Teli #1- #4). 
Lentiviruses expressing a scrambled shRNA were used as a control (Mock) which had no effect on endogenous 
Tel levels (shown in the accompanying Western blot of cell lysates). A 3-D fibrin assay was performed as 
described in (a). Also shown is a analysis of canonical VEGFR signaling. Stable HUVEC lines (Mock and Teli)  







targeting endogenous tel or a control shRNA, we established stable cell lines lacking Tel 
(Teli) or expressing wild type Tel levels (Mock) (Fig 1b). Fig 1b shows that mock infected 
cells efficiently execute vessel formation (indistinguishable from uninfected wild type 
HUVECs or ECRF cells, data not shown) and that Tel is indispensable for endothelial 
sprouting because cells lacking Tel (Teli) fail to form vessels. The inability of these cells to 
sprout is not caused simply by a failure of these cells to respond to VEGF. Analysis of the 
canonical VEGFR signal transduction pathway of these primary cells, by monitoring 
downstream ERK phosphorylation, indicated that depletion of Tel did not overtly disrupt 
this pathway suggesting that the basic VEGFR signaling apparatus is both present and 
functional in these cells (Fig 1b). We validated the Teli phenotype initially by two means 
(and further corroborated by experiments described in Fig 5). First, we employed four 
different Tel-specific shRNA-expressing lentiviruses each of which strongly abrogated Tel 
levels and correspondingly abolished endothelial sprouting (Fig 1b). Second, we performed 
'rescue' experiments employing ectopically expressed Tel. Fig 1c shows that ectopic Tel 
expression excites the opposite effect of loss of Tel and strongly stimulated sprouting of 
HUVECs. Moreover, ectopic Tel expression in a loss of function Tel HUVECs line, 
resolved the block to sprouting of these cells (Fig 1c). Together, these data suggest that Tel 
is essential for endothelial sprouting. 
 
Since Tel is a dedicated repressor of gene expression we surmised that it directly 
orchestrates endothelial sprouting by means of transcriptional repression. Thus, we sought 
to decipher the mechanistic details of repression of gene expression by Tel and to identify 
targets of the Tel repression complex that together control angiogenesis.  
 
 
Tel interacts with CtBP 
To elucidate the mechanism by which Tel regulates endothelial sprouting we first 
investigated a previously unknown interaction between Tel and the generic co-repressor C-
terminal Binding Protein (CtBP) (see Fig 2). CtBPs are evolutionarily conserved, 
ubiquitiously expressed transcriptional co-factors
62,63
 that are essential for normal 
development
71
 by associating with their partners via a consensus binding motif
72
 (see Fig 
2a). We found a consensus CtBP-binding motif in the Drosophila orthologue of Tel (named 
Yan) that is conserved in all known invertebrate Yan homologues and is essential for the 
binding of Yan to Drosophila CtBP in vitro and in tissue-culture cells (data not shown). All 
known vertebrate Tel proteins harbour a completely conserved motif with a strong 
resemblance to this sequence (Fig 2a), suggesting that this interaction is conserved. To test 
this, we first employed the recently developed technique of Proximity Ligation In Situ 
Assay (P-LISA) that enables a quantitative visualization of defined endogenous protein 
By this means, we showed that a Tel:CtBP complex is present in primary endothelial cells 
(Fig 2b). This endogenous interaction was confirmed biochemically using a Tel-specific 
 
directly in Laemmli buffer and Western blotting was performed using the indicated antibodies. c. Ectopic 
expression of Tel stimulates sprouting, and rescues the loss-of-function Tel phenotype, of primary endothelial 
cells. Primary endothelial were stably infected with lentiviruses expressing either control shRNA (Mock) or an 
shRNA directed against the non-coding region of tel for the down regulation of endogenous Tel (Teli). These cell 
lines were subsequently further stably infected with lentiviruses for expressing either control GFP or HA epitope 
tagged Tel that was resistant to the inhibitory effect of the co-expressed Tel shRNA. A 3-D fibrin assay was 
performed as described in (a & b). Expression of endogenous and ectopic Tel was confirmed by Western 
blotting.complexes in cells73.  
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antibody that co-purified Tel and CtBP from lysates prepared from primary HUVECs (see 
Fig 2b). To corroborate this evidence and to test if the human Tel and CtBP associate via 
the consensus CtBP-binding motif, we performed multiple molecular and biochemical 
analyses of endogenously expressed proteins, as well as ectopically expressed mutants that 
collectively established the following. First, using both ectopically expressed proteins (Fig 
2c) and also endogenous proteins (Fig 2d), we demonstrated that Tel and CtBP associated 





have developed and refined a model for Tel activity that suggests that Tel, 
broadly speaking, exists in two different forms: relatively stable (repressing) oligomers and 
unstable (non-repressing) monomers. Our data suggests that in contrast to the efficient 
association with Tel oligomers, the interaction between CtBP and Tel monomers (TelA*) is 
relatively transitory in cells (Fig 2c & 2d), although Tel monomers and CtBP do efficiently 
interact in vitro (data not shown). Second, both the PxEIM sequence of Tel (Fig 2c & 2d) 
and the previously determined substrate-binding cleft of CtBP1 and CtBP2
64
 (Fig 2e), are 
each indispensable for CtBP binding to Tel. Third, we found that Tel preferentially 
associated with CtBP2 with relatively high affinity, but to a far lesser degree to CtBP1 (see 
Fig 2c & 3a). To further validate this, we employed a DNA binding assay and demonstrated 
that Tel efficiently associated with the Ets binding site in association with CtBP2 but not 
CtBP1 (Fig 3a). The specificity of this interaction was confirmed by the absence of binding 
to Tel of a CtBP2 mutant harbouring a mutation of its binding cleft (see Fig 2e) that 
precludes interaction with the CtBP-binding motif of Tel (Fig 3a). Indeed, our data suggests 
that CtBP1 might competitively antagonize CtBP2 binding to DNA-bound Tel (Fig 3b). 
CtBP1 and CtBP2 share a high degree of sequence homology (80% identity; 91% overall 
similarity), but differ completely in the composition of their N-termini (composed of 
fourteen amino acids and twenty amino-acids respectively). Our mutational analysis of 
CtBP2 suggests that the substantially higher binding of CtBP2 to Tel is mediated by the 
positively charged residues in this region (that are absent in CtBP1). These residues could 
selectively reinforce binding to Tel through ionic interactions with the negatively charged 
amino acids abutting the Tel PxEIM motif. Fig 3c shows that the N-terminus of CtBP2 (but 
not CtBP1) is positively charged due to three arginine residues (and a histidine residue) 
together with three lysine residues (K6, K8 and K10) that are known substrates of 
acetylation and which are required for correct CtBP2 subcellular localization (via 
acetylation of K10)
78
. We found that mutation of these residues had no effect on the 
interaction between Tel and CtBP2 so long as the positive charge was preserved, whereas 
loss of the charge abrogated the interaction (Fig 3c). As expected
78
, mutation of these 
residues to either arginine or alanine resulted in mislocalization of CtBP2 (data not shown). 
In light of these findings, it is noteworthy that knock-out studies in mice revealed that 
whereas mice lacking CtBP1 are viable and fertile (although 30% smaller), loss of CtBP2 
leads to embryonic lethality
71
. This implies that some CtBP2 functions are non-redundant 
and our evidence suggests that regulation of Tel could be one such case. Overall, these data 
show that Tel harbours a bona fide CtBP-binding site through which it binds to CtBP1 and 
CtBP2 but to CtBP2 with substantially higher efficiency. 
 
CtBP control of Tel Stability requires its NAD(H) binding cleft 
Having established that Tel and CtBP2 associate with one another, next we defined the 
mechanistic consequences of this interaction. Our investigations uncovered two prominent 
effects suggesting that CtBP2 is required for stable Tel function in the nucleus. First, 




H. sapiens     --MKTPDEIMSGRTDRLEHLESQELDEQIYQEDEC------------------------------------- 
M. musculus    --MKTPDEIMSGRTDRLEHLESQVLDEQTYQEDEPTIASPVGWPRGNLPTGTAGGVMEAGELGVAVKEETRE 
G. gallus      --MKTPDEIMSGRTDRLEHLESQALDEQIYQEDEC-------------------------------------    
X. tropicalis  --MKTPEEIMSGRTDRLEHLESQELDEQMYQEDEC------------------------------------- 
D. rerio      --MKTPDEIMSGQTERLEHLESD-TDDQIYVKEEC------------------------------------- 
 
 
D. melanogaster   -–DLKPTDLSVSSKSTATSNED(50)MDQASEQAQPVPMESDCNGGESEDSFRHMQQ 
B. mori  --EEMPTDLSMSASEPWRKRARSDTATAPPSSTQHDKHRISTLIGDNMIMKREVDYSAEHYALNLKSEKCEQ 
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Figure 2. Tel associates with CtBP via a bona-fide consensus binding motif. a. The Tel 
CtBP-binding motif is highly conserved. An alignment of the Tel C-termini of different species reveals a strongly 
conserved motif with significant resemblance to the previously described CtBP-binding motifs. b. Tel and CtBP 
are present as a complex in primary endothelial cells. Primary HUVEC cells were stably infected with shRNA-
expressing lentivruses for the targeted disruption of Tel (Teli), CtBP2 (CtBP2i) or a non-specific shRNA (Mock). 
Effective knock downs were confirmed by Western blotting as shown. To demonstrate an endogenous Tel:CtBP 
complex we deployed the recently developed technology of proximity ligation in situ assay (P-LISA)73. For this 





mutation, not only abolished binding of CtBP2 to Tel (see Fig 2), but also led to a 
pronounced mislocalization of Tel from the nucleus to the cytoplasm (Fig 4a). Second, we 
found that loss of CtBP2 caused a progressive loss of endogenous Tel stability (Fig 4b) and 
consistently, ectopic expression of CtBP enhanced Tel protein levels (see Fig 4b & 4c; data 
not shown). These effects were post-translational since tel transcript levels remained 
relatively unaltered under these conditions (data not shown). 
 
Previous studies have reported that the interaction of CtBP1 with certain cellular repressors 
appears to be dramatically enhanced by NADH but not NAD+ 
66,67
. Consequently, CtBP 
has been postulated to be a redox sensor that links the cellular metabolic status to 
transcriptional regulation. To assess whether CtBP-dependent  regulation of Tel stability 
required binding of NAD(H) to CtBP, we engineered versions of CtBP, expressing a point 
mutation in the NAD(H) binding cleft, such that it is unable to complex with these 
metabolites
64
. Fig 4d shows that this mutant appeared to function in a dominant negative 
manner because wild type Tel, but not a Tel mutant lacking the CtBP-binding consensus 
motif, was significantly more labile when co-expressed with this CtBP mutant (Fig 4d). 
Together, these experiments suggest that CtBP is needed for maintaining normal Tel 
stability which is dependent on the NAD(H)-binding cleft of CtBP, presumably via 
differential binding of NAD(H). The coupling of Tel and the redox sensor CtBP raises the 
possibility that Tel function might be linked to the metabolic status of the cell that could be 
especially relevant to metabolically sensitive processes like angiogenesis, a theme that will 
be further elaborated in the discussion (see Supplementary data).  
 
Tel regulation of endothelial sprouting requires CtBP 
Our discovery of an endogenous Tel:CtBP complex in primary endothelial cells (Fig 2b) 
coupled to our earlier demonstration of the necessity of Tel for endothelial sprouting (see 
Fig 1) suggested that Tel control of endothelial sprouting might be CtBP-dependent.  We 
first explored this by monitoring the behaviour of the endogenous Tel:CtBP complex in 
primary endothelial cells, in response to the primary angiogenesis-promoting signal, VEGF. 
Stimulation with VEGF triggered a wave of ERK phosphorylation during a period of 
approximately 30 minutes and peaking between 5-10 minutes (Fig 5a), demonstrating that 
the VEGFR signal transduction pathway was activated. Concurrent to this, we observed a  
 
human CtBP. The accompanying table shows a quantitative measure of relative complex formation per cell 
(RCP/cell) that is abolished by ablation of either Tel or CtBP. The lower right panel shows the co-purification of 
an endogenous Tel:CtBP complex from primary HUVECs. The indicated cells lysates were incubated with a Tel 
antibody antibody and CtBP proteins were detected using a CtBP polyclonal antibody (Santa Cruz). c. Tel 
associates most readily with CtBP2 in cells, via its encoded PxEIM motif. Cells were transfected with the 
indicated constructs and Tel:CtBP complexes were purified from the cells then detected (by Western blotting) 
using the indicated antibodies. Tel∆PxEIM lacks the PxEIM motif and TelA* is a monomeric version of Tel that is 
unable to oligomerize57,58. TelIM-GG describes a mutant in which the isoleucine and methionine residues (IM) of 
the PxEIM motif have been replaced by two glycines (GG). d. Tel association with endogenous CtBP2 requires 
the PxEIM motif. Stable cell lines expressing the indicated Tel proteins were established and association with 
endogenous CtBP2 was determined by immunopurification of the complexes from cell lysates using the indicated 
antibodies. TelA* is a monomeric version of Tel. Tel∆SAM, Tel∆Ets and Tel∆C34 respectively harbour deletions 
of the SAM domain, DNA-binding domain and the C-terminal 34 amino acids (including PxEIM) of Tel. e. The 
substrate-binding cleft of CtBP2 that interacts specifically with the PxEIM motif, is essential for binding of Tel 
and CtBP. Cells were transfected with the indicated constructs and complexes were purified from cell lysates 
using the indicated antibodies. CtBP2A58E and CtBP2V72R each express single point mutations in their substrate 
binding cleft. Structural analysis and computer modeling demonstrated that these amino acids should contact the 
PxEIM motif64. CtBPK10R harbors a substitution of lysine at position 10 for an arginine residue.  
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Figure 3. The N-terminus of CtBP2 reinforces stable interactions between CtBP2 and 
Tel. a. CtBP2 but not CtBP1 associates with DNA–bound Tel. Lysates were prepared from tissue culture cells 
containing the indicated proteins and biotin-labeled Tel DNA-binding sites were used to co-purify Tel and Tel-
associated proteins. Mutant CtBP proteins are described in Fig 2e. Specific proteins were detected by Western 
blotting. b. CtBP1 disrupts the interaction between CtBP2 and DNA-bound Tel. An assay was performed exactly 
as described in a. c. The positively charged N-terminus of CtBP2 mediates high affinity binding to Tel. Shown is 
an alignment of the N-termini of CtBP1 and CtBP2 highlighting the charged residues of CtBP2 (italic and 
underlined) that were changed either to arginine (R) or alanine (A). CtBP1∆dim and CtBP2∆dim each harbour 
mutations of the dimerization interface that abolish binding to Tel. Shading marks the beginning of high amino 
acid conservation. The indicated combinations of constructs were expressed in tissue culture cells, and complexes 
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Figure 4. CtBP regulates Tel stability and sub-cellular localization. a. Disruption of the 
CtBP-interacting motif of Tel leads to mis-localization of Tel from the nucleus to the cytoplasm. Cells were 
transfected with indicated constructs and immunofluorescence was performed with the indicated antibodies. 
Tel∆PxEIM and TelIM-GG are described in Fig 2c and each fail to bind Tel. b. Loss of CtBP promotes Tel 
instability. Specific shRNA-expressing lentiviruses were used to ablate expression of tel, ctbp1 and ctbp2 in ECRF 
endothelial cells. Resultant stable cell lines were cultured for three weeks and the effects on endogenous protein 
levels was assessed by Western Blotting with the indicated antibodies. c. Elevating CtBP levels stabilizes Tel. 
Cells were stably transfected with the shown combinations of Flag-epitope tagged versions of CtBP. The effects 
on endogenous Tel were determined by Western blotting of cell lysates. d. Tissue culture cells were transfected 
with the indicated constructs and Western blotting of cell lysates was performed using the indicated antibodies. 
CtBP1∆NAD and CtBP2∆NAD each express point mutations of the NAD(H) binding cleft that excludes 




transient disassembly of the endogenous Tel:CtBP complex for a duration mirroring the 
kinetics of ERK phosphorylation (see also Fig 6c). The uncoupling of the Tel:CtBP 
complex was not associated with either a global, detectable degradation or sub-cellular 
redistribution of the Tel or CtBP (data not shown). These findings suggest that the 
Tel:CtBP complex is finely attuned to the VEGFR signal transduction pathway in primary 
endothelial cells and several lines of evidence lent extra support to the notion that Tel 
control of endothelial sprouting requires CtBP. First, in common with loss of Tel, ablation 
of CtBP2 (and CtBP1, but to a lesser degree, data not shown), strongly inhibited endothelial 
sprouting (Fig 5b). Analysis of downstream ERK phosphorylation, showed that in common 
with loss of Tel, loss of CtBP did not overtly disrupt the basic VEGFR signaling apparatus 
of these cells (see Fig 5b). Second, in contrast to the ability of ectopically expressed Tel to 
stimulate sprouting of wild type endothelial cells, ectopic Tel expression failed to trigger 
sprouting of endothelial cells lacking CtBP2 (Fig 5c). Third, whereas ectopic expression of 
wild type Tel promoted endothelial sprouting, expression of Tel lacking the CtBP-binding 
motif, failed to stimulate sprouting (Fig 5d). Finally, unlike ectopic expression of wild type 
Tel, ectopic expression of Tel lacking the CtBP-binding motif was unable to rescue the Tel 
loss-of-function phenotype in endothelial cells (Fig 5d). Together, these findings favour the 
view that Tel control of endothelial sprouting requires CtBP. Tellingly, comparison of two 
prior mouse studies shows that Tel -/- embryos
60
 and CtBP2 -/- embryos (but not CtBP1 -/- 
embryos)
71
 similarly exhibit yolk sac vasculature defects. 
 
Tel:CtBP-dependent control of dll4, spry and ve-cadherin expression regulates 
endothelial sprouting 
Angiogenesis results when the averaging of stimulatory and inhibitory cues favours 
sprouting and it is increasingly established that hierarchical signaling between two 
apparently counterposed signal transduction pathways are integral to the process: 
intracellular VEGFR signaling and intercellular Notch signaling. Although there is 
evidence that these opposing signaling networks are functionally integrated
13,36
, to date, a 
basic transcriptional machinery that moderates the interplay between the pathways has not 
been identified. We reasoned that Tel conditions endothelial cells for sprouting by 
repressing the expression of factors that serve to constrain process. To test this, we first 
determined the global gene expression profiles of wild type primary endothelial cells 
(infected with Mock shRNA) and primary endothelial cells lacking either Tel (Teli) or 
CtBP2 (CtBP2i). As expected, the expression levels of a substantial proportion (>50%) of 
the genes that were significantly enhanced (de-repressed) in Teli endothelial cells were also 
enhanced in the CtBP2i endothelial cells (See Supplementary Table 1). Notably, the 
expression of the Notch ligand dll4, as well as downstream targets of the Notch signaling 
pathway (e.g hey1 and hes4) were strongly enhanced. Thus, we initially focused on the 
regulation of the endothelial-restricted Notch receptor ligand Dll4, for which there is 
compelling evidence that it is a potent antagonist of angiogenesis (see above).  In support of 
the transcriptome analysis, using quantitative real time pcr, we confirmed that loss of either 
Tel or CtBP2 in HUVECs triggered a significant net increase in the expression of dll4 
suggesting that the Tel:CtBP complex normally acts to repress its expression (Fig 6a). 
Consistent with this, we found that loss of Tel from HUVECs yielded increased levels of 
Dll4 protein (Fig 6b). Dll4 is one of five known Notch receptor ligands and we found 
expression of dll1, dll4 and jagged1 in HUVECs. Whereas the net expression of dll4 was 
sharply enhanced in cells lacking Tel or CtBP2, the net expression of both dll1 and jagged1 





        
 






              




Figure 5. Tel control of endothelial sprouting requires CtBP. a. The Tel:CtBP complex is 
sensitized to VEGFR signaling. Primary endothelial cells were cultured without serum then stimulated with 50 
ng/ml VEGF for the indicated periods. The lower panel shows (by Western blotting) the kinetics of MAPK 
phosphorylation during the indicated time-course. Above this are images of a P-LISA atop a graphic 
representation of a quantitative measure of the relative amounts of complex during the same time-course. b. Tel 
and CtBP2 are each required for endothelial sprouting. Stable HUVECs cell lines were established in which the 
levels of Tel or CtBP2 were abrogated by specific shRNA-expressing lentiviruses (see Western blot). A 3-D fibrin 
assay was performed as described in Fig 1a. To ensure specificity, at least 4 different shRNA constructs were 
tested and ingle representatives are shown. In these cells, canonical VEGFR signaling is not overtly disrupted by 







specifically regulates dll4 expression. This is interesting in light of recent work that showed 
that different Notch ligands play distinct roles in angiogenesis- inhibition of angiogenesis 




To establish if Tel:CtBP control of Dll4 availability is attuned to VEGFR signaling, we first 
determined the profile of dll4 expression in primary endothelial cells in response to VEGF. 
As previously highlighted in Fig 5a, stimulation with VEGF elicited a wave of ERK 
phosphorylation and a concomitant, transitory splitting of the Tel:CtBP complex (Fig 6c). 
Accompanying this, we observed a sharp pulse of dll4 expression peaking between 30-60 
mins (Fig 6c). This resembles previous reports highlighting the upregulation of dll4 (in the 
case of blood vessels)
 20,29,39,40
 and its Drosophila orthologue delta (during tracheal 
development)
 1,37,38,43
 in response to VEGF and FGF signaling respectively. Our evidence 
indicates that this program is enacted cell-autonomously since VEGF also stimulated a 
pulse of dll4 expression, of comparable amplitude and duration, in primary endothelial cells 
that were sparsely plated and thus do not engage direct cell-cell signaling pathways (data 
not shown). We next tested whether Tel associates with the dll4 promoter and if the VEGF-
driven disassembly of the Tel:CtBP complex is accompanied by a loss of Tel DNA-
binding. The putative human and mouse dll4 promoters share a high degree of homology 
and the sequence upstream of the predicted transcription start site is rich in consensus ETS 
DNA-binding sites (Fig 6d). Fig 6d shows that Tel associated with dll4 gene elements 
proximal to the predicted transcription start site (and not to sequences distal to this, data not 
shown). Furthermore, VEGF stimulated the expulsion of Tel from the dll4 promoter during 
a time-frame mirroring the splitting of the Tel:CtBP complex (Fig 6d). The absence of an 
effective antibody precluded a similar, conclusive analysis of CtBP. Collectively, these data 
suggest that the Tel:CtBP complex orchestrates the temporal control of Dll4 availability by 
VEGF signaling.  
 
To ascertain whether the elevated levels of Dll4 in endothelial cells lacking Tel contributes 
to their failure to sprout, we abrogated the activity of Dll4. Generic pharmacological 
inhibitors of Notch signaling have been shown to stimulate endothelial sprouting
17,22
. In 
light of our data that revealed Tel to be a specific regulator of Dll4 availability (see Fig 6a), 
we selectively targeted this pathway. For this, we exploited a recently reported neutralizing 
anti-Dll4 antibody that directly inhibited Dll4 function causing potent, aberrant sprouting of 
HUVECs
30
. In full agreement with their study, we found that the same antibody  
 
either control shRNA-expressing lentiviruses (Mock) or specific shRNA-expressing lentiviruses to diminish 
expression of Tel (Teli) or CtBP2 (CtBP2i). Effective knock-down was confirmed by Western blotting. Cells were 
cultured in serum-free medium and stimulated with 50ng/ml VEGFA for the indicated periods of time. Cells were 
lysed in sample buffer and Western blotting performed with the indicated antibodies. c. Stimulation of endothelial 
sprouting by ectopically expressed Tel requires CtBP2. Stable primary endothelial cell lines were established by  
infection with lentiviruses expressing either control shRNA (Mock) or an shRNA directed against ctbp2 for the 
down regulation of endogenous CtBP2 (CtBP2i). These cell lines were subsequently further stably infected with 
lentiviruses for expressing either control GFP or HA epitope tagged Tel. A 3-D fibrin assay was performed as 
described above. Levels of endogenous and ectopically expressed proteins were determined by Western blotting. 
d. Ectopic expression of Tel but not Tel∆PxEIM stimulates endothelial sprouting and rescues the loss-of-function 
Tel phenotype. Primary endothelial were stably infected with lentiviruses expressing either control shRNA (Mock) 
or an shRNA directed against the non-coding region of tel for the down regulation of endogenous Tel (Teli). These 
cell lines were subsequently further stably infected with lentiviruses for expressing either control GFP or HA 
epitope tagged versions of Tel or Tel∆PxEIM each of which were resistant to the inhibitory effect of the co-
expressed Tel-specific shRNA. A 3-D fibrin assay was performed as described above. Levels of endogenous and 




dramatically stimulated sprouting of HUVECs (Fig 6e). Furthermore, inhibiting Dll4 
function with the antibody restored sprouting by cells lacking Tel or CtBP2 (Fig 6e). The 
anti-Dll4 antibody stimulated Mock cells more than Teli cells presumably because of the 
aberrant upregulation of other angiogenesis-constraining factors, in addition to dll4, in Teli 
cells. 
 
As well as Notch-Dll4 intercellular signaling, the activity of a number of other factors 
strongly influence angiogenesis and ensure that signaling of an appropriate stringency 
elicits an appropriate cellular response. An early, initiating step of angiogenesis is the loss 
of cell adhesion and subsequent migration of endothelial cells away from the vessel wall. 
This is achieved through alterations in the pattern of expression of ve-cadherin, the 
primary, endothelial adhesion molecule
3,80
. Sprouty proteins (encoded by spry) are 
inhibitors of tyrosine kinase signaling first described as mediators of tracheal development 
in Drosophila
1,37,81
. In this system it appears that Yan, the Drosophila orthologue of Tel, 
might orchestrate secondary tracheal branching by repressing spry expression thus 
preventing inappropriate inhibition of FGF signalling
42
. We investigated whether the 
Tel:CtBP complex regulates the expression of ve-cadherin and spry family members. We 
initiated this study by determining the expression profiles of these genes (by qPCR) in 
stable cell lines prepared from HUVECs (and ECRF cells), in which the levels of Tel or 
CtBP2 were abrogated by specific shRNA-expressing lentiviruses (Fig 6a). Like dll4 
expression, we found that loss of Tel or CtBP2 led to a significant net increase in the 
expression of ve-cadherin and spry4 (there are 4 human spry genes
81
 all of which were 
similarly effected (data not shown) suggesting that the Tel:CtBP complex normally acts to 
repress expression of these genes. Consistent with this, we found that loss of Tel from 
HUVECs was associated with increased levels of VE-Cadherin protein (Fig 6b). Our global 
expression profiling analyses found the expression of spry4 to be augmented both in cells 
lacking Tel and in cells lacking CtBP2. ve-cadherin expression levels were found to be 
significantly increased in cells lacking CtBP2 but not in cells lacking Tel (see 
Supplementary Table 1).  
 
To determine if mis-expression of ve-cadherin, like illicit expression of dll4, also 
contributes to the observed failure of endothelial sprouting due to loss of Tel, we abrogated 
expression of ve-cadherin in these cells and assessed sprouting. The intolerance of cells to 
loss of spry precluded an analysis of Tel regulation of spry in these assays. To inhibit 
expression of ve-cadherin, we deployed shRNA-expressing lentiviruses specifically 
targeting ve-cadherin expression. Fig 6f, shows that loss of ve-cadherin alone, stimulated 
endothelial sprouting (similarly to ectopic expression of wild type Tel) and as expected, 
loss of Tel provoked a failure of sprouting. However, loss of ve-cadherin in cells lacking 
Tel partly compensated for the loss of Tel and reconstituted sprouting of these cells (Fig 
6f). 
 
Altogether, from the above studies we deduce that the Tel:CtBP complex operates as a hub 
that co-ordinates the stimulatory and inhibitory signaling networks that collaboratively 











        
 
Figure 6. Tel primes endothelial sprouting by constraining expression of sprouting 
antagonists.  
a. Loss of Tel or CtBP2 augments expression of dll4, ve-cadherin and spry genes. Stable primary HUVECs cell 
lines were derived following their infection with either control shRNA-expressing lentiviruses (Mock) or specific 
shRNA-expressing lentiviruses to diminish expression of Tel (Teli) or CtBP2 (CtBP2i). Effective knock-down was 
confirmed by Western blotting. Expression levels of the indicated transcripts were determined by real time qPCR. 
All values were averaged relative to three different control genes: TATA binding protein (TBP), signal recognition 
particle receptor (SRPR) and calcium-activated neutral proteinase 1 (CAPNS1). b. Loss of Tel leads to a 
concomitant increase in the levels of Dll4 and VE-Cadherin. Immunofluorescence was performed on cells (as 
described in 6b) using the indicated antibodies. The left panel shows double-staining with Tel and Dll4 antibodies. 
The right panel shows VE-cadherin staining (double-staining was precluded due to the absence of available 
antibodies). c. The Tel:CtBP regulates dll4 expression in response to VEGFR signaling. Primary endothelial cells 
were cultured without serum then stimulated with 50 ng/ml VEGF fro the indicated periods. Three assays were 
performed. The top right panel shows (by Western blotting) the kinetics of MAPK phosphorylation during the 
indicated time-course. Next to this are images of a P-LISA atop a graphic representation of a quantitative measure 
of the relative amounts of complex during the same time-course. For the bottom panel, RNA was collected at each 
time-point, and qPCR was performed (as above) to determine the levels of dll4 expression. d. Tel associates with 
conserved elements in the dll4 promoter. An alignment of the human and mouse putative dll4 promoter. The 
presumed transcription start site is highlighted in italics. Conserved core consensus Ets DNA-binding sites are 
shown in bold. A ChIP analysis was performed on primary endothelial cells incubated with or without 50 ng/ml 
VEGF for the indicated times. Three different primer sets centered on the illustrated promoter region were used 
and a single representative is shown (all three gave very similar results). Equivalent amounts of rabbit IgG were 
used as a control and results are presented as fold changes in recovery (as a fraction of input) relative to the 
control. The lower panel shows endogenous dll4 expression levels under identical conditions. e. Inhibition of Dll4  
 









restores the sprouting of cells lacking Tel. Stable primary endothelial cell lines were established by  infection with 
lentiviruses expressing either control shRNA (Mock) or an shRNA directed against tel or ctbp2 for the down 
regulation of endogenous Tel (Teli) or CtBP2 (CtBP2i). A 3-D fibrin assay was performed as described above in 
the presence or absence of a neutralizing anti-Dll4 antibody (5ug/ml)30. Endogenous protein levels were 
determined by Western blotting with the indicated antibodies. f. Loss of VE-Cadherin allows endothelial cells  
 






Human   AGGAAAAGGAGATCGGATTTCCC-TAGCGCTGGTTTTTGCATTCCGGGCTTAAGTTCTTT 414 
Mouse   AGGAAAGGGAGATCC-AAATCCCCTGGTCCTGCTTTTTGCTTTCCTAGTTTAAGCTTTCC 403 
        ****** *******  *  **** * *  *********** ****  * ***** * *   
 
Human   TTACCTGCTTTGGAACACTAGGTAACTAGCGCCTGCTGCGGATGCACAGCCTACAGGGAC 474 
Mouse   CCACCTGCTAGAGGACTGTAGGTATCTAATGCCTGGATCAGGTGCACCGCCTACGGGGAC 463 
          *******   * **  ****** ***  *****   * * ***** ****** ***** 
 
Human   TGCCTAGTGTCTCCGCCCCCAAGACCATCCCCGAACCACCCACTCACCTCCTGCCCCATT 534 
Mouse   CCCTTAGAGTTTCCACCCCCTGGACCATTCGGGAACCACC---TCACCTCCCGCCGCATC 520 
          * *** ** *** *****  ****** *  ********   ******** *** ***  
 
Human   ACCGGGCAACCCCTCTATCCTCCGGCGGCCAGGGTCTCAGCCCTTAACCCCGCCATCACG 594 
Mouse   ACTGGGCTACCCTCCTATCCTCTGGTGGCGAGGGTCTCAGCCTTTAAGCAGACGATCTCT 580 
        ** **** ****  ******** ** *** ************ **** *   * *** *  
 
Human   GAGGACTGGTCACCTCGGCACGCGCAGAGCTGGGGGACCTAGAGGTTGGGAGCGGCACGG 654 
Mouse   AAGGACTGCTCGCCG-GGCACGCGCAGAGCTGGAAG-CCCAGAAGTT-GGAA-------G 630 
         ******* ** **  *****************  * ** *** *** ***        * 
 
Human   AGGGGCGGGGACCTGCGCCCGACTGGCTGACGGGGAGGGGGGAGCGGCGGGGGCGGAGGC 714 
Mouse   AGGGGCGGGGACCTGCGCCCTACTGGCTGGCTGACAGGG-GGAGCGGCGGGGGCGGAGGC 689 
         ******************* ******** * *  **** ******************** 
 
Human   CCCCTCCGGGCGGCGCTGGGACTGTAGCAGCTAGAGGCCGGGAGGGGAGGGGAGAATGAC 774 
Mouse   CCCCTCCGGTGGGTGCTGGGACTGTAGCCACTAGAGGCCTGGAGGGGAGGGGAGAGTGAC 749 
        *********  ** **************  ********* *************** **** 
 
Human   CATGAGTCTGAGTGACAGGCGG--CGAGGAGAGGAGCCAATATATATAA 821 
Mouse   CGTGAGTCTGTCTGACTGACAGGCTGCGAAGAGCAGCCAATATATATAA 798 
        * ********  **** * * *   * * **** *************** 
 
lacking Tel to sprout. Stable primary endothelial cell lines were established by infection with lentiviruses 
expressing either control shRNA (Mock) or an shRNA directed against tel for the down regulation of endogenous 
Tel (Teli). These cell lines were subsequently further stably infected with lentiviruses for expressing either control 
shRNA (Mock) or an shRNA directed against ve-cadherin. A 3-D fibrin assay was performed as described above. 
Endogenous protein levels were determined by Western blotting with the indicated antibodies. 
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The Tel:CtBP complex is required for normal development of zebrafish embryo 
vasculature 
To explore this model in a developmental context, we investigated the role of the Tel:CtBP 
complex in blood vessel formation during early Danio rerio embryogenesis.  
All vertebrate Tel proteins share a very high degree of homology including the consensus 
CtBP-binding motif (see Fig 2a). To establish if there might be functional conservation 
between human and Danio rerio Tel we first analysed zebrafish Tel (zTel) in human 
endothelial cells. Fig 7a shows that in common with ectopic expression of human Tel 
(hTel), zTel stimulated endothelial sprouting, whereas zTel lacking the CtBP-binding motif 
failed to do so. Moreover, like hTel, ectopic expression of zTel but not zTel without the 
CtBP-binding motif, restored the capacity to sprout of primary endothelial cells lacking 
endogenous Tel. Thus, in this assay, zTel could replace the ability of hTel to stimulate 
sprouting of human primary endothelial cells. 
 
The founding of the zebrafish embryo circulatory system provides a readily accessible 
arena in which to interrogate the molecular mechanisms governing angiogenesis in vivo. 
The fli1a:gfp transgenic line
82
 produces embryos in which all of the endothelial cells are 
marked by GFP and coupled to the optically diaphanous nature of the embryos, this allows 
systematic visualization of in vivo angiogenesis. During the first couple of days following 
fertilization, the processes of vasculogenesis and angiogenesis collaboratively establish the 
circulatory system. Particularly striking, is the reiterated pattern of intersegmental trunk 
vessels. These are formed by angiogenic sprouts from dorsal aorta (DA) endothelial cells 
that grow to the dorsal side of the trunk where they interconnect to form the dorsal 
longitudinal anastomotic vessel (DLAV)
83
 (see Fig 7b). Our results using primary human 
endothelial cells raised three predictions. First, disrupting Tel function would perturb 
normal zebrafish embryo angiogenesis. Second, loss of CtBP2 would enhance this effect. 
Third, inhibiting the Tel:CtBP complex would illicitly de-repress expression of downstream 
target genes of the Notch/Delta pathway as well as spry4. To test this we employed 
morpholinos (MOs) targeting endogenous zebrafish Tel and CtBP2. To confirm the 
effectiveness of the MOs, we generated GFP mRNA transcripts that included sequences 
complementary to our MOs such that their translation in zebrafish embryos would be 
blocked by co-injection of the functional, specific MO. Supplementary Fig 1 shows that 
GFP mRNA including sequences complementary to either the Tel MO or CtBP2 MO 
efficiently produced GFP protein in zebrafish embryos when co-injected with a non-
complementary MO but failed to translate GFP in the presence of its complementary MO, 
demonstrating that the MOs can efficiently block translation in a sequence-specific fashion. 
We further confirmed the efficiency of the two Tel MOs used in the study by Western 
blotting of embryo lysates using a zebrafish Tel polyclonal antibody (see Supplementary 
Fig 1). Fig 7b shows that whereas injection of a control MO had no detectable effect on the 
pattern of intersegmental vessels, injection of 2 ng of Tel MO caused a clear disruption of 
the pattern in most (70-80%) of the injected embryos, manifested by a reduction in the 
number of vessels and the premature stalling of dorsal aorta sprouts resulting in gaps in the 
DLAV (embryos were scored mutant if a minimum of 10-20% of the intersegmental vessels 
were disrupted). Increasing the concentration of injected MOs induced proportionately 
more severe phenotypes in the majority (70-80%) of embryos (data not shown). Similar 
effects were observed with two different Tel MOs. Like the Tel MOs, injection of the 
CtBP2 MO (at concentrations > 1 ng) caused disruption of the intersegmental vessels in the 















Figure 7. Tel and CtBP2 are required for zebrafish embryo angiogenesis. a. Zebrafish Tel 
(zTel) can replace the ability of human Tel (hTel) to stimulate sprouting of human endothelial cells. ECRF cells 
were stably infected with lentiviruses expressing either control shRNA (Mock) or an shRNA directed against the 
non-coding region of tel for the down regulation of endogenous Tel (Teli). These cell lines were subsequently 
further stably infected with lentiviruses for expressing either control GFP or HA epitope tagged versions of zTel or 
zTel∆PxEIM each of which were resistant to the inhibitory effect of the co-expressed Tel-specific shRNA. A 3-D 
fibrin assay was performed as described above. Levels of endogenous and ectopically expressed proteins were 
determined by Western blotting. b. Zebrafish embryos derived from the transgenic fli1a-gfp line were injected at 
the 1-2 cell stage with the indicated MOs. Vessels were visualized by confocal microscopy 4 days after 
fertilization. The dorsal aorta (DA) and dorsal longitudinal anastomotic vessel (DLAV) is highlighted. The 
accompanying table show the results of a typical experiment. Grade I mutants exhibited alterations of a minimum 
of 10-20% of the intersegmental vessels. Grade II mutants exhibited alterations in >50% of the intersegmental 
vessels. At least 50 embryos of each MO injection were scored. Similar results were obtained in 5 separate 
experiments. c. Zebrafish embryos were injected with the indicated MOs at the 1-2 cell stage. Following 24 hours 
of development, RNA was prepared from 30 staged embryos from each condition. Expression levels of the 
indicated transcripts were determined by real time qPCR. All values were averaged relative to expression of 
elongation factor-1 alpha (EF-1a) whose expression remains relatively invariant during the early stages of 
zebrafish development. The mean values of 3 separate experiments are shown. 
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CtBP2 MO was increased (data not shown). Fig 7b demonstrates that injection of 1ng of 
CtBP2 MO, like the control MO, had no obvious effects on the intersegmental vessels. 
However, the same concentration of CtBP2 synergistically enhanced the Tel MO phenotype 
suggesting that in common with Tel:CtBP control of human endothelial sprouting, Tel and 
CtBP2 cooperatively regulate normal zebrafish embryo intersegmental vessel formation 
(Fig 7b).  
 
To gain mechanistic insight into the role of Tel and CtBP in zebrafish embryo angiogenesis, 
we monitored the expression of hey 1 and hey 2, which are downstream targets of the Notch 
/Delta pathway, as well spry4 which negatively regulates VEGFR signaling. Through an 
unbiased transcriptome analysis and by qPCR, we previously established that the Tel:CtBP 
complex controls expression of these genes in primary human endothelial cells (see Fig 6). 
Fig 7c shows that loss of Tel in zebrafish embryos, led to increased expression of hey1, 
hey2 and spry4. Furthermore, co-injection with the CtBP2 MO enhanced this effect, 
particularly in the case of hey1 and hey2. The relatively low levels of expression of dll4 
precluded a conclusive, quantitative analysis of its expression. These results are in 
agreement with previous analyses in zebrafish embryos that showed that the net effect of 




Collectively, these data suggests that the Tel:CtBP complex plays an evolutionarily 
conserved role in the control of angiogenesis. By constraining expression of negative 
regulators of VEGFR signaling, in a spatio-temporally controlled manner, this complex 
modulates the signaling output from the opposing Notch/Dll4 and VEGFR signal 
transduction pathways and ensures appropriate endothelial sprouting. This work also 




During the last few years two prominent and counterposed pathways have emerged as key 
orchestrators of angiogenesis: intracellular VEGF/VEGFR signaling and intercellular 
lateral inhibition governed by Dll4/Notch signaling. Together, these pathways guide and 
influence many facets of angiogenesis such as alterations in cell proliferation, migration 
and adhesiveness. There is good evidence that these pathways directly interact via positive 
and negative feedback mechanisms, however, to date, a transcriptional apparatus that 
underlies endothelial sprouting and regulates the relative output of this signaling network, 
has not been described. Here, we have identified a Tel:CtBP complex as instrumental to 
endothelial sprouting. Tel:CtBP functions as a VEGF-regulated barrier that fine tunes 
angiogenesis by modulating the equilibrium between pro-angiogenic cues and those factors 
that serve to constrain the process, such as Dll4-Notch signaling, Spry production and VE-
Cadherin levels. 
 
VEGF-Dependent Control of Dll4 availability by the Tel:CtBP Complex 
To elicit an appropriate cellular response, the activity of interacting signaling networks 
must be precisely controlled temporally. In primary human endothelial cells we have 
discovered a cell-autonomously encoded signaling algorithm that links pro-angiogenic 
intracellular VEGFR signaling directly to the intercellular Notch/Dll4 pathway that serves 
to restrain angiogenesis. We have found that in response to VEGF, a repressive Tel:CtBP 
complex transiently splits and dissociates from dll4 promoter elements (during the course 
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of 30 mins) liberating a pulse of dll4 gene expression that peaks 30-60 mins following the 
addition of VEGF (Fig 6). This is a refinement of previously published work demonstrating 
that VEGF stimulates dll4 expression
20,29,39,40
. This characteristic response is cell-
autonomous since it occurred in the presence or absence of cell-cell contact. In this way the 
Tel;CtBP complex conditions the cell for angiogenesis since the availability of Dll4, is rate 
limiting for the activation of Notch receptor signaling. Consequently, prolonged loss of the 
complex leads to illicit expression of dll4 and activation of Notch/Dll4 signaling which 
inhibits normal sprouting (Fig 6 & Supplementary Table 1). Consistently, in cells lacking 
the Tel:CtBP complex, the capacity to sprout can be revived by realigning the activities of 
the VEGF/VEGFR and Notch/Dll4 pathways by specifically inhibiting the increased levels 
of Dll4 found in these cells (Fig 6e). This program appears to be evolutionary conserved in 
vertebrates since the sprouting defects in both primary human endothelial cells as well as 
zebrafish embryos, due to disruption of the Tel:CtBP complex, are associated with elevated 
expression of Notch/Delta downstream target genes (Figs 6 & 7). The dll4 promoter 
harbours a number of conserved consensus Ets DNA-binding sites, so in addition to the Tel 
repressor, other Ets family members might be required for the control of dll4 expression. 
By analogy with Drosophila tracheal branching, Tel might compete with Ets transcriptional 
activators for common DNA sites. Intriguingly, there is one (perhaps two) highly conserved 
AP-1 binding sites (see Fig 6d- also present in the promoter of zebrafish dll4) immediately 
upstream of the putative transcription start site and in close proximity to a cluster of 
consensus Ets DNA-binding sites, raising the possibility of an interplay between Tel:CtBP 
and the essential AP-1 complex in the regulation of dll4 expression by VEGF. Tellingly, in 
primary endothelial cells, we found the expression of both Jun and Fos, each of which 
interact to form the herterodimeric AP-1 complex, to be sharply increased in response to 
VEGF (MGR & DAB unpublished).  
 
In addition to (indirectly) regulating expression of Notch downstream target genes, by 
controlling Notch receptor activation via regulation of the availability of the Dll4 ligand, 
Tel:CtBP might also play a more direct role in regulating their expression. Both our 
unbiased transcriptome analysis of primary human endothelial cells and our directed, 
quantitative analyses of gene expression in both primary human cells as well as zebrafish 
embryos, revealed that loss of Tel:CtBP led to enhanced expression of the downstream 
effectors of Notch signaling such as the Hairy/Enhancer of Split (Hes) and hairy/enhancer-
of-split related with YRPW motif (Hey) family members (see Figs 6 & 7). The Notch 
signaling pathway is highly conserved. Upon ligand binding, the intracellular portion of the 
Notch receptor translocates to the nucleus where it promotes transcription of the Hes and 
Hey family of transcriptional repressors by interacting with CSL (named after vertebrate 
CBF1, Drosophila Su(H), and C. elegans LAG1) thereby converting it from a 
transcriptional repressor to a transcriptional activator
84,85
. The consensus DNA-binding site 
of CSL, GTGGGAA
86
, includes the core (GGA) Ets DNA-binding site raising the 
possibility that Hes and Hey expression could result from direct competition for DNA-
binding between the CSL and Tel:CtBP complex. 
 





Drosophila border cell movement
88
, endothelial tip cells pioneer the formation of 
endothelial sprouts along growth factor gradients. Elegant in vivo experiments with mouse 
retinas established that a defined gradient of VEGF is essential for normal 
angiogenesis
16,17,19
. By example, perturbing this gradient by increasing the concentration of 
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VEGF in the retina inhibited plexus spreading
16
. In this light, with the caveat that the 
experiments were conducted on isolated primary cells in 2-D cultures, it is noteworthy that 
Tel:CtBP-dependent control of dll4 expression by VEGF was not reiterative when the 
supply of VEGF was continuous. Thus, following the initial wave of dll4 expression, 
further addition of VEGF failed to stimulate either ERK phosphorylation or a further 
subsequent wave of controlled de-repression of dll4 (MGR & DAB unpublished). However, 
removal of the VEGF following the initial pulse of dll4 expression, reset the cells to 
execute the response following a lag of between 40 mins (half maximal response) to 60 
mins (full response). Presumably, this reflects the dynamics of VEGFR recycling, a notion 
supported by a report that prolonged stimulation with VEGF failed to completely mobilize 
VEGFR2 receptors from their sub-membranal endosomal pool
89
. Moreover, a number of 





The VEGF-VEGFR/Dll4-Notch network delimits temporally (and spatially) the behaviour 
of endothelial cells. In this view, the Tel:CtBP complex prescribes the duration of VEGFR 
signaling by linking it to the constraining influence of the Dll4-Notch pathway as well as to 
other factors that serve to control VEGFR signaling output, the subject of the ensuing 
section. 
 
An Evolutionarily Conserved Mechanism of Branching Morphogenesis 
Previously, studies in mice and (less obviously) Drosophila, provided the best evidence of a 
role for Tel in angiogenesis. Mouse embryos lacking Tel failed to maintain yolk sac 
vasculature and exhibited angiogenic defects
47
. In common with vertebrate angiogenesis, in 
Drosophila, the concerted action of two central pathways shape tracheal branching 
morphogenesis: intracellular RTK (FGF-FGFR) and Notch/Delta signaling
1,37,38,42,43
. In this 
system, FGFR signaling is modulated via the opposing actions of the Ets transcription 
activator Pointed (the orthologue of vertebrate Ets-1) and the repressor Yan (the orthologue 
of vertebrate Tel)
42
. Each are phosphorylated by ERK which differently effects their 
function; Pointed is activated whereas Yan in down regulated. During tracheal 
development, the best characterized common target of these transcription factors is sprouty, 
which encodes an antagonist of RTK-signaling. Thus, evidence indicates that FGFR 
signaling inactivates Yan thereby favouring Pointed-driven expression of sprouty that 
negatively regulates FGFR signaling. Collectively, our analyses of human primary 
endothelial cells and early development of the zebrafish circulatory system, suggest that 
transcriptional control of spry expression by Yan/Tel is evolutionarily conserved and is 
required for appropriate sprouting of endothelial cells because in both systems, disruption 
of the Tel:CtBP complex caused a sharp rise in spry4 expression (see Figs 6 & 7). 
Currently, the exact mechanism by which Sprouty proteins control RTK signaling is poorly 
understood so it should be of considerable interest to define precisely how post-
translational control of these factors modulates angiogenesis. Our transcriptome analyses of 
the primary human endothelial cells also highlighted another potential layer of control of 
VEGFR output by the Tel:CtBP complex (see Supplementary Table 1). Both loss of Tel 
and loss of CtBP2 led to a sharp increase in the levels of the dual specificity phosphatases 
(DUSP) 1 and 5 (the expression of both is also strongly augmented in response to VEGF, 
MGR & DAB unpublished). DUSPs are negative regulators of RTK signaling
90
 and DUSP5 
appears to be an endothelial cell-restricted enzyme where it is found in complex with ERK 
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1/2 and negatively regulates the activity of VEGFR signaling through controlled 




To supply the demands of tissue growth and the need to rapidly repair wounds, the 
vertebrate vasculature is quiescent rather than irreversibly fixed and has retained the 
embryonic capacity for remodeling through angiogenesis. Together, our data suggests that 
by repressing factors that normally serve to constrain VEGFR signaling, the Tel:CtBP 
complex conditions endothelial cells for angiogenesis by controlling the balance between 
pro- and anti-angiogenic cues. In vivo, Dll4 signaling acts downstream of VEGFR signaling 
and inhibits excessive sprouting by delimiting the number of active tip cells
2,17
. Our model 
suggests that the Tel:CtBP complex permits efficient fine tuning of this response. VEGF 
stimulates rapid and transient disassembly of the Tel:CtBP barrier and concomitant 
depression of target genes, but without degradation of this complex. This allows readily 
controllable pulses of gene expression in response to VEGF that can be quickly translated 
into a cellular response.  
 
Operationally, and in addition to defined, genetically encoded algorithms, angiogenesis is 
also governed by stochastic element(s) which is perfectly illustrated by the variation 
between individuals in the patterns of the astronomical number of capillaries that innervate 
vertebrates. This can result from differential access to a variable, such as VEGF (because of 
altered expression of the receptors and/or availability of ligand) or changes in the metabolic 
status of the tissue. By analogy with terminal branching of Drosophila tracheae
37,38
, 
angiogenesis is controlled, in part, by the metabolic status of the tissue microenvironment
91
. 
In humans, this was tragically demonstrated by an epidemic of retinopathy of prematurity 
leading to 12,000 babies being blinded between 1941-1953. The cause was found to be 
artificially high levels of oxygen used in incubators that provoked aberrant angiogenesis in 
retinas of the newborn children
92
. In both mouse retina
2,17 
and Drosophila tracheae 
development
37,38
, cells compete for the position of pioneering tip cell and tissue metabolism 
impinges on the process, for example by hypoxia induced changes in VEGF expression that 
ultimately triggers dll4 expression or by direct regulation of the Dll4 promoter by 
hypoxia
93
. Since CtBP is a redox sensor, our coupling of Tel and CtBP raises the possibility 
that the activity of this complex might be directly sensitized to the metabolic status of the 
tissue and thus play a role in the metabolism-driven integration of the VEGF and Dll4 
signaling pathways. This possibility will be explored below and further discussed in the 
context of the metabolically-sensitive angiogenic switch of tumours. 
 
Tel:CtBP in Tumour Angiogenesis: sensing tumour metabolism? 
The necessary latent angiogenicity of the adult vasculature allows tumours to re-route local 
vessels that ensures an adequate supply of growth promoting factors. The exact 
mechanisms that govern this process are ill-understood, however, the tumour 
microenvironment appears to play an important role. The tumor microenvironment is 
moulded by multiple influences including metabolism. The metabolic "eye-view" of cancer 
was articulated some eighty years ago by Otto Warburg, and encapsulated by the Warburg 
effect
94
. This effect described the fact that many tumours primarily utilize glycolysis, rather 
than mitochondrial-driven respiration, as their primary source of energy. Although there is 
controversy regarding the precise role of metabolism in tumourigenesis, there is 
unequivocal evidence that tumor tissue has an altered metabolic status primarily due to the 
high metabolic rate of tumor cells
95
. This leads to islands of hypoxia and elevated levels of 
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lactic acid. Currently, how these conditions influence the transcriptional machinery to 
produce behavioral responses such as angiogenesis and metastasis is poorly understood. 
 
We found that Tel is expressed in the vasculature of a number of different tumours (see 
Supplementary Fig 2) and our finding that a Tel:CtBP complex is indispensible for normal 
endothelial sprouting provides a potential avenue through which the metabolic tumour 
microenvironment might trigger angiogenesis by influencing repression of gene expression 
by Tel in local endothelial cells. Repression of gene expression by Tel requires CtBP which 
requires NADH to effect its functional dimerization
64,65
. Thus, changes in metabolism that 
influence the NAD/NADH ratio can potentially impact on Tel function. In light of that, it is 
of interest that Tel protein levels are modulated by the metabolic status of the cell. 
Supplementary Fig 3a shows that endogenous Tel protein levels of human endothelial cells 
are enhanced when cultured in high concentrations of lactate that is characteristic of the 
tumor microenvironment (and that reportedly elevates the NADH levels)
95,96
. By contrast, 
2-deoxyglucose (2-DG) or pyruvate (data not shown), but not D-glucose or the non-
metabolizable isomer, L-glucose, served to lower Tel protein levels and the levels of 
endogenous CtBP1 and CtBP2, but not the levels of a variety of other proteins including 
p53, Mdm2, HAUSP and tubulin (see Supplementary Fig 3b). 2-DG is a widely studied 
glucose analogue that acts as a competitive
 
inhibitor of glucose metabolism
97
 and has been 
shown to influence the cellular redox status by lowering the ratio of lactate:pyruvate (and 
thereby presumably suppressing intracellular levels of NADH)
98
. Future work will be 
directed towards elucidating the precise in vivo role of the Tel:CtBP complex in 
pathological angiogenesis and developing therapeutic strategies aimed at inhibiting aberrant 




3D Fibrin assay for endothelial sprouting  
Endothelial sprouting assays were performed largely as described before
68
 with 
modifications. Briefly, endothelial cells were grown in EGM-2 medium (Lonza) for at least 
12 hrs. The next day the cells were trypsinized and mixed with Cytodex microcarrier beads 
(Sigma) in a ratio of 1x10
6
 cells per 2500 beads. Coating was performed for 4 hrs at 37
o
C in 
a FACS tube, which was shaken every 20 minutes. After 4 hrs the coated beads were 
transferred to a 6-well dish in a total volume of 2 ml of EGM-2. The next day the coated 
beads were washed with EGM-2 three times and dissolved in a solution of fibrinogen 
(Sigma; 2 mg/ml) and aprotinin (USB; 0,15 U/ml) in EGM-2. The solution was added to 
the appropriate amount of thrombin in a 24-well plate. The plate was left for 5 minutes at 
room temperature and subsequently for 15 minutes at 37
o
C. Clots were overlaid with 2 x 
10
4
 primary human fibroblasts (VH10) and incubated with 2 mls EGM-2 medium per well. 
The medium was replaced every 2 days and vessels formation was analyzed following 7-10 
days. Immunostaining of endothelial sprouting assays was performed as described
68
. To 
visualize cross sections the fibrin matrix was removed from the well and embedded in 
paraffin according to standard procedures. Cross sections were taken and stained by 





Human CtBP1- and CtBP2 plasmid (a kind gift of Prof . Chinnadurai) were fused in frame 
with a Flag epitope by PCR and cloned into PCS2. Tel-HA PCS2 has been described 
before
57
. Mutants were generated by site-directed mutagenesis.  
 
Production of lentiviruses and infection of primary endothelial cells  
For lentiviral constructs expressing Tel and Tel∆PXEIM the TelHA (∆PXEIM) PCS2 
constructs were used as templates to clone Tel(∆PXEIM) HA in the PLV.CMV.GFP 
vector. ShRNA lentiviral constructs for the knock down of tel (TRCN0000003852- 
TRCN0000003856), ctbp1 (TRCN0000013738-TRCN0000013742), 
ctbp2(TRCN0000013743- TRCN0000013747) and ve-cadherin (TRCN0000054089- 
TRCN0000054091)were obtained from the Sigma-Aldrich Mission shRNA library. 
Recombinant lentiviruses were produced by the transfection of 293T cells.Transduction of 
endothelial cells was performed at a multiplicity of infection of 1, with the addition of 
Polybrene to a final concentration of 8 g/ml. One day postinfection, 
the medium was replaced with fresh medium (supplemented with puromycin 
for cells infected with Mission shRNA viruses). 
 
Antibodies, growth factor and drugs 
Recombinant Human VEGF 165 (R & D Systems) and used at a concentration of 50 ng/ml 
unless potherwise indicated. Humanized Dll4 neutralizing antibody was kindly provided by 
Genentech. Other reagents were obtained from the following sources: Phallaoidin 
Rhodamin (Molecular Probes), PECAM-1 M20 (Santa Cruz), ETV6/Tel mouse monoclonal 
antibody (Abcam); Tel (H-214) X Rabbit antibody (Santa Cruz); Mouse anti CtBP1 Mab 
(BD Transduction Laboratories); Mouse anti CtBP2 Mab (BD Transduction Laboratories); 
Rabbit polyclonal CtBP (H-440) antibody (Santa Cruz); anti- Flag mouse M2 monoclonal 
(Sigma-Aldrich); anti-HA.11 mouse monoclonal (Covance); anti- Ha rabbit polyclonal 
(Abcam); anti- VE-Cadherin (F8) (Santa Cruz) ; Rabbit polyclonal Dll4 antibody (Abcam);  
 
Cell culture, biochemistry and molecular biology 
Primary HUVECs were harvested from umbilical cords by standard procedures
69
 in strict 
accordance with established guidelines.  HUVECs were cultured in EGM2 medium 
(Lonza). ECRF cells were cultured in M199 medium (invitrogen), supplemented with 20% 
Foetal Bovine Serum, Bovine Pituitary Extract (Gibco), Heparin (5000 IU; Leo Pharma) 
and antibiotics. Transfections, immunofluorescence, Western blotting, co-





Proximity Ligation Assay 
Proximity Ligation Assay was performed using Duolink in situ PLA kit (Olink Bioscience) 
according to the manufacturer’s protocol. Statistical analysis of fluorescent signal was 
performed by using Blobfinder (http://www.cb.uu.se/~amin/BlobFinder/).  
 
Microarray procedure and analysis 
Total RNA was isolated using Trizol (Invitrogen) and further purified using RNeasy 
Minikit (Qiagen). Total RNA was labeled using Illumina RNA Amplification kit (Ambion). 
Duplicate samples from two independent experiments were tested. Gene profiles were 
determined by hybridization to Sentrix HumanHT-12 Expression Beadchips. Expression 
levels of genes in Teli and CtBP2i HUVEC cell lines were compared with Mock infected 
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HUVECs. Enhanced (de-repressed) expression levels were determined for genes found to 
have B>1 in both Teli and CtBP2i compared to Mock. Microarray data has been posted on 
GEO database under number GSE19335. 
 
Analysis of mRNA expression  
RNA isolation, first strand cDNA synthesis and analysis of expression of transcripts by 
quantitative PCR were performed as previously described
57
.  
The following primer sets were used:  
 
Gapdh:5’-tgccatgtagaccccttgaag,3’-atggtacatgacaaggtgcgg  
Dll4 (human):  5’-ccctggcaatgtacttgtgat, 3’-tggtgggtgcagtagttgag 
Spry1(human): 5’-gtgtgggaagtgcaagtgtg, 3’- caggccaaacaggatggtag 
Spry2 (human): 5’-tgtgctgacaacccatgttc, 3’- catggctgaccatcgtgta 
Spry3 (human): 5’-tccacccaaaggctgatg, 3’-ctagggtgccctgcagatt 
Spry4 (human): 5’-ctgggtctgcaaccagga, 3’-cacgtgccatagttgaccag 
VE-Cadherin: 5’-caggggcgccaaaagagaga, 3’-ctggttttccttcagctggaagtggt 
Jagged1: 5’-cacagtggtgccaagtgc, 3’-gccccatctggtatcacact 
Jagged2: 5’-ctgctggtgttgctttgc, 3’-gctgctgtcaggcaggtc 
Dll1: 5’-gtggggagaaagtgtgcaa, 3’-tcacaaaatccatgctgctc 
Hey1 (Danio Rerio): 5’-gaaggagagtgcggatgaaa, 3’-cttctcgatgatccctctgc 
Hey2 (Danio Rerio): 5’-attgcagatgacagtggatca, 3’-gagaatgagcgtcgaaatatcc 
Spry4(Danio Rerio): 5’-tactggacagccgcgttc,3’-ctatggggtagacggtcagc 
 
ChIP  
Chips were performed with confluent 10 cm tissue culture dishes of HUVECs and ECRFs. 
Cells were cross-linked for 10 minutes with formaldehyde (final concentration = 1%). 
Glycine was added to a final concentration of 0,125 M and incubated for 5 minutes. Cells 
were washed 2x with PBS and subsequently lysed in Chip Lysis Buffer (1%SDS,10 mM 
EDTA, 50mM Tris-HCL pH 8.1) supplemented with protease inhibitors.  
Chromatin was sheared by sonication (Bioruptor UCD-200 ultrasound sonicator from 
Diagenode), resulting in DNA fragments between 500 and 1000 bp in size. After 
centrifugation, 10% of the sample was kept as Input. Chromatin was diluted 10x in dilution 
buffer (1%Triton X-100, 2mM EDTA pH 8.0, 150 mM NaCL, 20 mM Tris-HCl pH 8.1 
supplemented with protease inhibitors). For immunoprecipitation, 2 µg of test or control 
antibody was added to the diluted chromatin and incubated overnight at 4°C. The following 
day, blocked (10ug of sonicated herring sperm DNA) protein A-Sepharose beads were 
added for 2 hrs. Beads were extensively washed (0.1 % SDS, 0.1% NaDOC, 1% TritonX-
100, 0.15 M NaCl, 1mM EDTA, 0.5 mM EGTA, 20 mM HEPES) and eluted with elution 
buffer (1% SDS, 0.1 M NaH2CO3, 0,2 M NaCL) at 65
o
C overnight to reverse crosslinking. 
After proteinase K digestion (100 µg/IP) for 1hr at 55
o
C, associated DNA was purified by 
phenol chloroform extraction and ethanol precipitation. Quantitative PCR was used to 
determine recovery of specific DNA fragments.  
  
The following primersets were used:  
Dll4 promoter 1: 5’-gggccagaacctcattacc, 3’-gtggtcccggaggtagga  
Dll4 promoter 2: 5’-ttctttttacctgctttggaaca, 3’-agtccctgtaggctgtgcat 





All zebrafish strains were maintained in the Hubrecht Institute
 
under standard husbandry 
conditions. Animal experiments were
 
performed in accordance with the rules of the Animal 
Experimentation
 
Committee of the Royal Netherlands Academy of Arts and Sciences
 









MOs targeting the tel and ctbp2 start codons were:  
tel ATG
 
MO 1: 5'-CATGTCTCGTTGAAATTCAGGAAGT- 3',  
tel ATG
 
MO 2: 5'-TATTGTGTTTCCACTTTCCTCTCCT- 3',  
ctbp2
 
ATG MO, 5'-CCTTGTGTTTGTCAATCAAAGCCAT-3'.   
 
Imaging of vessels was carried out by using a Leica SP2 confocal microscope (Leica 
Microsystems)
 
using a 10x or 20x objective with digital zoom. Total RNA was isolated 
from zebrafish embryo’s (24h pf) by using Trizol according to manufacturers protocol and 
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Supplementary Figure 1. Testing MO efficacy. Sequences that are exactly complementary to either the 
Tel or CtBP2 MOs were incorporated into the 5’ end of a transcript encoding GFP. 50pg of capped, in vitro 
transcribed mRNA, prepared from each of these constructs, was injected into zebrafish embryos at the 1-2 cell 
stage together with the indicated MO. Expression of GFP was determined by fluorescence microscopy. The lower 
panel shows a Western of the indicated embryo lysates using an antibody directed against zTel and a control 














Supplementary Figure 2. Tel is expressed in Tumour Vasculature. Serial sections were 
made from different tumours and immunohistochemistry was performed using antibodies 
directed against either the endothelial marker CD31 or Tel. Nuclei were counterstained with 



















Supplementary Figure 3. Metabolite regulation of endogenous Tel. a. ECRF cells were 
cultured in the indicated concentrations of lactate and endogenous Tel protein levels were 
assessed by Western blotting. b. ECRF cells were cultured in the indicated concentrations 
of 2-deoxy-glucosse, D-glucosse or L-glucose. Endogenous protein levels of the indicated 












ACTA2 actin, alpha 2, smooth muscle, aorta 
ADIPOR1 adiponectin receptor 1 
AHNAK AHNAK nucleoprotein 
ALG13 asparagine-linked glycosylation 13 homolog (S. cerevisiae) 
ANAPC11 APC11 anaphase promoting complex subunit 11 
AP2B1 adaptor-related protein complex 2, beta 1 subunit 
APLP2 amyloid beta (A4) precursor-like protein 2 
ARPC3 actin related protein 2/3 complex, subunit 3, 21kDa 
ATOX1 ATX1 antioxidant protein 1 homolog (yeast) 
ATP1A1 ATPase, Na+/K+ transporting, alpha 1 polypeptide 
ATP2A2 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 
ATP5E ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit 
ATP5EP2 
ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit  
pseudogene 2 
ATP5H ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d 
ATP5I ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E 
ATP5J ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F6 
ATP5J2 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2 
ATP5L ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G 
ATP6V0A1 ATPase, H+ transporting, lysosomal V0 subunit a1 
ATP6V0C ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c 
ATP6V1F ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F 
ATPIF1 ATPase inhibitory factor 1 
AURKAIP1 aurora kinase A interacting protein 1 
AXUD1 AXIN1 up-regulated 1 
BAT2 HLA-B associated transcript 2 
BDNF brain-derived neurotrophic factor 
BOLA2 bolA homolog 2 (E. coli) 
BOLA3 bolA homolog 3 (E. coli) 
BSG basigin (Ok blood group) 
BTG2 BTG family, member 2 
BTG3 BTG family, member 3 
C10orf116 chromosome 10 open reading frame 116 
C11orf10 chromosome 11 open reading frame 10 
C11orf48 chromosome 11 open reading frame 48 
C11orf67 chromosome 11 open reading frame 67 
C12orf44 chromosome 12 open reading frame 44 
C12orf62 chromosome 12 open reading frame 62 
C14orf102 chromosome 14 open reading frame 102 
C14orf156 chromosome 14 open reading frame 156 
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C15orf61 chromosome 15 open reading frame 61 
C19orf56 chromosome 19 open reading frame 56 
C19orf6 chromosome 19 open reading frame 6 
C19orf70 chromosome 19 open reading frame 70 
C1orf122 chromosome 1 open reading frame 122 
C1orf50 chromosome 1 open reading frame 50 
C20orf3 chromosome 20 open reading frame 3 
C20orf52 chromosome 20 open reading frame 52 
C6orf125 chromosome 6 open reading frame 125 
C6orf66 chromosome 6 open reading frame 66 
C8orf59 chromosome 8 open reading frame 59 
C9orf167 chromosome 9 open reading frame 167 
C9orf86 chromosome 9 open reading frame 86 
CALR calreticulin 
CASP4 caspase 4, apoptosis-related cysteine peptidase 
CCRN4L CCR4 carbon catabolite repression 4-like (S. cerevisiae) 
CD79B CD79b molecule, immunoglobulin-associated beta 
CDK6 cyclin-dependent kinase 6 
CDKN2B cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 
CEACAM1 carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) 
CHIC2 cysteine-rich hydrophobic domain 2 
CKLF chemokine-like factor 
CLDN1 claudin 1 
CLPTM1 cleft lip and palate associated transmembrane protein 1 
CLPTM1L CLPTM1-like 
CMC1 COX assembly mitochondrial protein homolog (S. cerevisiae) 
CMTM3 CKLF-like MARVEL transmembrane domain containing 3 
COL13A1 collagen, type XIII, alpha 1 
COL8A1 collagen, type VIII, alpha 1 
COMMD6 COMM domain containing 6 
COX17 COX17 cytochrome c oxidase assembly homolog (S. cerevisiae) 
COX5B cytochrome c oxidase subunit Vb 
COX6A1 cytochrome c oxidase subunit VIa polypeptide 1 
COX6B1 cytochrome c oxidase subunit Vib polypeptide 1 (ubiquitous) 
COX6C cytochrome c oxidase subunit VIc 
COX7A1 cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) 
COX7A2 cytochrome c oxidase subunit VIIa polypeptide 2 (liver) 
COX7C cytochrome c oxidase subunit VIIc 
COX8A cytochrome c oxidase subunit 8A (ubiquitous) 
CRYBB2 crystallin, beta B2 
CSTB cystatin B (stefin B) 
CTSC cathepsin C 




CYTL1 cytokine-like 1 
DBI 
diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding  
protein) 
DCBLD2 discoidin, CUB and LCCL domain containing 2 
DEF8 differentially expressed in FDCP 8 homolog (mouse) 
DLC1 deleted in liver cancer 1 
DLL4 delta-like 4 (Drosophila) 
DPH3 DPH3, KTI11 homolog (S. cerevisiae) 
DPM3 dolichyl-phosphate mannosyltransferase polypeptide 3 
DRAP1 DR1-associated protein 1 (negative cofactor 2 alpha) 
DUSP1 dual specificity phosphatase 1 
DUSP14 dual specificity phosphatase 14 
DUSP5 dual specificity phosphatase 5 
DYNLL2 dynein, light chain, LC8-type 2 
DYNLRB1 dynein, light chain, roadblock-type 1 
EIF4E2 eukaryotic translation initiation factor 4E family member 2 
ENDOGL1 endonuclease G-like 1 
ENG endoglin (Osler-Rendu-Weber syndrome 1) 
EPHA2 EPH receptor A2 
ESRRA estrogen-related receptor alpha 
FABP5L7 fatty acid binding protein 5-like 7 
FAM134A family with sequence similarity 134, member A 
FAM148B family with sequence similarity 148, member B 
FAM24B family with sequence similarity 24, member B 
FAM36A family with sequence similarity 36, member A 
FAM46A family with sequence similarity 46, member A 
FAM70B family with sequence similarity 70, member B 
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 
FIG4 FIG4 homolog (S. cerevisiae) 
FKBP11 FK506 binding protein 11, 19 kDa 
FKBP2 FK506 binding protein 2, 13kDa 
FLJ77644 similar to transmembrane protein 106A 
GBA2 glucosidase, beta (bile acid) 2 
GDF15 growth differentiation factor 15 
GLRX2 glutaredoxin 2 
GNG5 guanine nucleotide binding protein (G protein), gamma 5 
GPC5 glypican 5 
GPR116 G protein-coupled receptor 116 
GRINA 
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1  
(glutamate binding) 
GRN granulin 
GTF2H5 general transcription factor IIH, polypeptide 5 
HBEGF heparin-binding EGF-like growth factor 
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HBXIP hepatitis B virus x interacting protein 
hCG_1789710 




HES4 hairy and enhancer of split 4 (Drosophila) 
HEY1 hairy/enhancer-of-split related with YRPW motif 1 
HIST1H4C histone cluster 1, H4c 
HIST1H4J histone cluster 1, H4j 
HNRNPUL2 heterogeneous nuclear ribonucleoprotein U-like 2 
HOXB1 homeobox B1 
HSD17B2 hydroxysteroid (17-beta) dehydrogenase 2 
HSPB11 heat shock protein family B (small), member 11 
HYAL2 hyaluronoglucosaminidase 2 
HYOU1 hypoxia up-regulated 1 
IFI27 interferon, alpha-inducible protein 27 
IFI6 interferon, alpha-inducible protein 6 
IL6 interleukin 6 (interferon, beta 2) 
IL8 interleukin 8 
ISG15 ISG15 ubiquitin-like modifier 
ITGB1 
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29  
includes MDF2, MSK12) 
JARID1A jumonji, AT rich interactive domain 1A 
JOSD2 Josephin domain containing 2 




KIF13B kinesin family member 13B 
KPNA6 karyopherin alpha 6 (importin alpha 7) 
KRT10 keratin 10 
KRT7 keratin 7 
KRTCAP2 keratinocyte associated protein 2 
LDLR low density lipoprotein receptor 
LEPREL1 leprecan-like 1 
LGMN legumain 
LOC100128731 similar to hCG23722 
LOC100130070 similar to metallopanstimulin 
LOC100130394 hypothetical LOC100130394 
LOC100131971 similar to 40S ribosomal protein S26 
LOC100132291 similar to hCG2027326 
LOC100132425 hypothetical protein LOC100132425 
LOC100133812 similar to metallopanstimulin 
LOC127295 similar to 60S ribosomal protein L36 
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LOC158376 hypothetical LOC158376 
LOC205251 LOC205251 
LOC26010 viral DNA polymerase-transactivated protein 6 
LOC347292 similar to ribosomal protein L36 
LOC387763 hypothetical LOC387763 
LOC388789 hypothetical LOC388789 
LOC401115 hypothetical LOC401115 
LOC440737 similar to ribosomal protein L35 
LOC541471 hypothetical LOC541471 
LOC552889 hypothetical LOC552889 
LOC642892 similar to mCG7602 
LOC643949 hypothetical LOC643949 
LOC646766 similar to ribosomal protein L35 
LOC728153 similar to FAM133B protein 
LOC729101 similar to mCG22010 
LOC729345 hypothetical LOC729345 
LOC729973 hypothetical LOC729973 
LOC732360 similar to G/T mismatch-specific thymine DNA glycosylase 
LPCAT2 lysophosphatidylcholine acyltransferase 2 
LRPAP1 low density lipoprotein receptor-related protein associated protein 1 
LSM10 LSM10, U7 small nuclear RNA associated 
LSMD1 LSM domain containing 1 
LYPLAL1 lysophospholipase-like 1 
LYRM2 LYR motif containing 2 
Magmas 
mitochondria-associated protein involved in granulocyte-macrophage  
colony-stimulating factor signal transduction 
MAN1B1 mannosidase, alpha, class 1B, member 1 
MAPKAP1 mitogen-activated protein kinase associated protein 1 
MARCH4 membrane-associated ring finger (C3HC4) 4 
MBOAT7 membrane bound O-acyltransferase domain containing 7 
MGAT4B 
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase,  
isozyme B 
MGST2 microsomal glutathione S-transferase 2 
MIDN midnolin 
MLF2 myeloid leukemia factor 2 
MRPL17 mitochondrial ribosomal protein L17 
MRPL27 mitochondrial ribosomal protein L27 
MRPL33 mitochondrial ribosomal protein L33 
MRPL34 mitochondrial ribosomal protein L34 
MRPL41 mitochondrial ribosomal protein L41 
MRPL53 mitochondrial ribosomal protein L53 
MRPS18C mitochondrial ribosomal protein S18C 
MSRB2 methionine sulfoxide reductase B2 
MT1A metallothionein 1A 
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MT1E metallothionein 1E 
MT1IP metallothionein 1I (pseudogene) 
MT1X metallothionein 1X 
MTF1 metal-regulatory transcription factor 1 
MX1 
myxovirus (influenza virus) resistance 1, interferon-inducible protein  
p78 (mouse) 
MYL9 myosin, light chain 9, regulatory 
MYO1C myosin IC 
N6AMT1 N-6 adenine-specific DNA methyltransferase 1 (putative) 
NCOR2 nuclear receptor co-repressor 2 
NDST1 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1 
NDUFA1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa 
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 
NDUFA12 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 
NDUFA13 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13 
NDUFA3 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa 
NDUFA7 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa 
NDUFB11 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa 
NDUFB2 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa 
NDUFB3 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa 
NDUFB6 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa 
NDUFB7 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa 
NDUFC1 NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa 
NECAP1 NECAP endocytosis associated 1 
NEDD8 neural precursor cell expressed, developmentally down-regulated 8 
NEK6 NIMA (never in mitosis gene a)-related kinase 6 
NENF neuron derived neurotrophic factor 
NME2 non-metastatic cells 2, protein (NM23B) expressed in 
NME4 non-metastatic cells 4, protein expressed in 
NOLA3 nucleolar protein family A, member 3 (H/ACA small nucleolar RNPs) 
NOMO1 NODAL modulator 1 
NOMO2 NODAL modulator 2 
NPEPPS aminopeptidase puromycin sensitive 
NT5DC2 5'-nucleotidase domain containing 2 
P4HA2 
procollagen-proline, 2-oxoglutarate 4-dioxygenase (proline 4-hydroxylase),  
alpha polypeptide II 
PCDH10 protocadherin 10 
PDLIM7 PDZ and LIM domain 7 (enigma) 
PEX11B peroxisomal biogenesis factor 11 beta 
PHPT1 phosphohistidine phosphatase 1 
PIGP phosphatidylinositol glycan anchor biosynthesis, class P 
PITPNM1 phosphatidylinositol transfer protein, membrane-associated 1 
PKM2 pyruvate kinase, muscle 
PLXNA2 plexin A2 
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PLXNB2 plexin B2 
PMP22 peripheral myelin protein 22 
POLD4 polymerase (DNA-directed), delta 4 
POLR2F polymerase (RNA) II (DNA directed) polypeptide F 
POP7 processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae) 
PRKCE protein kinase C, epsilon 
PTGS2 
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase  
and cyclooxygenase) 
PTS 6-pyruvoyltetrahydropterin synthase 
QSOX1 quiescin Q6 sulfhydryl oxidase 1 
RNASEK ribonuclease, RNase K 
RNF121 ring finger protein 121 
RNF181 ring finger protein 181 
RNF19A ring finger protein 19A 
RP11-
336K24.9 mitogen-activated protein-binding protein-interacting protein 
RPL23AP7 ribosomal protein L23a pseudogene 7 
RPL34 ribosomal protein L34 
RPL36 ribosomal protein L36 
RPL36A ribosomal protein L36a 
RPL36AL ribosomal protein L36a-like 
RPL39 ribosomal protein L39 
RPL41 ribosomal protein L41 
RPLP1 ribosomal protein, large, P1 
RPP21 ribonuclease P/MRP 21kDa subunit 
RPS15 ribosomal protein S15 
RPS19BP1 ribosomal protein S19 binding protein 1 
RPS21 ribosomal protein S21 
RPS26L 40S ribosomal protein S26-like 
RPS26L1 ribosomal protein S26-like 1 
RPS27L ribosomal protein S27-like 
RPS28 ribosomal protein S28 
RPS29 ribosomal protein S29 
RSPO3 R-spondin 3 homolog (Xenopus laevis) 
RTN2 reticulon 2 
S100A11 S100 calcium binding protein A11 
SAMSN1 SAM domain, SH3 domain and nuclear localization signals 1 
SBDSP Shwachman-Bodian-Diamond syndrome pseudogene 
SCAMP5 secretory carrier membrane protein 5 
SCFD1 sec1 family domain containing 1 
SDF2L1 stromal cell-derived factor 2-like 1 
SDSL serine dehydratase-like 
SELM selenoprotein M 




sema domain, immunoglobulin domain (Ig), short basic domain, secreted,  
(semaphorin) 3A 
SEMA4D 
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM)  
and short cytoplasmic domain, (semaphorin) 4D 
SERF2 small EDRK-rich factor 2 
SERTAD1 SERTA domain containing 1 
SFT2D1 SFT2 domain containing 1 
SGK1 serum/glucocorticoid regulated kinase 1 
SHFM1 split hand/foot malformation (ectrodactyly) type 1 
SIL1 SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae) 
SLC16A3 solute carrier family 16, member 3 (monocarboxylic acid transporter 4) 
SLC35A4 solute carrier family 35, member A4 
SLC35B2 solute carrier family 35, member B2 
SLC35D2 solute carrier family 35, member D2 
SNAR-A1 small ILF3/NF90-associated RNA A1 
SNRPB2 small nuclear ribonucleoprotein polypeptide B'' 
SNRPF small nuclear ribonucleoprotein polypeptide F 
SOD2 superoxide dismutase 2, mitochondrial 
SPRY4 sprouty homolog 4 (Drosophila) 
SRP19 signal recognition particle 19kDa 
SRRM2 serine/arginine repetitive matrix 2 
SSR4 signal sequence receptor, delta (translocon-associated protein delta) 
SSSCA1 Sjogren syndrome/scleroderma autoantigen 1 
STX1A syntaxin 1A (brain) 
STXBP2 syntaxin binding protein 2 
TAGLN transgelin 
TBCA tubulin folding cofactor A 
tcag7.1239 similar to Huntingtin interacting protein K 
TCEB1 transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C) 
TCEB2 transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) 
TCEB3 transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A) 
TFPT TCF3 (E2A) fusion partner (in childhood Leukemia) 
TGFBI transforming growth factor, beta-induced, 68kDa 
TIMM10 translocase of inner mitochondrial membrane 10 homolog (yeast) 
TM9SF1 transmembrane 9 superfamily member 1 
TMC6 transmembrane channel-like 6 
TMED5 transmembrane emp24 protein transport domain containing 5 
TMED9 transmembrane emp24 protein transport domain containing 9 
TMEM184B transmembrane protein 184B 
TMEM2 transmembrane protein 2 
TMEM217 transmembrane protein 217 
TMEM219 transmembrane protein 219 
TMEM93 transmembrane protein 93 
TNFRSF10B tumor necrosis factor receptor superfamily, member 10b 
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TNIP2 TNFAIP3 interacting protein 2 
TOMM7 translocase of outer mitochondrial membrane 7 homolog (yeast) 
TP53AP1 TP53 activated protein 1 
TPK1 thiamin pyrophosphokinase 1 
TPMT thiopurine S-methyltransferase 
TRAPPC4 trafficking protein particle complex 4 
TRIM8 tripartite motif-containing 8 
TRIOBP TRIO and F-actin binding protein 
TRMU tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase 
TXNDC11 thioredoxin domain containing 11 
TXNDC17 thioredoxin domain containing 17 
TYMP thymidine phosphorylase 
UBA1 ubiquitin-like modifier activating enzyme 1 
UBL5 ubiquitin-like 5 
UCRC ubiquinol-cytochrome c reductase complex (7.2 kD) 
UPF2 UPF2 regulator of nonsense transcripts homolog (yeast) 
UQCRB ubiquinol-cytochrome c reductase binding protein 
UQCRQ ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kDa 
VAMP8 vesicle-associated membrane protein 8 (endobrevin) 
WDR37 WD repeat domain 37 
YRDC yrdC domain containing (E. coli) 
ZDHHC12 zinc finger, DHHC-type containing 12 
ZNHIT1 zinc finger, HIT type 1 
 
Supplementary Table I. Genes commonly “de-repressed” in primary 
human endothelial cells following depletion of either Tel or CtBP2. 
 
Expression levels of genes in HUVECs lacking either Tel (Teli) or CtBP2 
(CtBP2i), were compared with control HUVECs.  Shown are those genes 
whose expression was significantly upregulated in both Teli and CtBP2i  






























The Ets family of transcription factors is one of the largest families of transcription factors 
and they have been intensively studied for their central roles during development and 
disease. Tel is unique in the family in being a dedicated repressor of gene expression. The 
majority of studies have focused on its role in cancer in which it has been found to be part 
of at least 40 different chromosomal translocations involving up to 22 different genes (1). 
The work in this thesis has aimed to elucidate the mode of action of this transcription 
factor. By taking an evolutionary approach, simultaneously studying Tel and its 
invertebrate counterpart, Yan, in a variety of species, we have uncovered fundamental 
aspects of Tel/Yan regulation. 
 
Posttranslational control of the pool of Tel/Yan proteins 
Despite its critical role in development coupled to its clinical importance there is a relative 
lack of mechanistic insight into its function. Over the years a model has emerged that 
envisions the transcriptional repressors Tel and Yan to exist in a dynamic equilibrium of 
monomers and DNA bound oligomers. Deciphering the mechanisms that guide transitions 
between these forms is of major importance for understanding Tel/Yan function. In 
Drosophila, the protein Mae (Modulator of the Activity of Ets) fulfills a crucial role to 
control the balance between actively repressing oligomeric Yan and the monomeric forms. 
Mae sensitizes Yan for MAPK-mediated down regulation and negatively regulates 
oligomeric repression via depolymerization. By binding to monomers it also prevents overt 
nuclear export by inhibiting access of the exportin Crm1 to Yan. A pool of Mae-bound Yan 
monomers are subsequently available to be either exported or to be incorporated into (DNA 
bound) oligomers (2-6). 
A mammalian Mae gene has not been identified; our studies on regulation of Tel by SUMO 
as described in chapter 2 indicate that functionally, SUMO controls the balance between 
repressive and nonrepressive forms of Tel. We found that SUMOylation on lysine 11 (K11) 
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serves to limit DNA binding of Tel and thus inhibits repression. In cells SUMOylation of 
oligomers is stable, but SUMOylation of monomers seems to sensitize them for 
degradation. Importantly, this was one of the first demonstrations that SUMOylation can 
sensitize proteins for proteasomal degradation. It appears Tel function can be readily 
adjusted according to a particular need as a pool of SUMOylated oligomers can be (rapidly) 
mobilized to the DNA and affect repression of target genes. A prerequisite here is that these 
SUMOylated Tel proteins are deSUMOylated, which implies a crucial role for SUMO-
proteases in the regulation of repression by Tel. Indeed we have found that the family of 
SENPs can induce deSUMOylation of Tel (Roukens & Baker unpublished data). 
Alternatively, the pool of SUMOylated Tel can be monomerized leading to its subsequent 
degradation.  
The fact that SUMOylated monomers are sensitized for degradation, coupled to the fact that 
Yan appears to be actively degraded as it is absent in differentiated cells, suggested that 
degradation could play an important role in regulating Tel/Yan function. Significantly, in 
yeast-2-hybrid screens we identified the F-box protein Fbl6 as a common interacting 
protein for both Tel and Yan. Since F-box proteins are the substrate recognition modules in 
the SCF (for Skp-Cullin-F-box) complexes, which serve as ubiquitin E3 ligases, this 
implied that Tel and Yan are subject to ubiquitin mediated degradation. Indeed the findings 
in Chapter 3 establish that Fbl6 mediated ubiquitination is an important evolutionarily 
conserved mechanism of downregulation of Tel and Yan.  
The fact that Tel is degraded exposed a novel angle into its downregulation, since Tel is a 
relatively stable protein. We found that Tel is ubiquitinated in cells and that this process 
was stimulated by Fbl6. Consistent with our findings in chapter 2 we found that monomeric 
forms of Tel were particularly labile, and were strongly ubiquitinated. This supported the 
idea that SUMOylation sensitizes monomeric Tel for degradation via the 
ubiquitin/proteasome system. These findings were among the first to highlight crosstalk 
between SUMOylation and ubiquitination in the regulation of a target protein. Indeed the 
idea of coregulation by SUMOylation and ubiquitination has garnered major interest since 
and for many proteins it has been subsequently found that SUMOylation can stimulate 
proteasomal degradation (7). In the case of Tel, this interplay appears to be specific to 
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monomeric forms of Tel. It raises the intriguing possibility that SUMOylated monomers are 
more accessible for binding by Fbl6, leading to their subsequent degradation. 
Interestingly we have also found that other Ets factors, such as Fli-1, Erg and Tel2 are 
SUMOylated and that the SUMOylated fraction is strongly stabilized upon proteasomal 
inhibition (Roukens and Baker, unpublished data). As we have also found that Tel2 is 
ubiquitinated by Fbl6 it will be interesting to study whether cooperation between 
SUMOylation and F-box mediated degradation is a more general strategy to regulate the 
stability of Ets factors. 
Proteasomal degradation was not restricted to Tel, but was also shown to be relevant for 
Yan regulation.  Previous studies have implicated that Yan is degraded, but this had not 
been formally demonstrated (8).We have shown that Fbl6 mediated ubiquitination serves to 
downregulate Yan protein in cells and in vivo. However, it appears that Yan is 
downregulated by multiple complementary mechanisms. This can be inferred from the 
following: proteasomal inhibition was unable to fully rescue degradation induced by Mae 
and Ras, suggesting a concommittant proteasome independent mechanism of 
downregulation. This may reflect the role of nuclear export which subsequently leads to 
inactivation of Yan. Since ubiquitination of Yan via Fbl6 mainly occurs in the nucleus it is 
likely that these form two separated pathways of downregulation that may both be 
stimulated by Ras/MAPK/Mae activity. It is also possible that Fbl6 finetunes Yan activity 
in the nucleus in absence of phosphorylation, whereas activation of MAPK phosphorylation 
then stimulates a strong degradative response that downregulates Yan via both mechanisms.  
 
CtBP is a crucial component of the Tel complex 
The posttranslational modifications by SUMO and ubiquitin control the pool of Tel/Yan 
that is available for repression. As mentioned in Chapter 1 repression might be achieved via 
multiple mechanisms. This involves the formation of homotypic oligomers that block 
access of transcriptional activators. However, another crucial aspect is the recruitment of 
corepressors which are instrumental in mediating repression. A greater understanding of the 
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interplay between Tel and its corepressors is pivotal for determining how Tel mediates 
repression of its target genes.     
Our work presented in Chapter 4 has added a new dimension for understanding how 
repression by Tel is regulated specifically through recruitment of the generic corepressor C-
terminal Binding Protein (CtBP). Our evolutionary approach again proved to be invaluable 
as we identified a CtBP binding motif in the amino acid sequence of Yan. A highly similar 
sequence was conserved in all Tel proteins in vertebrates and was indeed found to be 
indispensable for binding of CtBP by Tel. In the ensuing studies we found that CtBP is 
integral to Tel function and appears to regulate stable nuclear complex formation. CtBP 
stabilizes Tel protein levels and the deletion of the CtBP binding motif in Tel induces 
mislocalization into the cytoplasm. It stably associates with oligomers but not with 
monomers, which may indicate that CtBP reinforces the formation of Tel oligomers. The 
fact that CtBP can dimerize may provide a mechanism that can further regulate the nature 
and extent of the oligomer; perhaps a CtBP dimer can connect two ends of a oligomeric Tel 
complex, and thus effectively induce the formation of a closed oligomer. This may further 
limit depolymerization or degradation as CtBP forms a barrier for access of SUMO, Fbl6 or 
any other factor leading to a loss of DNA-bound Tel. Similarly in this context CtBP could 
act antagonistically to Mae in Drosophila. Structural studies should be employed to 
determine exactly how the Tel:CtBP complex is ordered and this may shed light on the 
mechanism of how CtBP regulates Tel stability.  
 A major implication of the link with CtBP is that Tel function is sensitized to the metabolic 
status of the cell, since CtBP has been postulated to be a redox sensor (9,10). Indeed we 
find that metabolic alterations can strongly affect Tel protein stability and this is of 
particular interest in processes such as angiogenesis or tumor progression where 
metabolical conditions may be highly altered. This will be further elaborated upon below. 
Our results have thus placed CtBP as a corepressor of major importance in the regulation of 
repression by Tel. There are two different vertebrate ctbp genes encoding the CtBP1 and 
CtBP2 proteins, which exhibit a high degree of sequence homology. We have shown that 
CtBP2 is preferentially associated with Tel and that CtBP1 can even inhibit binding of 
CtBP2 to Tel. This is a first demonstration of differential binding of a target by CtBP1 and 
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CtBP2. This finding further illustrates that corepressors may regulate the recruitment of 
other cofactors by transcription factors. Numerous reports have previously highlighted the 
importance of corepressor recruitment by Tel (11-16), but it is currently unclear what the 
interplay between these various corepressors is. It will be of great interest to determine 
whether other corepressors, such as mSIN3A, NCOR and SMRT will similarly exhibit 
hierarchical recruitment and whether they affect or are affected by CtBP.  
 
Regulation of angiogenesis by Tel 
Since Drosophila Yan is an important mediator of tracheal branching (see Chapter 1), a 
process which shares many molecular mechanisms with angiogenesis, and loss of Tel is 
associated with a yolk sac angiogenesis defect (17), we hypothesized that Tel would also be 
a central regulator of angiogenesis. Interestingly, the CtBP2 knockout mice exhibit a 
similar lack of vitelline vessels. For many years the underlying mechanism of the 
angiogenesis defect in Tel knockout mice had remained elusive, but our work in Chapter 4 
shows that Tel acts directly in endothelial cells, that it controls endothelial cell sprouting 
and provides the mechanism by which this is achieved. Moreover, we show that its activity 
during endothelial sprouting is dependent on CtBP. Importantly, we found that Tel is the 
crucial transcriptional link between pro-angiogenic Vascular Endothelial Growth Factor 
(VEGF) signaling and the intercellular anti-angiogenic Delta-like 4 (Dll4)/Notch pathway. 
In endothelial cells a pulse of VEGF leads to a transitory loss of the Tel:CtBP complex at 
the DNA, which allows target genes such as dll4 to be derepressed. The increase in dll4 
expression guides a regulated formation of a sprout by determining tip/stalk cell fate and 
prevents excessive sprouting. Besides the prominent effect on dll4 expression Tel similarly 
regulates the repression of many other angiogenic genes; by constraining the expression of 
these downstream targets Tel controls the stringency of the transcriptional response to 
VEGF, ensuring that genes required for angiogenesis are only activated once VEGF 
signaling is activated beyond a certain threshold. The transient nature of the dissociation of 
the Tel complex further ensures that these genes are activated for a defined period of time, 
which provides a refined control over the growth of the forming blood vessel. By these 
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mechanisms Tel is instrumental in the regulation of the position, length and integrity of the 
new sprout that forms.  
This process by which Tel mediates angiogenesis is reminiscent of the way that Yan 
regulates tracheal development which requires inhibition of Yan via receptor tyrosine 
kinase (RTK) FGF signaling (18). But the regulation of Tel by RTK signaling appears to be 
fundamentally different to the reported effect of RTK signaling on Yan. It was suggested 
that RTK signaling triggers Yan down regulation; however RTK signaling in endothelial 
cells does not alter Tel protein levels but does alter the timing of its action. Since the 
transitory dissociation of the Tel:CtBP complex occurs rapidly (within minutes) after 
activation of VEGF signaling it is likely that the loss of the complex is driven by 
posttranslational modifications of Tel (or CtBP). VEGF signaling activates a variety of 
different kinases which may phosphorylate Tel, leading to a loss Tel DNA-binding. In 
contrast with Yan, however, Tel does not get (permanently) downregulated but is, in time, 
reconfigured into a repressive complex. This temporary dissociation from the DNA may 
well be further regulated by SUMOylation of Tel, which presumably has evolved for such a 
purpose, i.e. to create a pool of Tel that can be readily mobilized for repression.  
Thus, by temporarily inactivating Tel, VEGF affects transitory phases of derepression of 
angiogenic genes. These genes are certainly subject to multiple layers of regulation and 
their upregulation following VEGF signaling will likely be enhanced by transcriptional 
activators. It will be of great interest to identify activators of these genes that will further 
guide the phase of transcriptional activation. Some transcriptional activators will likely bind 
to similar promoter elements as Tel, and they will therefore compete for these common 
binding sites. This concept of competition is known for a variety of contexts in Drosophila, 
where Yan and Pointed bind to common Ets Binding Sites (19-21). In vertebrates such a 
clear relationship between Tel and an activator has not been identified. A similar 
competition may exist between Tel and other Ets transcriptional activators such as Ets 1 
and/or Fli1, both of which have been suggested to be required for angiogenesis (22,23).  
The relationship with Fli-1 will be of particular interest since Tel and Fli-1 not only share a 
role in angiogenesis, but are also both required during hematopoiesis. A number of studies 
have shown that these Ets factors both affect promoters of megakaryocyte specific genes, 
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but in an opposing manner, but these studies have lacked mechanistic insight. An intriguing 
aspect of this relationship is that Fli-1 has been reported to interact with Tel (24, 25). 
Perhaps the binding serves to keep Fli-1 in an inactive form, but readily available to 
activate the genes once the barrier of Tel repression is relieved by VEGF signaling. 
Alternatively, Fli-1 may be a context dependent transcription factor, acting as a 
(co)repressor when bound to Tel. Our work on the role of Tel in angiogenesis provides an 
excellent base to explore the putative functional relationship between Tel and Fli-1 in this 
process. 
 
Other biological roles of Tel 
The work in chapter 4 has provided strong insight into how Tel regulates angiogenesis. 
These findings may provide indications of how Tel acts in other biological processes as 
well. For example, the interplay between signaling pathways and Tel function has not been 
well characterized. The work showing that VEGF signaling regulates Tel function is the 
first demonstration of how Tel is regulated by RTK signaling during development. By 
contrast, it is well established that signaling via RTKs can downregulate Yan and how this 
might drive development in Drosophila is reasonably well understood. Only a limited 
number of highly conserved signaling pathways have evolved that are used repeatedly to 
pattern all, or at least most, tissues. RTK signaling is one such pathway that regulates cell 
fate. In Drosophila, inhibiting Yan function appears to be an essential function of this 
pathway (8, 26-29). Since we have found that Tel functions to regulate the response of 
endothelial cells to VEGF signaling and many molecular regulations are highly conserved 
between Tel and Yan, it is not inconceivable that Tel, like Yan, is a target of multiple RTK 
signaling pathways. Moreover the fact that Tel is widely expressed also implies that it 
might regulate fundamental cell signaling events. For example, it is well established that 
Tel is essential for postnatal bone marrow hematopoiesis, by regulating survival of 
hematopoietic stem cells (HSC), but the mechanism by which Tel regulates HSC survival is 
unknown (30). Perhaps Tel will play a similar role in HSC survival by transcriptionally 
linking RTK signaling to the Notch pathway, which may serve to keep HSCs primed for 
differentiation.   
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Another area that has remained underexplored for Tel is its role in the development of the 
nervous system. In mice Tel exhibits particularly high expression in the cranial nerve 
ganglia, the dorsal root ganglia and in the ventral region of the caudal neural tube (17). 
Moreover the role of Yan in photoreceptor development is well characterized and loss of 
Yan flies exhibit strong defects in the medial parts of the brain (8,26,28). One interesting 
possibility is that Tel is involved in axonal guidance. Like the endothelial cell response to 
VEGF, neuronal growth is guided by a variety of guidance molecules. The migration of the 
growing axon further mirrors endothelial sprouting as it is led by a highly motile ‘tip cell’ 
called the growth cone (31). Our work has demonstrated that Tel is crucial for interpreting 
the VEGF signals in endothelial cells. By upregulating Dll4 expression Tel also inhibits tip 
cell characteristics in the stalk cells. In tumor cells, Tel was also found to inhibit focal 
adhesions (32), which may suggest that one of the features of Tel is that it inhibits enhanced 
motility of leading edge cells. Perhaps Tel could similarly affect axonal growth cones, by 
ensuring a regulated response to guidance cues and inhibiting the growth cone phenotype in 
trailing cells.   
Finally, the role of Tel in cancer progression is of major importance. Until now Tel has 
mostly been recognized as a causative agent in leukemias involving translocations of Tel. 
On the other hand studies in recent years have highlighted a possible role for Tel as a tumor 
suppressor (1). The data that we present indicates a more complicated involvement of Tel in 
tumor growth since Tel is indispensable for endothelial sprouting. Crucially, this exposes a 
novel mechanism by which Tel can actually promote tumor growth, via regulation of tumor 
angiogenesis. Angiogenesis is a key process in tumor progression, as tumors require active 
delivery of nutrients and oxygen via blood vessels to grow beyond a few millimeters in 
size. For this tumors signal to the local vasculature to stimulate aberrant angiogenesis. It is 
becoming increasingly clear that the tumor microenvironment plays an important 
instructive role in tumor angiogenesis. The tumor microenvironment is chemically and 
metabolically heterogeneous; local areas of hypoxia and high concentrations of lactate are 
generated because of the (initial) lack of vasculature and the high metabolic rate of tumors. 
These properties appear to stimulate tumor angiogenesis but how the tumor 
microenvironment affects transcriptional effectors of angiogenesis is ill-defined. Our 
finding that Tel function is linked to the redox sensor CtBP may prove to be central to 
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define this mechanism, as it indicates that Tel activity is critically dependent upon 
metabolic status. Indeed we find that hypoxia and lactate, which are abundant in the tumor 
microenvironment, can strongly stabilize Tel protein levels, which may subsequently 
stimulate tumor angiogenesis. It will be of great importance to test this hypothesis in vivo, 
and determine whether Tel is upregulated in tumor-associated endothelial cells. 
Importantly, this places Tel as a potential new target to inhibit tumor growth 
therapeutically.    
 
Concluding remarks 
The work in this thesis has provided substantial insight into how Tel and Yan are regulated. 
SUMOylation of Tel on K11 and Fbl6-mediated ubiquitination control the balance between 
repressive and nonrepressive forms. These processes underscore the importance of 
posttranslational regulation of these transcription factors. In contrast, recruitment of the 
generic corepressor CtBP is required for stable Tel complex formation. Crucially our work 
unraveled mechanistically how Tel mediates angiogenesis. Arguably the greatest 
conceptual insights in this thesis have resulted from taking an evolutionary approach, which 
has directed this work towards many important conserved aspects of Tel/Yan function. 
Future studies will greatly benefit from an additional model system that we have recently 
employed (Chapter 4), namely the zebrafish, Danio Rerio. The zebrafish is genetically 
tractable, it is a vertebrate with a very short development time, and using reverse genetics 
allows the study of Tel during early development. We have already shown that Tel is 
crucial for vascular development in zebrafish and this powerful model system should yield 
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In this thesis the regulation of the Ets transcription factor Tel is investigated. Tel and its 
Drosophila orthologue Yan belong to the Ets family of transcription factors and they are 
essential genes for development. They are unique transcriptional repressors, characterized 
by a highly conserved Ets DNA binding domain and a SAM domain which is involved in 
protein-protein interactions and in (self)oligomerization. A model has emerged that 
suggests that Tel and Yan repress target genes by binding to DNA as oligomers, thus 
preventing access of transcriptional activators. Their activity is reportedly regulated by 
posttranslational mechanisms, such as phosphorylation and SUMOylation. Furthermore, 
Tel function is supported by the activity of a variety of corepressors. Biologically, the role 
of Yan in development is well described; Yan is a general inhibitor of differentiation in 
Drosophila and is downregulated by MAPK signaling to allow differentiation. In mice, Tel 
is required normal adult hematopoiesis and loss of Tel leads to defects in yolk sac 
abnormalities. Clinically, Tel is very important and is associated with a large number of 
leukemogenic translocations, but its mechanisms of action in these biological processes are 
not well defined.  
Chapter 2 reports a previously unreported mechanism by which sumoylation regulates 
transcription. By mass spectrometry we identified the highly conserved lysine 11 (K11), as 
the major site of sumoylation in Tel. Sumoylation on K11 is stimulated by the SUMO E3 
ligase, PIAS3, which binds via the Ets domain. Sumoylation on oligomeric Tel is relatively 
stable, whereas Sumoylation on monomers is transitory and appears to sensitize monomeric 
Tel for degradation. Sumoylation of Tel is further regulated posttranscriptionally, since 
initiation from an internal methionine M43 yields an isoform of Tel (TelM43) that cannot 
be sumoylated. SUMO was found to negatively regulate repression by Tel since both a 
TelK11R mutant and the naturally occurring TelM43 were stronger repressors of mmp3 
expression than Tel. Correspondingly we found that SUMOylated Tel is inhibited in its 
DNA binding, which places SUMO as a major negative regulator of Tel.   
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Although some of the mechanistic details of the Tel/Yan function have been previously 
investigated, some crucial insights such as control of their protein levels have remained 
elusive.  In Chapter 3 the regulation of Tel and Yan by Fbl6-mediated ubiquitination is 
described.  In yeast 2 hybrid screens using Tel and Yan as baits to identify common 
regulators the F-box protein Fbl6 was found. Binding of both Tel and Yan to Fbl6 was 
confirmed both in vitro and in cells, and was found to require the SAM domain. Moreover, 
both Tel and Yan are ubiquitinated, which was stimulated by Fbl6 and led to their 
proteasomal degradation. Consistent with our results presented in Chapter 2, monomeric 
forms of Tel were found to be particularly sensitive to ubiquitination. Finally, Yan protein 
levels were strongly stabilized in loss of Fbl6 flies, establishing that Fbl6 is an important 
regulator of Yan stability in vivo. 
Chapter 4 uncovers a role for Tel in angiogenesis and delineates the mechanism by which it 
executes this function. Tel was found to be essential for sprouting of primary human 
endothelial cells. To modulate this process, Tel recruits the generic corepressor CtBP to 
effect repression of key target genes that serve to constrain this process, such as dll4, ve-
cadherin and sprouty. Importantly, in response to VEGF signaling Tel is transiently 
inactivated, resulting in dissociation from its corepressor CtBP and a concomitant loss of 
DNA binding. This dissociation allows a pulse of dll4 expression, which subsequently 
serves to inhibit the response to VEGF in neighbouring cells via intercellular Notch 
signaling. Thus, we identify Tel as the previously unknown transcriptional mediator linking 
the major pro angiogenic signals of VEGF to the prime inhibitory pathway of Dll4 
mediated Notch signaling.   
By adopting an evolutionary perspective, the work presented in this thesis has provided 
unique insight into how the transcription factor Tel is regulated. Moreover our work 
provides a first clear mechanism by which Tel regulates a biological process, namely 
angiogenesis. The unveiling of Tel as a key regulator of angiogenesis highlights Tel and its 
associated networks as previously overlooked targets for the development of therapeutic 










Alle organismen bestaan uit miljoenen cellen die allen een gespecialiseerde functie hebben. 
In elke cel bevinden zich vele moleculen die samenwerken om tot een goede functie van de 
cel te komen. De complexiteit van deze communicatie tussen de moleculen is zeer groot en 
elk molecuul zal door een groot aantal andere moleculen beïnvloed worden. In dit 
proefschrift hebben wij onderzocht hoe het eiwit Tel (Translocation E26 Specific) 
gereguleerd wordt. Tel is een belangrijk eiwit, dat niet alleen in mensen voorkomt, maar 
ook in bijna alle andere gewervelde dieren en zelfs in insecten zoals fruitvlieg (waar het 
Yan genoemd wordt). Tel is een transcriptiefactor, een eiwit dat de transcriptie van genen 
(onderdelen van het DNA die voor eiwitten coderen) activeert of remt. Twee stukken van 
het Tel eiwit (domeinen) zijn belangrijk voor deze functie, namelijk het SAM domein en 
het Ets domein. Het SAM domein zorgt ervoor dat Tel moleculen aan elkaar kunnen binden 
en hierdoor kan Tel een oligomere structuur vormen. Deze Tel oligomeer bindt aan het 
DNA via het Ets domein en remt zo de transcriptie van dit DNA. Zodoende zal het eiwit 
waar dit DNA voor codeert niet geproduceerd worden.  
Tel speelt een belangrijke rol bij embryonale ontwikkeling, wat blijkt uit het feit dat 
genetisch gemanipuleerde muizen die geen Tel eiwit hebben (zogenaamde Tel knockout 
muizen) niet levensvatbaar zijn. Tevens worden er vaak Tel eiwitten met een defect 
gevonden in patiënten met leukemie. Dit maakt dat het bestuderen van Tel belangrijk is om 
te begrijpen hoe het een rol speelt bij de normale ontwikkeling van organismen (en 
specifiek bij de mens) en bij de ontwikkeling van kanker. Desondanks is er nog niet heel 
veel bekend over hoe de functie van Tel gereguleerd wordt.  
In hoofdstuk 2 wordt beschreven hoe Tel beïnvloed wordt door het eiwit SUMO. SUMO is 
een klein eiwit wat aan andere eiwitten bindt in een proces dat sumoylatie genoemd wordt. 
Sumoylatie beïnvloedt de activiteit van het andere eiwit.  Wij hebben gevonden dat SUMO 
aan een specifiek aminozuur (lysine nummer 11) in Tel bindt. Deze binding wordt 
gestimuleerd door PIAS3 wat aan het Ets domein van Tel bindt. SUMOylatie van Tel is 
relatief stabiel als Tel een oligomere structuur vormt, maar bij monomeren van Tel (die dus 
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niet aan andere Tel moleculen gebonden zijn) leidt sumoylatie tot degradatie van Tel. 
Binding van SUMO aan Tel zorgt ervoor dat de binding van Tel aan DNA geremd wordt, 
waardoor repressie van genen door Tel afneemt. In de cel bestaat ook een vorm van Tel die 
niet gesumoyleerd kan worden omdat deze vorm de lysine 11 niet heeft; zoals we 
verwachten is deze vorm van Tel (Tel M43) meer repressief dan de normale vorm van Tel. 
SUMO is dus een belangrijke negatieve regulator van Tel. 
In hoofdstuk 3 wordt beschreven hoe de stabiliteit van Tel geregeld wordt. We vonden dat 
zowel Tel als Yan een interactie aangaan met het F-box eiwit Fbl6. F-box-eiwitten staan 
bekend als onderdelen van een complex dat ervoor zorgt dat eiwitten door ubiquitine 
gebonden worden. Ubiquitine is een eiwit dat als lange ketens aan target eiwitten bindt. 
Deze ketens vormen een signaal dat het eiwit gedegradeerd moet worden. We vonden dat 
zowel aan Tel als aan Yan ubiquitine ketens gekoppeld worden en dat dit proces 
gestimuleerd wordt door Fbl6. Deze koppeling leidt tot degradatie van Tel (en Yan). 
Bovendien werden monomere vormen van Tel sterker gedegradeerd dan de oligomere 
vormen, wat in overeenstemming was met de bevindingen in hoofdstuk 2. Ten slotte zagen 
we dat fruitvliegen die geen Fbl6 hebben verhoogde hoeveelheden van Yan hebben, wat 
erop duidt dat Fbl6 dus ook in vivo (in een levend organisme) de stabiliteit van Yan 
beïnvloedt. 
Hoofdstuk 4 beschrijft dat Tel een belangrijke rol heeft in angiogenese. Angiogenese is het 
proces waarbij nieuwe bloedvaten gevormd worden uit reeds bestaande bloedvaten. Hierbij 
spelen endotheelcellen een belangrijke rol, die de binnenste laag van de bloedvaten vormen. 
Bij angiogenese ontspruiten zij van de bestaande bloedvaten en groeien tot een groot 
complex vaatstelsel. We ontdekten dat Tel onmisbaar is voor dit proces. Tel rekruteert een 
hulprepressor CtBP die samen met Tel aan het DNA bindt en zo de transcriptie van een 
groep genen remt die cruciaal zijn voor angiogenese. Angiogenese wordt gestimuleerd door 
VEGF, een groeifactor die zich buiten de cellen bevindt. Als endotheelcellen in contact 
komen met VEGF leidt dit tot een tijdelijke inactivatie van het Tel:CtBP complex. Deze 
tijdelijke inactivatie zorgt dat de angiogene genen die door Tel geremd werden nu 
geactiveerd worden en dit leidt tot een gecontroleerde groei van het nieuwe bloedvat. Een 
van deze genen is Dll4, een signaalmolecuul, dat ervoor zorgt dat niet te veel nieuwe 
bloedvaten zich ontwikkelen. Dit is nodig omdat de bloedvaten anders alle kanten op 
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zouden groeien. Ons werk heeft laten zien dat Tel een cruciale regulator is van 
angiogenese. 
 
Het werk in dit proefschrift heeft belangrijke nieuwe inzichten in de regulatie van Tel 
verschaft. Bovendien heeft het als eerste aangetoond hoe Tel een biologisch proces, 
namelijk angiogenese, reguleert. Dit is ook belangrijk aangezien angiogenese ook 
belangrijk is voor tumorgroei. Aldus vormt Tel een mogelijk therapeutisch doelwit voor het 
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Appendix: List of abbreviations 
Crm1  = Chromosome Region Maintenance 1 (Exportin 1) 
DJNK  = Drosophila Jun N-terminal Kinase  
ECM  = Extracellular Matrix 
EGF  = Epidermal Growth Factor  
Elk-1  = Ets Like transcription factor 1 
ERK  = Extracellular signal Regulated Kinase 
ES cells  = Embryonic Stem cells 
Ets   = E26 translocation specific 
FGF  = Fibroblast Growth Factor  
Fli-1  = Friend Leukemia virus integration 1 
GABP  = Growth Associated Binding Protein  
HAT  = Histone Acetyl Transferase 
HDAC  = histone deacetylase 
HSC  = Haematopoietic Stem cells 
L(3)MBT = lethal(3)malignant brain tumor 
Mae   = Modulator of the Activity of Ets 
MAPK  = Mitogen Activated Protein Kinase  
MMP3   = Matrix Metallo Proteinase 3 
mSIN3A = mammalian orthologue of Sin3 A 
NCOR  = Nuclear Corepressor 
PDGFRβ  = platelet derived growth factor receptor β 
PU.1  = Purine Rich box 1 
RTK  = Receptor Tyrosine Kinase  
SAM  = Sterile Alpha Motif 
SAP-1  = SRF Accessory Protein 1 
SMRT  = silencing mediator of retinoid and thyroid hormone receptors 
Su(H)  = Suppressor of Hairless  
SUMO   = Small Ubiquitin-like Modifier 
Tel   = Translocation Ets Leukemia 
TIP 60  = 60 kDa trans-acting regulatory protein of HIV type 1 (Tat)-interacting 
protein 
UBC9  = Ubiquitin Conjugating Enzyme 9 
VEGF  = Vascular Endothelial Growth Factor 
v-Src  = Viral Sarcoma 
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